JUVENILE DIABETES A M EDICAL D ICTIONARY , B IBLIOGRAPHY , AND A NNOTATED R ESEARCH G UIDE TO I NTERNET R E FERENCES
J AMES N. P ARKER , M.D. AND P HILIP M. P ARKER , P H .D., E DITORS
ii
ICON Health Publications ICON Group International, Inc. 4370 La Jolla Village Drive, 4th Floor San Diego, CA 92122 USA Copyright ©2004 by ICON Group International, Inc. Copyright ©2004 by ICON Group International, Inc. All rights reserved. This book is protected by copyright. No part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission from the publisher. Printed in the United States of America. Last digit indicates print number: 10 9 8 7 6 4 5 3 2 1
Publisher, Health Care: Philip Parker, Ph.D. Editor(s): James Parker, M.D., Philip Parker, Ph.D. Publisher's note: The ideas, procedures, and suggestions contained in this book are not intended for the diagnosis or treatment of a health problem. As new medical or scientific information becomes available from academic and clinical research, recommended treatments and drug therapies may undergo changes. The authors, editors, and publisher have attempted to make the information in this book up to date and accurate in accord with accepted standards at the time of publication. The authors, editors, and publisher are not responsible for errors or omissions or for consequences from application of the book, and make no warranty, expressed or implied, in regard to the contents of this book. Any practice described in this book should be applied by the reader in accordance with professional standards of care used in regard to the unique circumstances that may apply in each situation. The reader is advised to always check product information (package inserts) for changes and new information regarding dosage and contraindications before prescribing any drug or pharmacological product. Caution is especially urged when using new or infrequently ordered drugs, herbal remedies, vitamins and supplements, alternative therapies, complementary therapies and medicines, and integrative medical treatments. Cataloging-in-Publication Data Parker, James N., 1961Parker, Philip M., 1960Juvenile Diabetes: A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References / James N. Parker and Philip M. Parker, editors p. cm. Includes bibliographical references, glossary, and index. ISBN: 0-597-83948-4 1. Juvenile Diabetes-Popular works. I. Title.
iii
Disclaimer This publication is not intended to be used for the diagnosis or treatment of a health problem. It is sold with the understanding that the publisher, editors, and authors are not engaging in the rendering of medical, psychological, financial, legal, or other professional services. References to any entity, product, service, or source of information that may be contained in this publication should not be considered an endorsement, either direct or implied, by the publisher, editors, or authors. ICON Group International, Inc., the editors, and the authors are not responsible for the content of any Web pages or publications referenced in this publication.
Copyright Notice If a physician wishes to copy limited passages from this book for patient use, this right is automatically granted without written permission from ICON Group International, Inc. (ICON Group). However, all of ICON Group publications have copyrights. With exception to the above, copying our publications in whole or in part, for whatever reason, is a violation of copyright laws and can lead to penalties and fines. Should you want to copy tables, graphs, or other materials, please contact us to request permission (E-mail:
[email protected]). ICON Group often grants permission for very limited reproduction of our publications for internal use, press releases, and academic research. Such reproduction requires confirmed permission from ICON Group International Inc. The disclaimer above must accompany all reproductions, in whole or in part, of this book.
iv
Acknowledgements The collective knowledge generated from academic and applied research summarized in various references has been critical in the creation of this book which is best viewed as a comprehensive compilation and collection of information prepared by various official agencies which produce publications on juvenile diabetes. Books in this series draw from various agencies and institutions associated with the United States Department of Health and Human Services, and in particular, the Office of the Secretary of Health and Human Services (OS), the Administration for Children and Families (ACF), the Administration on Aging (AOA), the Agency for Healthcare Research and Quality (AHRQ), the Agency for Toxic Substances and Disease Registry (ATSDR), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the Healthcare Financing Administration (HCFA), the Health Resources and Services Administration (HRSA), the Indian Health Service (IHS), the institutions of the National Institutes of Health (NIH), the Program Support Center (PSC), and the Substance Abuse and Mental Health Services Administration (SAMHSA). In addition to these sources, information gathered from the National Library of Medicine, the United States Patent Office, the European Union, and their related organizations has been invaluable in the creation of this book. Some of the work represented was financially supported by the Research and Development Committee at INSEAD. This support is gratefully acknowledged. Finally, special thanks are owed to Tiffany Freeman for her excellent editorial support.
v
About the Editors James N. Parker, M.D. Dr. James N. Parker received his Bachelor of Science degree in Psychobiology from the University of California, Riverside and his M.D. from the University of California, San Diego. In addition to authoring numerous research publications, he has lectured at various academic institutions. Dr. Parker is the medical editor for health books by ICON Health Publications. Philip M. Parker, Ph.D. Philip M. Parker is the Eli Lilly Chair Professor of Innovation, Business and Society at INSEAD (Fontainebleau, France and Singapore). Dr. Parker has also been Professor at the University of California, San Diego and has taught courses at Harvard University, the Hong Kong University of Science and Technology, the Massachusetts Institute of Technology, Stanford University, and UCLA. Dr. Parker is the associate editor for ICON Health Publications.
vi
About ICON Health Publications To discover more about ICON Health Publications, simply check with your preferred online booksellers, including Barnes&Noble.com and Amazon.com which currently carry all of our titles. Or, feel free to contact us directly for bulk purchases or institutional discounts: ICON Group International, Inc. 4370 La Jolla Village Drive, Fourth Floor San Diego, CA 92122 USA Fax: 858-546-4341 Web site: www.icongrouponline.com/health
vii
Table of Contents FORWARD .......................................................................................................................................... 1 CHAPTER 1. STUDIES ON JUVENILE DIABETES .................................................................................. 3 Overview........................................................................................................................................ 3 The Combined Health Information Database................................................................................. 3 Federally Funded Research on Juvenile Diabetes........................................................................... 6 E-Journals: PubMed Central ....................................................................................................... 14 The National Library of Medicine: PubMed ................................................................................ 14 CHAPTER 2. NUTRITION AND JUVENILE DIABETES ........................................................................ 57 Overview...................................................................................................................................... 57 Finding Nutrition Studies on Juvenile Diabetes ......................................................................... 57 Federal Resources on Nutrition ................................................................................................... 58 Additional Web Resources ........................................................................................................... 59 CHAPTER 3. ALTERNATIVE MEDICINE AND JUVENILE DIABETES .................................................. 61 Overview...................................................................................................................................... 61 National Center for Complementary and Alternative Medicine.................................................. 61 Additional Web Resources ........................................................................................................... 62 General References ....................................................................................................................... 63 CHAPTER 4. DISSERTATIONS ON JUVENILE DIABETES .................................................................... 65 Overview...................................................................................................................................... 65 Dissertations on Juvenile Diabetes .............................................................................................. 65 Keeping Current .......................................................................................................................... 66 CHAPTER 5. CLINICAL TRIALS AND JUVENILE DIABETES............................................................... 67 Overview...................................................................................................................................... 67 Recent Trials on Juvenile Diabetes .............................................................................................. 67 Keeping Current on Clinical Trials ............................................................................................. 69 CHAPTER 6. PATENTS ON JUVENILE DIABETES ............................................................................... 71 Overview...................................................................................................................................... 71 Patents on Juvenile Diabetes........................................................................................................ 71 Patent Applications on Juvenile Diabetes.................................................................................... 79 Keeping Current .......................................................................................................................... 81 CHAPTER 7. BOOKS ON JUVENILE DIABETES .................................................................................. 83 Overview...................................................................................................................................... 83 Book Summaries: Federal Agencies.............................................................................................. 83 Book Summaries: Online Booksellers........................................................................................... 84 The National Library of Medicine Book Index ............................................................................. 85 Chapters on Juvenile Diabetes ..................................................................................................... 86 Directories.................................................................................................................................... 86 CHAPTER 8. MULTIMEDIA ON JUVENILE DIABETES........................................................................ 89 Overview...................................................................................................................................... 89 Video Recordings ......................................................................................................................... 89 Bibliography: Multimedia on Juvenile Diabetes .......................................................................... 90 CHAPTER 9. PERIODICALS AND NEWS ON JUVENILE DIABETES ..................................................... 91 Overview...................................................................................................................................... 91 News Services and Press Releases................................................................................................ 91 Academic Periodicals covering Juvenile Diabetes ........................................................................ 93 APPENDIX A. PHYSICIAN RESOURCES ............................................................................................ 97 Overview...................................................................................................................................... 97 NIH Guidelines............................................................................................................................ 97 NIH Databases............................................................................................................................. 99 Other Commercial Databases..................................................................................................... 102 APPENDIX B. PATIENT RESOURCES ............................................................................................... 103
viii Contents
Overview.................................................................................................................................... 103 Patient Guideline Sources.......................................................................................................... 103 Associations and Juvenile Diabetes............................................................................................ 111 Finding Associations.................................................................................................................. 112 APPENDIX C. FINDING MEDICAL LIBRARIES ................................................................................ 115 Overview.................................................................................................................................... 115 Preparation................................................................................................................................. 115 Finding a Local Medical Library................................................................................................ 115 Medical Libraries in the U.S. and Canada ................................................................................. 115 ONLINE GLOSSARIES................................................................................................................ 121 Online Dictionary Directories ................................................................................................... 125 JUVENILE DIABETES DICTIONARY ...................................................................................... 127 INDEX .............................................................................................................................................. 171
1
FORWARD In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading."1 Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing. Since only the smallest fraction of information dealing with juvenile diabetes is indexed in search engines, such as www.google.com or others, a non-systematic approach to Internet research can be not only time consuming, but also incomplete. This book was created for medical professionals, students, and members of the general public who want to know as much as possible about juvenile diabetes, using the most advanced research tools available and spending the least amount of time doing so. In addition to offering a structured and comprehensive bibliography, the pages that follow will tell you where and how to find reliable information covering virtually all topics related to juvenile diabetes, from the essentials to the most advanced areas of research. Public, academic, government, and peer-reviewed research studies are emphasized. Various abstracts are reproduced to give you some of the latest official information available to date on juvenile diabetes. Abundant guidance is given on how to obtain free-of-charge primary research results via the Internet. While this book focuses on the field of medicine, when some sources provide access to non-medical information relating to juvenile diabetes, these are noted in the text. E-book and electronic versions of this book are fully interactive with each of the Internet sites mentioned (clicking on a hyperlink automatically opens your browser to the site indicated). If you are using the hard copy version of this book, you can access a cited Web site by typing the provided Web address directly into your Internet browser. You may find it useful to refer to synonyms or related terms when accessing these Internet databases. NOTE: At the time of publication, the Web addresses were functional. However, some links may fail due to URL address changes, which is a common occurrence on the Internet. For readers unfamiliar with the Internet, detailed instructions are offered on how to access electronic resources. For readers unfamiliar with medical terminology, a comprehensive glossary is provided. For readers without access to Internet resources, a directory of medical libraries, that have or can locate references cited here, is given. We hope these resources will prove useful to the widest possible audience seeking information on juvenile diabetes. The Editors
1
From the NIH, National Cancer Institute (NCI): http://www.cancer.gov/cancerinfo/ten-things-to-know.
3
CHAPTER 1. STUDIES ON JUVENILE DIABETES Overview In this chapter, we will show you how to locate peer-reviewed references and studies on juvenile diabetes.
The Combined Health Information Database The Combined Health Information Database summarizes studies across numerous federal agencies. To limit your investigation to research studies and juvenile diabetes, you will need to use the advanced search options. First, go to http://chid.nih.gov/index.html. From there, select the “Detailed Search” option (or go directly to that page with the following hyperlink: http://chid.nih.gov/detail/detail.html). The trick in extracting studies is found in the drop boxes at the bottom of the search page where “You may refine your search by.” Select the dates and language you prefer, and the format option “Journal Article.” At the top of the search form, select the number of records you would like to see (we recommend 100) and check the box to display “whole records.” We recommend that you type “juvenile diabetes” (or synonyms) into the “For these words:” box. Consider using the option “anywhere in record” to make your search as broad as possible. If you want to limit the search to only a particular field, such as the title of the journal, then select this option in the “Search in these fields” drop box. The following is what you can expect from this type of search: •
Workshop on Aldose Reductase Inhibitors Source: JDF International Countdown. Juvenile Diabetes Foundation International Countdown. 12(1): 62-63. Winter 1991. Contact: Available from Juvenile Diabetes Foundation International. 120 Wall Street, 19th Floor, New York, NY 10005. (800) 223-1138 or (212) 785-9500. Fax (212) 785-9595. Summary: Aldose reductase inhibitors (ARIs) are being investigated as possible agents to reverse or prevent some of the complications of diabetes mellitus. This article reports on a scientific workshop on ARIs sponsored by the Juvenile Diabetes Foundation and the National Eye Institute that was held in September 1991. Topics include early use of ARIs to treat cataracts, animal models used for investigations in diabetic retinopathy, the first clinical trial of an ARI in humans, and the future use of ARIs. The workshop
4
Juvenile Diabetes
participants also collaborated to design specific criteria, including patient eligibility, study duration, and sample size, for future clinical trials. •
Widening Spectrum of Celiac Disease Source: American Journal of Clinical Nutrition. 69(3): 354-365. March 1999. Contact: Available from American Journal of Clinical Nutrition. Production Office, 9650 Rockville Pike, Bethesda, MD 20814. (301) 530-7038. Fax (301) 571-8303. Website: www.ajcn.org. Summary: Celiac disease is a permanent intolerance to ingested gluten that results in immunologically mediated inflammatory damage to the small intestinal mucosa. This article considers the widening spectrum of celiac disease. Celiac disease is associated with both human leukocyte antigen (HLA) and non HLA genes and with other immune disorders, notably juvenile diabetes and thyroid disease. The classic sprue syndrome of steatorrhea (fat in the feces) and malnutrition coupled with multiple deficiency states may be less common than more subtle and often monosymptomatic presentations of the disease. Diverse problems such as dental anomalies, short stature, osteopenic bone disease, lactose intolerance, infertility, and nonspecific abdominal pain among many others may be the only manifestations of celiac disease. The rate at which celiac disease is diagnosed depends on the level of suspicion for the disease. Although diagnosis relies on intestinal biopsy findings, serologic tests are useful as screening tools and as an adjunct to diagnosis. The treatment of celiac disease is lifelong avoidance of dietary gluten. Gluten free diets are now readily achievable with appropriate professional instruction and community support. Both benign and malignant complications of celiac disease occur but these can often be avoided by early diagnosis and compliance with a gluten-free diet. 5 figures. 4 tables. 121 references.
•
Community Partnerships for Parent-to-Parent Support Source: Diabetes Educator. 27(1): 36, 38-40, 43-44. January-February 2001. Contact: Available from American Association of Diabetes Educators. 100 West Monroe Street, 4th Floor, Chicago, IL 60603-1901. (312) 424-2426. Summary: This article describes a parent to parent support group, the Diabetes Children and Families Support Group, that was developed through a partnership between a managed care group and a local Juvenile Diabetes Foundation chapter. This group provides a monthly forum for discussion of informational topics and a structure for parent to parent support. Support groups are the result of the self help movement, and they are based upon the dynamics of mutual aid. These dynamics include sharing data, feeling free to express ideas and attitudes, discussing taboos, feeling a common bond, being committed to mutual support, having respect for the needs of others, learning to formulate personal solutions to problems, identifying new ways of looking at old issues, and experiencing the power of the group. The article discusses the evolution of the group in terms of organizing the group, accomplishing support group goals, strengthening community alliances, and evaluating the group. In addition, the article describes group activities and analyzes the factors that have made the support group successful. The article concludes that parent support groups are an invaluable resource for children and families who are living with diabetes. 4 tables. 12 references.
•
Complications Connection Source: JDF International Countdown. 20(2): 12-14, 16-18. Spring 1999.
Studies
5
Contact: Available from Juvenile Diabetes Foundation International. 120 Wall Street, New York, NY 10005-4001. (800) 533-2873 or (212) 785-9500. Website: www.jdfcure.com. Summary: This article focuses on the microvascular diabetic complications of nephropathy, retinopathy, and neuropathy. The metabolic effects of diabetes cause changes in the cells of small blood vessels and nerve fibers, leaving small vessels in the kidney, retina, and nerves vulnerable. The most common disturbance in people with diabetes is a thickening of the basement membrane in vulnerable blood vessels. Although other factors may be involved, hyperglycemia, or high blood sugar, is usually accepted as the leading cause of microvascular complications. The Diabetes Control and Complications Trial has produced the most convincing evidence of the value of good diabetes control. Various investigations on the alternations caused by excess glucose are underway. For example, researchers are studying the effect of hyperglycemia on the sorbitol pathway, investigating the enzyme protein kinase C and its activation by diacylglycerol, and attempting to determine how high blood sugar interferes with the ability of cells to use calcium. The various cellular changes caused by hyperglycemia vary among people with diabetes, suggesting that other factors are involved. For example, certain genetic factors may allow some people to overcome negative effects. In addition, the diabetic damage to the kidneys, eyes, and nerves has distinctive features in each location. Much research is being conducted on diabetic microvascular complications, including research funded by the Juvenile Diabetes Foundation. 4 figures. •
Reading Between the Headlines: Making Sense of Medical News Source: Diabetes Self-Management. 7(3): 21-24. May-June 1990. Summary: This article helps a person to become a critical, analytical reader or listener, particularly in regard to medical news concerning diabetes. It offers some questions to ask in order to test the validity of scientific reports: are these initial findings? Was the study performed with animals or humans? Was there a comparison (control) group that did not receive the treatment? Is the study a 'blind' study? Is the study funded by a party that might have a financial interest in the outcome? How many and what types of subjects were used? How long did the study last? What sorts of tests were used? How were the results depicted? Do the conclusions follow logically from the results? If the research is reported in a consumer publication, does the article include a comment from a credible spokesperson? Each of these questions is discussed. Questions about diabetesrelated studies can be answered or verification of diabetes research findings can be obtained from the American Diabetes Association, the Juvenile Diabetes Foundation, and the National Diabetes Information Clearinghouse (addresses are provided). A sidebar describes a study that reveals the newsworthiness of diabetes, compared with heart disease and cancer.
•
Big, Wide World of the World Wide Web Source: Diabetes Self-Management. 17(1): 7-8, 10-13. January-February 2000. Contact: Available from R.A. Rapaport Publishing, Inc. 150 West 22nd Street, New York, NY 10011. (800) 234-0923. Summary: This article provides people who have diabetes with tips for finding information about diabetes and its treatment on the Internet. The most popular way to obtain information on the Internet is to surf the World Wide Web. To search the Web, a person needs a computer, a modem, a phone or cable line, an Internet provider, and a Web browser. When a person surfs the Web, he or she is visiting one or more Web sites.
6
Juvenile Diabetes
These sites may be posted by nonprofit organizations, government agencies, universities, or publications. All Web sites have specific codes called Web addresses. These addresses usually appear as a series of letters, symbols, periods, and slashes. Almost all addresses begin with 'http://' and are followed by 'www.' Search engines can be used in the absence of a specific address. They sort through information on the Web to help a user find what he or she wants. Search engines are used by typing a keyword and allowing the browser to track down a list of Web sites that reference the keyword. Results are listed with a brief description of the site. Many Web pages have links to other Web pages and other Web sites. Web sites that seem to offer reliable information about diabetes are those provided by the American Diabetes Association, the National Institute of Diabetes and Digestive and Kidney Diseases, the Centers for Disease Control and Prevention, the Juvenile Diabetes Foundation, the Joslin Diabetes Center, Diabetes.com, Children with Diabetes, the Healing Handbook for Persons with Diabetes, and Diabetes Self-Management. The article provides information on these sites and offers specific Web addresses for information on various diabetes related topics.
Federally Funded Research on Juvenile Diabetes The U.S. Government supports a variety of research studies relating to juvenile diabetes. These studies are tracked by the Office of Extramural Research at the National Institutes of Health.2 CRISP (Computerized Retrieval of Information on Scientific Projects) is a searchable database of federally funded biomedical research projects conducted at universities, hospitals, and other institutions. Search the CRISP Web site at http://crisp.cit.nih.gov/crisp/crisp_query.generate_screen. You will have the option to perform targeted searches by various criteria, including geography, date, and topics related to juvenile diabetes. For most of the studies, the agencies reporting into CRISP provide summaries or abstracts. As opposed to clinical trial research using patients, many federally funded studies use animals or simulated models to explore juvenile diabetes. The following is typical of the type of information found when searching the CRISP database for juvenile diabetes: •
Project Title: CORE--HUMAN ISLET Principal Investigator & Institution: Mohankumar, University Lindell and Skinker Blvd St. Louis, Mo 63130
Thalachallour;
Washington
Timing: Fiscal Year 2003; Project Start 01-DEC-2002; Project End 30-NOV-2007 Summary: The aims for this core are to isolate, purify, and culture high quality human islets and make them available to investigators with qualifying grants for their ongoing research. The core also provides training and guidance to these investigators in the handling and investigation of human islets. Washington University has been one of the leading institutions in the development of islet cell transplantation as a therapy for type 1 diabetes. The dramatic improvement in the outcomes of islet cell transplantation following the introduction of the Edmonton protocol and the increase in the number of centers that have developed islet cell transplant programs, make the availability of 2 Healthcare projects are funded by the National Institutes of Health (NIH), Substance Abuse and Mental Health Services (SAMHSA), Health Resources and Services Administration (HRSA), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDCP), Agency for Healthcare Research and Quality (AHRQ), and Office of Assistant Secretary of Health (OASH).
Studies
7
human islets for study an even more important diabetes research priority. This Core laboratory has served and continues to serve as a local and national resource for the provision of human islets to investigators at Washington University and at other centers across the United States. The laboratory was set up as part of the Human Islet Transplant Center of Washington University. After a period of diminished clinical transplant activity, Washington University once again has an active clinical islet transplant program and has successfully performed a clinical transplant in February 2002 with additional transplants anticipated. The DRTC core laboratory benefits from being able to use the resources and infrastructure of the Human Islet Transplant Center of Washington University to provide human islets for research rather than clinical purposes to funded investigators. Under the direction of Dr. T. Mohanakumar the laboratory has continued to supply islets from humans and large animals for diabetes research. During the present funding period the function of the Core was focused towards increasing the efficiency of the isolation process, the improvement of islet purification and yield, and expansion of our islet distribution to more qualified investigators across the country. Support from the Juvenile Diabetes Research Foundation (JDRF) has supplemented these efforts allowing the laboratory to meet its goals. With the increasing importance of human islet cell transplantation, in the next funding period we plan to focus on providing human islets to investigators. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: CORE--MOLECULAR BIOLOGY Principal Investigator & Institution: Seed, Brian; Professor; Massachusetts General Hospital 55 Fruit St Boston, Ma 02114 Timing: Fiscal Year 2002 Summary: (Adapted from the application) The Molecular Biology Core is dedicated to providing cost-effective access to services common to most applications of modern molecular biology and to provide training and technology to exploit a variety of more advanced gene discovery tools. The application of molecular genetic approaches to the study of diabetes is widely recognized as a crucial element in the progress toward an understanding of the detailed mechanism of glucose homeostasis and of the still poorly understood pathophysiology of adult onset diabetes. In addition, molecular tools have already played an essential role in elucidating some of the factors contributing to the immunological derangements responsible for the inception of the beta cell destruction underlying juvenile diabetes mellitus. However, the application of the powerful tools of molecular biology increasingly requires the mastery of a broad spectrum of technologies. Common to many of these technologies is a requirement for facile gene isolation and manipulation, which in turn calls for the libraries, cell lines, and protein and nucleic acid probes needed to isolate genes and analyze them. The speed and convenience with which nucleic acids can be manipulated are in turn dependent on key reagents and services which can be expensive and time-consuming to develop on an individual laboratory basis. In addition to making available the approaches in use for expression-based discovery of gene products and their interactions, the Molecular Biology Core will, by consolidating the intellectually broader user base of the diabetes research community with the very high volume of activity ongoing in the Department of Molecular Biology, afford substantial incremental savings for Center-affiliated investigators for reagents and services, such as the provision of synthetic oligonucleotides, automated DNA sequencing, colony picking, and DNA arraying. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
8
Juvenile Diabetes
•
Project Title: DNA VACCINATION AS EAE IMMUNOTHERAPY Principal Investigator & Institution: Steinman, Lawrence; Stanford University Stanford, Ca 94305 Timing: Fiscal Year 2001 Summary: Vaccination was initiated empirically 200 years ago by Jenner and consolidated conceptually 100 years ago by Pasteur, and the procedure still provides surprises. Among the latest is vaccination with DNA. A particular variable region gene of the T cell receptor, Vbeta8.2, is rearranged and its product is expressed on pathogenic T cells that induce experimental autoimmune encephalomyelitis (EAE) and its product is expressed on pathogenic T cells that induce experimental autoimmune encephalomyelitis (EAE) in H-2/u mice following immunization with myelin basic protein (MBP). Vaccination of H-2/u mice with naked DNA pathogenic portion of the MBP molecule, indicated in the vaccinated mice there was a reversal of the autoimmune response from Th2 to Th2. This shift may make this approach attractive for treatment of recently of Th1 mediated diseases like multiple sclerosis, juvenile diabetes, and rheumatoid arthritis. We have recently extended this approach to the treatment of autoimmune diseases with altered peptide ligands. In this portion of the program project proposal, we aim to: 1. Extend studies on the mechanism whereby DNA vaccination with TCR Vb constructs induces Th2 responses and suppresses EAE. 2. Test vaccination with DNA minigens encoding myelin epitopes for peptide- and APL-based treatment of EAE. 3. Investigate bacterial CpG sequences inducing gamma interferon and IL- 12, and their application for suppression of EAE. 4. Utilize DNA vaccination to chemokines for treatment of EAE. 5. Develop tandem cytokine and chemokine constructs for treatment of EAE. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: EXPERIMENTAL JUVENILE TYPE DIABETES Principal Investigator & Institution: Rossini, Aldo A.; Professor; Medicine; Univ of Massachusetts Med Sch Worcester Office of Research Funding Worcester, Ma 01655 Timing: Fiscal Year 2001; Project Start 01-SEP-1978; Project End 31-AUG-2004 Summary: Our objective is to understand the defect in cellular immunity that lead to autoimmune insulin-dependent diabetes mellitus (IDDM) using the BB rat disease model. Our hypothesis, developed over the last decade, is that IDDM in the BB rt results from an imbalance between beta cytotoxic effector cells and regulatory T cells. This hypothesis has been strengthened by two fundamental observations. First, we discovered that in BB rats the balance between auto-reactive and regulatory cells is already disequilibrated intrathymically. Large numbers of diabetogenic cells are present in the thymus of BB rats but not of normal animals. Second, we have obtained experimental evidence for the presence of multiple regulatory systems based on RT6+ regulatory cells. Second, we have obtained experimental evidence from the presence of multiple regulatory systems based on RT6+ regulatory cells, RT6 enzymatic activity, and soluble RT6 protein. Second Aim No. 1 is to investigate the antigen-specificity and activities of intrathymic autoreactive cells in BB rats. This aim will examine effects of intrathymic exposure to islet autoantigens, and the mechanism(s) involved in islet betacell-specific destruction by autoreactive cells. Specific Aim No. 2 is to investigate the mechanism(s) by which peripheral RT6+ regulatory cells, or RT6 protein itself, can modulate autoimmunity. The results of our studies will define the T cell populations in B rats that determine whether or not IDDM will occur. They will tell us how these populations interact and how the equilibrium between them is maintained or disrupted.
Studies
9
We hope that an understanding of these cellular interactions will eventually translate into the design of rational strategies for the prevention of human juvenile diabetes. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: FEDERATION OF CLINICAL IMMUNOLOGY SOCIETIES MEETING Principal Investigator & Institution: Hafler, David A.; Professor; Clinical Immunology Society 6900 Grove Rd Thorofare, Nj 08086 Timing: Fiscal Year 2001; Project Start 04-MAY-2001; Project End 03-MAY-2002 Summary: (Adapted from Applicant's Abstract) The Clinical Immunology Society (CIS) has undertaken the task of arranging a federated meeting for clinical immunology to be held yearly commencing in May 2001. This new meeting plans to provide an opportunity for members of each of the individual clinical immunology societies involved to meet together on a yearly basis. The first Federated meeting will be held in Boston, May 4-7, 2001. We believe that this new meeting will consolidate the field of Clinical Immunology as it reaches maturity, particularly as it relates to the major human autoimmune diseases including multiple sclerosis, rheumatoid arthritis, and juvenile diabetes. Resultant cross-fertilization from this meeting among the disease-centric investigators and members of the biotech and pharmaceutical community is of critical importance with the increasing numbers of therapeutics for treatment of these autoimmune diseases. This meeting reflects the new interdisciplinary nature now necessary for the investigation and treatment of human autoimmune diseases. It will also cover additional immune based diseases including, but not limited to, asthma, immuno-oncology, acquired immunodeficiency, primary immunodeficiency, transplantation tolerance and immuno-dermatology. Another key aspect will be the inclusion of the Immune Tolerance Network annual meeting. This will provide an important opportunity to inform industry about the Immune Tolerance Network and to disseminate new information about science and medicine. The format will be three days on topics of mutual interest to all constituent groups. There will be two major plenary lectures to begin each day, followed by concurrent major symposia on topics of interest to constituent groups. Afternoons will be abstract-driven interspersed with breakout meetings for the constituent societies and presentations by biotech and pharmaceutical firms concerning technologies of interest to the assembled groups. There will be two additional meetings held in conjunction with this meeting. The first of these is a "fellows day" in which plenary and abstract driven talks will be held on the day preceding the main scientific sessions. The second parallel session will be on "science for the nonclinician" which targets the lay societies representing the constituent scientific societies. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: FRONTIERS IN HUMAN EMBRYONIC STEM CELLS Principal Investigator & Institution: Schatten, Gerald P.; Professor; Magee-Women's Health Corporation 204 Craft Ave Pittsburgh, Pa 15213 Timing: Fiscal Year 2003; Project Start 23-APR-2003; Project End 31-MAR-2006 Summary: (provided by applicant): Frontiers in Human Embryonic Stem Cells (FrHESC) is a dynamic advanced training course that offers a fresh series of daily lecturers on emerging concepts, followed by extended discussions, laboratory research, technologically intense workshops and informal seminars over a three week period (April 28 - May 17, 2003). The Course is directed toward young independent scientists, physicians and established investigators. The Course will address critical concerns in stem cell biomedicine and is organized around four modules: Module A. HESC Growth,
10
Juvenile Diabetes
Propagation, Pluripotency; Module B. Transgenesis, Cloning and Epigenesis in HESCs; Module C. Realizing HESCs Clinical Promise: Juvenile Diabetes, Parkinson's, In Vivo Imaging (MRI and PET); and Module D. Regenerative Medicine: HESC Frontiers. The Frontiers in Human Embryonic Stem Cells (FrHESC) Training Course Program is directed by a Board of Scientific Counselors whose members are renowned leaders in embryonic stem cell research and proactively consider the national needs for this undertaking and solicit the intellectual and financial wherewithal to realize the promise of Human Embryonic Stem Cell Research. The FrHESC training course itself is organized by two Course Directors, Gerald Schatten and Roger Pedersen, who are experts in molecular cell biology, gametogenesis, preimplantation embryogenesis and stem cell research. The laboratory and lecture faculty selected to participate in the course are internationally acknowledged leaders in their fields. The purpose of this training course is to provide comprehensive and sophisticated training in research strategies and state-of-the-art methods on cellular, molecular and genetic approaches for advancing the Frontiers in Human Embryonic Stem Cell Research. The Training Course will conclude with a two-day International Symposium, "Embryonic Stem Cell Biomedicine: The Journey From Mice To Patients" with presentations by leading foreign and US Scientists. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: GENETICS OF AUTOIMMUNITY IN BB RATS Principal Investigator & Institution: Greiner, Dale L.; Professor of Medicine; Medicine; Univ of Massachusetts Med Sch Worcester Office of Research Funding Worcester, Ma 01655 Timing: Fiscal Year 2003; Project Start 01-AUG-1995; Project End 30-JUN-2007 Summary: (provided by applicant): The goals of this proposal are to identify and to understand the mechanism of action of the iddm4 gene, a critical non-MHC determinant of susceptibility to autoimmune diabetes in the BB rat. We have shown that the BBorigin allele at iddm4 has 79% sensitivity and 80% specificity in predicting diabetes susceptibility. To identify iddm4, we have generated the necessary tools and reagents, including a congenic iddm4 rat with a 2.8 cM region on the diabetes-resistant WF strain that is susceptible to diabetes and a radiation hybrid map of the iddm4 interval with a catalog of the candidate genes in this region. Specific Aim 1 is to generate congenic lines of rats with progressively smaller iddm4 intervals and to fine map the iddm4 region. Specific Aim 2 is to identify molecular and biological phenotypes associated with iddm4. We have shown that bone marrow, thymocytes, and peripheral T cells from BB rats, and thymocytes from WF congenic rats bearing the BB-origin iddm4 interval are capable of the adoptive transfer of diabetes. We hypothesize that iddm4 mediates its diabetogenic effects by expression in hematopoietic-origin cells during intrathymic development. Specific Aim 3 is to identify iddm4. We will identify iddm4 by a combination of bioinformatics, susceptibility testing, and functional assays. To achieve this goal, we will continue our close collaborative arrangement between cellular biologists at the University of Massachusetts Medical School and molecular geneticists at the Drexel University College of Medicine. Although centered on studies of diabetic rats, the real significance of this proposal is its relevance to human diabetes. With the sequence of the human genome now available, NIH and the Juvenile Diabetes Research Foundation (JDRF) have established a human type 1 diabetes genetics consortium to identify those genes that confer susceptibility to the disease. An important component of this strategy is to identify resistance and susceptibility loci in mouse and rat models of type 1 diabetes. The NIH/JDRF goal is to use available mouse and rat genome sequence
Studies
11
and orthologue maps to translate discoveries in animal models to humans. The genetic effect of iddm4 is large, and this work has will identify a major non-MHC susceptibility locus for autoimmune diabetes mellitus. The work we propose in the BB rat has the potential to contribute to that national goal. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: JUVENILE DIABETES MELLITUS EPIDEMIOLOGY AND ETIOLOGY Principal Investigator & Institution: Becker, Dorothy J.; Professor; Children's Hosp Pittsburgh/Upmc Hlth Sys of Upmc Health Systems Pittsburgh, Pa 15213 Timing: Fiscal Year 2001; Project Start 15-SEP-1978; Project End 30-NOV-2002 Summary: The proposed epidemiologic research is based on our prior 19-year achievements in the development of unique populations, both locally and globally, and a stored blood sample library. These resources will be used to search for environmental triggers that initiate beta cell destruction or precipitate clinical insulin dependent diabetes (IDDM) and identify factors that will differentiate those individuals who progress from autoimmune beta cell disease to total destruction for the insulin producing islet cells, from those who have an indolent autoimmune course without the development of diabetes or slow progression to insulin requirement. The hypothesis to be tested are: 1) IDDM is triggered by acute or chronic precipitating agents associated with evidence of an infection and immune reactions with characteristics typical of those which are superantigen mediated; 2) there is a variable rate of progression of the autoimmune process as identified by the presence of circulating islet cell antibodies. Independent determinants characterize rapid progressors or latent autoimmune diabetes in adults and non-progressors. Specific aims based on these hypothesis are: A) to evaluate the potential contribution of superantigens as triggering events in a large consecutive series of childhood onset IDDM cases representative of the local population; B) to compare islet cell GAD and ICA512 antibodies in relatives who have slow and rapid or no progression of IDDM after the initial detection of autoimmunity; C) to evaluate HLA haplotypes and T-cell responses and T-cell responses to beta cell antigens and superantigens in these groups. Data derived from this research will give clues as to the pathogenesis of IDDM, the time course and characteristics of the prodrome and risk factors for progression to clinical disease. These will assist in the design of intervention strategies and populations to be tested in future studies. This research will also form the basis of other potential substudies of genetic heterogeneity, autoimmune abnormalities and decreased insulin secretion as surrogate markers of beta cell damage. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
•
Project Title: PATHOGENESIS AND PREVENTION OF TYPE I DIABETES IN THE NOD MOUSE AND MAN Principal Investigator & Institution: Mcdevitt, Hugh O.; Burt & Marion Avery Professor of Immunol; Stanford University Stanford, Ca 94305 Timing: Fiscal Year 2001; Project Start 01-DEC-2000; Project End 30-NOV-2001 Summary: Susceptibility to juvenile onset insulin dependent diabetes mellitus (IDDM) is linked to two HLA DQ alleles--HLA DQ8 and HLA DQ2. Because of the great difficulty in isolating DQ restricted human T cell clones, information on the specificity of the DQ restricted T cell response to islet cell antigens is non-existent. Susceptible HLA DQ alleles lack aspartic acid in DQB position 57. (DQ8) exhibits striking differences in binding a number of peptide binding in comparison to DQ9, which is DQbeta57Asp+, and otherwise identical to DQ8. T/H2 CD4 + T/H1 T cells cause islet beta cell
12
Juvenile Diabetes
destruction. Islet antigen specific T/h2 cells are protective. One mechanism for DQ associated susceptibility is that susceptible alleles bind and present a distinct subset of peptides which induce a predominant T/H1 response. Resistant alleles binding other islet antigen peptides which induce a T/h2 responses. The proposed experiments will test whether susceptible and resistant alleles bind and present different subsets of peptides. This will be done by the production of transgenic mice expressing the relevant HLA DQ alleles, as well as human CD4, in the presence and absence of murine CD4. HLA DQ8.huCD4 transgenic mice at backcross 5 to NOD have been observed develop type I diabetes. Transgenic mice and non-transgenic littermate controls will be monitored for the spontaneous development of auto- antibodies to islet cell antigens and HLA DQ restricted T cell responses to GA65 and pre pro-insulin. Untreated transgenic mice and transgenic mice immunized with recombinant human GD65 and pre proinsulin will be used to assess the peptides presented by DQ8, DQ7 and DQ6 to T cells. This will be done by using lymph node and spleen T cells from these mice to the murine T cell hybridoma, DW5147. The resulting hybridomas will be analyzed for HLA DQ restriction and peptide specificity. Finally, those peptide epitopes presented by HLA DQ8 will be used to detect HLA DQ restricted responses in pre-diabetic and recent onset diabetic patients. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: PED ENDOCRINE CAREER DEVELOPMENT IN DIABETES RESEARCH Principal Investigator & Institution: Stanley, Charles A.; Chief; Children's Hospital of Philadelphia 34Th St and Civic Ctr Blvd Philadelphia, Pa 19104 Timing: Fiscal Year 2002; Project Start 30-SEP-2002; Project End 31-AUG-2007 Summary: (provided by applicant): The goal of this Career Development Program Is to develop a new generation of pediatric endocrinologists who will be equipped to carry out innovative, scientifically rigorous patient-oriented and laboratory-based research related to diabetes mellitus in children for this new 21st Century. One of the needs for this Program is the critical shortage of academic pediatric endocrinologists in diabetes research which has been emphasized by the organizations such as the American Diabetes Association, the Juvenile Diabetes Research Foundation, and the Pediatric Academic Societies. In addition, the Program recognizes the important new opportunities for advancing diabetes research in children provided by such recent scientific advances as the Human Genome Project and the successes in islet transplantation and production of biomechanical and bioengineered islets. The Program will support Scholars for up to 3 years of research career development at the junior faculty level. The Program faculty includes 19 scientific mentors from the Children's Hospital and the U Penn School of Medicine who have outstanding credentials and active research programs and training records. These mentors will supervise Scholars' career development through basic laboratory research and/or patient-oriented research related to diabetes in children. Career development opportunities will include 3 major areas of basic research 1) Signal Transduction: Mechanisms of Hormone Action; 2) Regulation of Pancreatic beta-Cell Function and Development; and 3) Genetic Approaches to Diabetes and Endocrine Diseases. Patient-oriented research opportunities will include the areas of 1) Islet Immunology, Transplantation, and Regulation; 2) Obesity and Insulin Resistance, 3) Diabetes Complications; and 4) Diabetes Epidemiology and Biostatistics. The Program includes a curriculum of formal training in all aspects of research, including biostatistics, bioethics, molecular biology, etc. The Program is strongly supported by access to a superb range of institutional resources,
Studies
13
including the CHOP GCRC and the UPenn DERC. Request is made for 2 Appointee slots in this Program each year. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen •
Project Title: UCHSC DIABETES ENDOCRINOLOGY RESEARCH CENTER Principal Investigator & Institution: Hutton, John C.; Professor; Pediatrics; University of Colorado Hlth Sciences Ctr P.O. Box 6508, Grants and Contracts Aurora, Co 800450508 Timing: Fiscal Year 2001; Project Start 01-JUN-2000; Project End 31-MAR-2005 Summary: The establishment and Endocrinology Research Center (DERC) at the Barbara Davis Center for Childhood Diabetes (BDC) at the University of Colorado Health Sciences (UCHSC) brings together the collective expertise of basic and clinical scientists from different faculty and research backgrounds to enhance productivity and the quality of diabetes and endocrinology research in the university. Interdisciplinary cooperation, communication and collaboration between researchers will be promoted by implementation of programs of training and academic enrichment, provision of Core facilities and a Pilot and Feasibility project program. The latter is aimed at fostering innovative ideas of young faculty and established researchers who wish to direct their research efforts to diabetes. All core facilities will be located at the BDC and managed by BDC members. Individuals with particular expertise at the UCHSC and National Jewish Medical Research Center have been included as investigators and advisors as a deliberate strategy aimed at providing further added value and cost effectiveness to the program. The Core facilities are structured around existing expertise services or large instrumentation which, by addition of staff and resources, will provide a productive and cost-effective resource to the maximum number of investigators. Five Cores are proposed: Administration (J. Hutton &G. Eisenbarth, directors); Cytometry (D. Bellgrau, directors); Animal Resources (R. Gill & D. Wegmann, directors); Cell and Molecular Resources (J. Hutton & L. Sussel, directors) and Clinical Investigation/Informatics (M. Rewers & P. Chase, directors). They will be accommodated in 2,147 square feet of approved reassigned space in the present BDC building on 9th and Colorado Blvd on the UCHSC campus. No items of large equipment are needed by the DERC Cores as these have been acquired. Two novel features of the proposed DERC are a "Molecular Bed and Breakfast" laboratory that will accommodate investigators for 2-4 weeks for inhouse, hands-on training in either basic or advanced molecular biology techniques for 24 weeks for in-house, hands-on training in either basic or advanced molecular biology techniques, and a Translational Research Unit which will guide investigators through the labyrinth of setting up a clinical study. Dr. Hutton, PhD will be the Director of the Center and Dr. Eisenbarth, MD, PhD will be his deputy. An External Advisory Board comprised of four distinguished investigators in the field of diabetes will be appointed to provide oversight, assist in the selection of Pilot and Feasibility Projects and conduct an annual review of the DERC. The activities of the DERC will be broadly disseminated to the NIDDK, UCHSC, local chapter of the Juvenile Diabetes Foundation International or the American Diabetes Association by direct communication and publicity of the BDC webpage. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
14
Juvenile Diabetes
E-Journals: PubMed Central3 PubMed Central (PMC) is a digital archive of life sciences journal literature developed and managed by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).4 Access to this growing archive of e-journals is free and unrestricted.5 To search, go to http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Pmc, and type “juvenile diabetes” (or synonyms) into the search box. This search gives you access to full-text articles. The following is a sample of items found for juvenile diabetes in the PubMed Central database: •
Worldwide Differences in the Incidence of Type I Diabetes are Associated with Amino Acid Variation at Position 57 of the HLA-DQ [beta] Chain. by Dorman JS, LaPorte RE, Stone RA, Trucco M.; 1990 Oct 1; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=54748
The National Library of Medicine: PubMed One of the quickest and most comprehensive ways to find academic studies in both English and other languages is to use PubMed, maintained by the National Library of Medicine.6 The advantage of PubMed over previously mentioned sources is that it covers a greater number of domestic and foreign references. It is also free to use. If the publisher has a Web site that offers full text of its journals, PubMed will provide links to that site, as well as to sites offering other related data. User registration, a subscription fee, or some other type of fee may be required to access the full text of articles in some journals. To generate your own bibliography of studies dealing with juvenile diabetes, simply go to the PubMed Web site at http://www.ncbi.nlm.nih.gov/pubmed. Type “juvenile diabetes” (or synonyms) into the search box, and click “Go.” The following is the type of output you can expect from PubMed for juvenile diabetes (hyperlinks lead to article summaries): •
3 4
A case of asymptomatic juvenile diabetes mellitus with severe insulin deficiency. Author(s): Rehfeld JF. Source: Acta Med Scand. 1970 April; 187(4): 305-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5447095&dopt=Abstract
Adapted from the National Library of Medicine: http://www.pubmedcentral.nih.gov/about/intro.html.
With PubMed Central, NCBI is taking the lead in preservation and maintenance of open access to electronic literature, just as NLM has done for decades with printed biomedical literature. PubMed Central aims to become a world-class library of the digital age. 5 The value of PubMed Central, in addition to its role as an archive, lies in the availability of data from diverse sources stored in a common format in a single repository. Many journals already have online publishing operations, and there is a growing tendency to publish material online only, to the exclusion of print. 6 PubMed was developed by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM) at the National Institutes of Health (NIH). The PubMed database was developed in conjunction with publishers of biomedical literature as a search tool for accessing literature citations and linking to full-text journal articles at Web sites of participating publishers. Publishers that participate in PubMed supply NLM with their citations electronically prior to or at the time of publication.
Studies
15
•
A family with dominantly inherited mild juvenile diabetes. Author(s): Johansen K, Gregersen G. Source: Acta Med Scand. 1977; 201(6): 567-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=878915&dopt=Abstract
•
A fatal instance of juvenile diabetes mellitus. Author(s): Warshaw JB, Levine M, Hyman V, Crawford JD. Source: Clinical Pediatrics. 1971 July; 10(7): 385-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4997166&dopt=Abstract
•
A grief experience in juvenile diabetes. Author(s): Taylor CJ. Source: J Psychiatr Nurs Ment Health Serv. 1977 January; 15(1): 26-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=189017&dopt=Abstract
•
A pediatrician's view. Juvenile diabetes: prevention, control, and cure. Author(s): Hoekelman RA. Source: Pediatric Annals. 1994 June; 23(6): 278-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8078702&dopt=Abstract
•
A quantitative electron microscopic study of mesangial regions in glomeruli from patients with short term juvenile diabetes mellitus. Author(s): Osterby R. Source: Laboratory Investigation; a Journal of Technical Methods and Pathology. 1973 July; 29(1): 99-110. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4728359&dopt=Abstract
•
A secular increase in the incidence of juvenile diabetes mellitus. Author(s): North AF Jr, Gorwitz K, Sultz HA. Source: The Journal of Pediatrics. 1977 November; 91(5): 706-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=909007&dopt=Abstract
•
A two locus model for juvenile diabetes. Author(s): Thomson G. Source: Annals of Human Genetics. 1980 May; 43(4): 383-98. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7396412&dopt=Abstract
•
Abnormal lung elasticity in juvenile diabetes mellitus. Author(s): Schuyler MR, Niewoehner DE, Inkley SR, Kohn R. Source: Am Rev Respir Dis. 1976 January; 113(1): 37-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1247213&dopt=Abstract
16
Juvenile Diabetes
•
Abnormal proinsulin/C-peptide ratio in juvenile diabetes. Author(s): Ludvigsson J, Heding L. Source: Acta Diabetol Lat. 1982 October-December; 19(4): 351-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6758459&dopt=Abstract
•
Absence of insulin resistance in 4 cases of mild juvenile diabetes. A preliminary report. Author(s): Thorell JI, Nilsson KO, Hager A. Source: Acta Paediatr Scand. 1975 March; 64(2): 248-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1130181&dopt=Abstract
•
Acetylsalicylic acid and bleeding time in juvenile diabetes mellitus. Author(s): Jorgensen KA, Mourits-Andersen HT, Ditzel J, Dyerberg J. Source: Thrombosis Research. 1980 December 1-15; 20(5-6): 611-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7233387&dopt=Abstract
•
Activation of platelet in vivo function and plasma levels of catecholamines and growth hormone during bicycle exercise in juvenile diabetes and healthy individuals. Author(s): Schernthaner G, Muhlhauser I, Seebacher C, Templ H, Sinzinger H, Silberbauer K. Source: Curr Probl Clin Biochem. 1982; 11: 69-83. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7083895&dopt=Abstract
•
Acute disc swelling in juvenile diabetes. Clinical profile and natural history of 12 cases. Author(s): Barr CC, Glaser JS, Blankenship G. Source: Archives of Ophthalmology. 1980 December; 98(12): 2185-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7447771&dopt=Abstract
•
Adjustment problems in juvenile diabetes. Author(s): Swift CR, Seidman F, Stein H. Source: Psychosomatic Medicine. 1967 November-December; 29(6): 555-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5582952&dopt=Abstract
•
Age, sex, and season of onset of juvenile diabetes in different geographic areas. Author(s): Fleegler FM, Rogers KD, Drash A, Rosenbloom AL, Travis LB, Court JM. Source: Pediatrics. 1979 March; 63(3): 374-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=440839&dopt=Abstract
Studies
17
•
Altered lysosomal glycohydrolase activities in juvenile diabetes mellitus. Author(s): Bomback FM, Nakagawa S, Kumin S, Nitowsky HM. Source: Diabetes. 1976 May; 25(5): 420-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1269840&dopt=Abstract
•
An “outbreak” of juvenile diabetes mellitus: consideration of a viral etiology. Author(s): Huff JC, Hierholzer JC, Farris WA. Source: American Journal of Epidemiology. 1974 October; 100(4): 277-87. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4371445&dopt=Abstract
•
An argument for the unmeasured diet in juvenile diabetes mellitus: the physical and emotional risks of the measured diet. Author(s): Schmitt BD. Source: Clinical Pediatrics. 1975 January; 14(1): 68-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1112075&dopt=Abstract
•
An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus. Author(s): Junker K, Egeberg J, Kromann H, Nerup J. Source: Acta Pathol Microbiol Scand [a]. 1977 September; 85(5): 699-706. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=335782&dopt=Abstract
•
An in vitro study of hydroxyproline synthesis by gingival fibroblasts in patients with juvenile diabetes. Author(s): el-Kishky M, Mahfouz SA, el-Habbak SM. Source: Egypt Dent J. 1986 January; 32(1): 15-27. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3460755&dopt=Abstract
•
An incidence peak of juvenile diabetes. Relation to Coxsackie B virus immune response. Author(s): Friman G, Fohlman J, Frisk G, Diderholm H, Ewald U, Kobbah M, Tuvemo T. Source: Acta Paediatr Scand Suppl. 1985; 320: 14-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3010631&dopt=Abstract
•
Angiopathy and neuropathy in mild juvenile diabetes. Author(s): Johansen K. Source: Adv Metab Disord. 1973; 2: Suppl 2: 29-40. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4720369&dopt=Abstract
18
Juvenile Diabetes
•
Anorexia nervosa and juvenile diabetes mellitus. Author(s): Handelsman MB. Source: N Y State J Med. 1984 February; 84(2): 58-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6583553&dopt=Abstract
•
Anorexia nervosa in a patient with juvenile diabetes. Author(s): Hardoff D, Shenker IR, Nussbaum M. Source: N Y State J Med. 1984 February; 84(2): 61. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6583555&dopt=Abstract
•
Antibody to encephalomyocarditis virus in juvenile diabetes. Author(s): Yoon JW, Huang SW, MacLaren NK, Wheeler CJ, Selvaggio SS, Notkins AL. Source: The New England Journal of Medicine. 1977 December 1; 297(22): 1235-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=199838&dopt=Abstract
•
Arthritis in a 15-year-old boy with juvenile diabetes mellitus. Author(s): Daugbjerg PS, Pedersen FK. Source: Dan Med Bull. 1984 August; 31(4): 346-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6478884&dopt=Abstract
•
Association of juvenile diabetes mellitus, primary optic atrophy and perceptive hearing loss in three sibs, with additional idiopathic diabetes mellitus insipidus in one case. Author(s): Ikkos DG, Fraser GR, Matsouki-Gavra E, Petrochilos M. Source: Acta Endocrinol (Copenh). 1970 September; 65(1): 95-102. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5468975&dopt=Abstract
•
Attitudes towards self-control with urinalysis in juvenile diabetes. Author(s): Ludvigsson J, Svensson PG. Source: Scand J Soc Med Suppl. 1980; 18: 73-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6939121&dopt=Abstract
•
Autoimmune insulitis. Pathological findings in experimental animal models and juvenile diabetes mellitus. Author(s): Egeberg J, Junker K, Kromann H, Nerup J. Source: Acta Endocrinol Suppl (Copenh). 1976; 205: 129-37. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=793275&dopt=Abstract
•
Benign migratory glossitis in patients with juvenile diabetes. Author(s): Wysocki GP, Daley TD. Source: Oral Surg Oral Med Oral Pathol. 1987 January; 63(1): 68-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3468467&dopt=Abstract
Studies
19
•
Beta adrenergic blockade and juvenile diabetes: acute studies and long-term therapeutic trial. Evidence for the role of catecholamines in mediating diabetic decompensation following emotional arousal. Author(s): Baker L, Barcai A, Kaye R, Haque N. Source: The Journal of Pediatrics. 1969 July; 75(1): 19-29. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4978148&dopt=Abstract
•
beta-lipoprotein and juvenile diabetes mellitus. Author(s): Rotenberg I, Pena-Aguilar MT, Barron C, Villalpando S, Perez-Pasten E. Source: Am J Dis Child. 1977 December; 131(12): 1403-4. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=201168&dopt=Abstract
•
Blood-reduced glutathione, serum ceruloplasmin and mineral changes in juvenile diabetes. Author(s): Awadallah R, El-Dessoukey EA, Doss H, Khalifa K, el-Hawary Z. Source: Zeitschrift Fur Ernahrungswissenschaft. 1978 June; 17(2): 79-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=685322&dopt=Abstract
•
Bone mineral density in children and adolescents with juvenile diabetes: selective measurement of bone mineral density of trabecular and cortical bone using peripheral quantitative computed tomography. Author(s): Lettgen B, Hauffa B, Mohlmann C, Jeken C, Reiners C. Source: Hormone Research. 1995; 43(5): 173-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7782045&dopt=Abstract
•
Capillary diffusion capacity for sodium in skeletal muscle in long-term juvenile diabetes mellitus. Author(s): Trap-Jensen J, Alpert JS, Garcia del Rio, Lassen NA. Source: Acta Med Scand Suppl. 1967; 476: 135-46. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5236036&dopt=Abstract
•
Capillary microscopy in juvenile diabetes mellitus. Author(s): Kontras SB, Bodenbender JG, Rettemnier SC, Shaffer TE. Source: Am J Dis Child. 1968 August; 116(2): 135-42. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5659289&dopt=Abstract
•
Changes of sialic acid content in cell membranes and plasma in juvenile diabetes mellitus. Author(s): Watala C, Nowak S. Source: Acta Med Pol. 1986; 27(1-2): 51-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3565077&dopt=Abstract
20
Juvenile Diabetes
•
Clinical evaluation and preliminary studies on the use of an artificial pancreatic beta cell in juvenile diabetes mellitus. Author(s): Clarke WL, Thomas L, Santiago JV. Source: The Journal of Pediatrics. 1977 October; 91(4): 590-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=561836&dopt=Abstract
•
Clinical profile of juvenile diabetes. Author(s): Patel JC, Kumbhat MM. Source: Indian Pediatrics. 1979 July; 16(7): 577-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=556369&dopt=Abstract
•
Clinico-pathological conference. Juvenile diabetes mellitus, rheumatic heart disease, fever, and massive hemoptysis. Author(s): Klion FM. Source: J Mt Sinai Hosp N Y. 1968 May-June; 35(3): 307-17. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5239560&dopt=Abstract
•
Comphrehensive management of juvenile diabetes at a camp for diabetic children. An experience with 204 children with diabetes. Author(s): Khurana RC, White P, Joslin AP. Source: Indian Journal of Medical Sciences. 1972 March; 26(3): 145-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5019529&dopt=Abstract
•
Compliance and the health relief model--its relevance to the treatment of juvenile diabetes mellitus. Author(s): Ludvigsson J, Richt B, Svensson PG. Source: Scand J Soc Med Suppl. 1980; 18: 57-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6939120&dopt=Abstract
•
Concentration of chromium in the hair of normal children and children with juvenile diabetes mellitus. Author(s): Hambidge KM, Rodgerson DO, O'Brien D. Source: Diabetes. 1968 August; 17(8): 517-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5673999&dopt=Abstract
•
Concerns of children with a chronic illness: a cognitive-developmental study of juvenile diabetes. Author(s): Allen DA, Affleck G, Tennen H, McGrade BJ, Ratzan S. Source: Child: Care, Health and Development. 1984 July-August; 10(4): 211-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6478546&dopt=Abstract
Studies
21
•
Continuous subcutaneous insulin infusion corrects exercise-induced albuminuria in juvenile diabetes. Author(s): Koivisto VA, Huttunen NP, Vierikko P. Source: British Medical Journal (Clinical Research Ed.). 1981 March 7; 282(6266): 778-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6783168&dopt=Abstract
•
Control of hyperlipidaemia in juvenile diabetes. Standard and corn-oil diets compared over a period of 10 years. Author(s): Chance GW, Albutt EC, Edkins SM. Source: British Medical Journal. 1969 September 13; 3(671): 616-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5811679&dopt=Abstract
•
Control of juvenile diabetes mellitus and its relationship to endogenous insulin secretion as measured by C-peptide immunoreactivity. Author(s): Grajwer LA, Pildes RS, Horwitz DL, Rubenstein AH. Source: The Journal of Pediatrics. 1977 January; 90(1): 42-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=830892&dopt=Abstract
•
Control of juvenile diabetes. Author(s): Brazier B. Source: The Medical Journal of Australia. 1984 April 14; 140(8): 512. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6369094&dopt=Abstract
•
Cortisol secretion in acidotic and nonacidotic juvenile diabetes mellitus. Author(s): Garces LY, Kenny FM, Drash A, Preeyasombat C. Source: The Journal of Pediatrics. 1969 April; 74(4): 517-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5767340&dopt=Abstract
•
Counting juvenile diabetes. Author(s): Hazlett J. Source: Fda Consumer. 2000 September-October; 34(5): 3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11681286&dopt=Abstract
•
Course of coxsackie B antibodies during juvenile diabetes. Author(s): Schmidt WA, Brade L, Muntefering H, Klein M. Source: Medical Microbiology and Immunology. 1978; 164(4): 291-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=45604&dopt=Abstract
•
C-peptide and HLA antigens in long-standing juvenile diabetes. Author(s): Joron GE, Shuster J, Webb JL. Source: Diabetes Care. 1980 November-December; 3(6): 703-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7004816&dopt=Abstract
22
Juvenile Diabetes
•
C-Peptide and the remission phase of juvenile diabetes. Author(s): Block MB. Source: Diabetes Care. 1978 September-October; 1(5): 330. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=720188&dopt=Abstract
•
C-peptide in children with juvenile diabetes. A preliminary report. Author(s): Ludvigsson J, Heding LG. Source: Diabetologia. 1976 December; 12(6): 627-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1001852&dopt=Abstract
•
C-peptide in juvenile diabetes. Author(s): Ludvigsson J, Heding LG. Source: Acta Paediatr Scand Suppl. 1977; (270): 53-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=356517&dopt=Abstract
•
C-peptide secretion during the remission phase of juvenile diabetes. Author(s): Heinze E, Beischer W, Keller L, Winkler G, Teller WM, Pfeiffer EF. Source: Diabetes. 1978 June; 27(6): 670-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=350677&dopt=Abstract
•
Cystathioninuria, mental retardation, and juvenile diabetes mellitus. Author(s): AvRuskin TW, Kang ES. Source: Am J Dis Child. 1974 February; 127(2): 250-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4810279&dopt=Abstract
•
Cystic fibrosis and juvenile diabetes mellitus: a case report. Author(s): Poncher JR, Rowley WF, Traisman HS. Source: J Indiana State Med Assoc. 1967 July; 60(7): 907-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6042794&dopt=Abstract
•
Daily production and metabolic clearance of growth hormone in juvenile diabetes mellitus. Author(s): Sperling MA, Wollesen F, DeLamater PV. Source: Diabetologia. 1973 October; 9(5): 380-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4773197&dopt=Abstract
•
Delayed-type hypersensitivity and juvenile diabetes mellitus. Author(s): Mejia-Laguna JE, P erez-Pasten E, Magos C, Zorrilla E. Source: Lancet. 1972 March 4; 1(7749): 542. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4110042&dopt=Abstract
Studies
23
•
Diabetes II: Can good control prevent degenerative complications of juvenile diabetes mellitus? Author(s): Marr TJ, Traisman HS, Traisman ES. Source: J Kans Med Soc. 1982 June; 83(6): 291-4. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7108335&dopt=Abstract
•
Diagnostic value of retinal fluorescence angiography in juvenile diabetes. Author(s): Barta L, Brooser G, Molnar M. Source: Acta Paediatr Acad Sci Hung. 1971; 12(3): 243-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5148787&dopt=Abstract
•
Dietary fats, the diurnal blood lipids and ketones in juvenile diabetes. Author(s): Sterky GC, Persson BE, Larsson YA. Source: Diabetologia. 1966 June; 2(1): 14-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6005287&dopt=Abstract
•
Digital sclerosis and juvenile diabetes. Author(s): Gonzalez T, Gantes M, Diaz-Flores L. Source: Arthritis and Rheumatism. 1984 April; 27(4): 478-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6712763&dopt=Abstract
•
Disease and family contributors to adaptation in juvenile rheumatoid arthritis and juvenile diabetes. Author(s): Frank RG, Hagglund KJ, Schopp LH, Thayer JF, Vieth AZ, Cassidy JT, Goldstein DE, Beck NC, Clay DL, Hewett JE, Johnson JC, Chaney JM, Kashani JH. Source: Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association. 1998 June; 11(3): 166-76. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9782808&dopt=Abstract
•
Does milk cause juvenile diabetes? Author(s): Cerrato PL. Source: Rn. 1993 January; 56(1): 69-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8451586&dopt=Abstract
•
Early detection of nephropathy in juvenile diabetes. Author(s): Morgese G, Chiarelli F, La Penna G, Verrotti A. Source: J Endocrinol Invest. 1989; 12(8 Suppl 3): 139-40. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2809091&dopt=Abstract
24
Juvenile Diabetes
•
Early diagnosis of retinopathy in juvenile diabetes by fluorescein angiography. Author(s): Toussaint D, Quaetaert M, Dorchy H, Loeb H. Source: Acta Paediatr Belg. 1976 July-September; 29(3): 177-80. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1007919&dopt=Abstract
•
Early onset juvenile diabetes mellitus controlled with nicotinic acid therapy. Author(s): Singh GR, Menon PS, Shah P, Virmani A. Source: Indian J Pediatr. 1994 July-August; 61(4): 441-2. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8002078&dopt=Abstract
•
Early onset juvenile diabetes mellitus controlled with nicotinic acid therapy. Author(s): Karmarkar DP, Rajput CS, Wagh SS, Kelkar PS. Source: Indian J Pediatr. 1993 November-December; 60(6): 825-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8200710&dopt=Abstract
•
Educational video game for juvenile diabetes: results of a controlled trial. Author(s): Brown SJ, Lieberman DA, Germeny BA, Fan YC, Wilson DM, Pasta DJ. Source: Med Inform (Lond). 1997 January-March; 22(1): 77-89. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9183781&dopt=Abstract
•
EEG abnormalities and convulsions in juvenile diabetes mellitus. Author(s): Keene DL, Metrakos K, Belmonte M, Watters GV, Singer S. Source: The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 1983 August; 10(3): 198-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6616350&dopt=Abstract
•
Effect of exogenous insulin on fasting serum levels of gastric inhibitory polypeptide (GIP) in juvenile diabetes. Author(s): Talaulicar M, Ebert R, Willms B, Creutzfeldt W. Source: Clinical Endocrinology. 1981 February; 14(2): 175-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7021006&dopt=Abstract
•
Effect of insulin on serum lipids in juvenile diabetes. Author(s): Barta L, Molnar M, Polgar M, Tichy M. Source: Acta Paediatr Acad Sci Hung. 1976; 17(2): 117-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1032732&dopt=Abstract
•
Effect of intravenous tolbutamide in juvenile diabetes mellitus. Author(s): de Belle R, Belmonte MM, Colle E. Source: Diabetes. 1967 April; 16(4): 215-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6023163&dopt=Abstract
Studies
25
•
Elevated levels of serum free non-glucose carbohydrates in juvenile diabetes. Author(s): Radhakrishnamurthy B, Fellman R, Berenson GS. Source: Hormone and Metabolic Research. Hormon- Und Stoffwechselforschung. Hormones Et Metabolisme. 1985 April; 17(4): 213-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4007772&dopt=Abstract
•
Emotional factors in juvenile diabetes mellitus: a study of early life experience of adolescent diabetics. Author(s): Stein SP, Charles E. Source: The American Journal of Psychiatry. 1971 December; 128(6): 700-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5147725&dopt=Abstract
•
Emotional factors in juvenile diabetes mellitus: a study of the early life experiences of eight diabetic children. Author(s): Stein SP, Charles ES. Source: Psychosomatic Medicine. 1975 May-June; 37(3): 237-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1058506&dopt=Abstract
•
End-stage renal failure in juvenile diabetes mellitus: a 5-year follow-up of treatment. Author(s): Mitchell JC. Source: Mayo Clinic Proceedings. 1977 May; 52(5): 281-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=323585&dopt=Abstract
•
Epidemiological and virological observations on juvenile diabetes. Author(s): Gamble DR. Source: Postgraduate Medical Journal. 1974 August; 50 Suppl 3: 538-43. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4467150&dopt=Abstract
•
Erythrocyte membrane cholesterol content in juvenile diabetes. Preliminary communication. Author(s): Sarnecka-Keller M, Kordowiak A, Ciba T. Source: Acta Med Pol. 1980; 21(3): 253-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7246218&dopt=Abstract
•
Etiologic variability of nephropathy in juvenile diabetes mellitus. Author(s): Gilboa N, Durante D, McIntosh RM, Guggenheim S. Source: Archives of Pathology & Laboratory Medicine. 1979 August; 103(9): 479-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=582380&dopt=Abstract
26
Juvenile Diabetes
•
Evaluation of dermatoglyphics in juvenile diabetes mellitus. Author(s): Saksena PN, Thakur S. Source: Indian Pediatrics. 1979 February; 16(2): 109-15. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=457225&dopt=Abstract
•
Factitial panniculitis and necrotizing fasciitis in juvenile diabetes. Author(s): Oh C, Ginsberg-Fellner F, Dolger H. Source: Diabetes. 1975 September; 24(9): 856-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1158045&dopt=Abstract
•
Familial perceptions of juvenile diabetes. Author(s): Kronenfeld JJ, Ory MG. Source: Postgraduate Medicine. 1981 October; 70(4): 83-95. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7291096&dopt=Abstract
•
Family interaction and metabolic balance in juvenile diabetes mellitus. A prospective study. Author(s): Gustafsson PA, Cederblad M, Ludvigsson J, Lundin B. Source: Diabetes Research and Clinical Practice. 1987 November; 4(1): 7-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3691301&dopt=Abstract
•
Family management style in juvenile diabetes: a case illustration. Author(s): Gallo AM. Source: Journal of Pediatric Nursing. 1990 February; 5(1): 23-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2308060&dopt=Abstract
•
Fat metabolism in juvenile diabetes mellitus. Author(s): Barta L, Szamosfalvi I, Tichy MV. Source: Acta Paediatr Acad Sci Hung. 1973; 14(2): 81-4. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4763563&dopt=Abstract
•
Fatty liver hepatitis and type 5 hyperlipoproteinemia in juvenile diabetes mellitus. Case report and review of the literature. Author(s): Lenaerts J, Verresen L, Van Steenbergen W, Fevery J. Source: Journal of Clinical Gastroenterology. 1990 February; 12(1): 93-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2406334&dopt=Abstract
•
Fibrous disease of the breast in juvenile diabetes. Author(s): Logan-Young WW, Hoffman NY. Source: N Y State J Med. 1990 December; 90(12): 618. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2277684&dopt=Abstract
Studies
27
•
Fibrous disease of the breast in juvenile diabetes. Author(s): Gump FE, McDermott J. Source: N Y State J Med. 1990 July; 90(7): 356-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2385388&dopt=Abstract
•
Flexibility of erythrocytes in juvenile diabetes mellitus. Author(s): Tillmann W, Merten A, Lakomek M, Gahr M, Fiechtl J, Schroter W. Source: Blut. 1981 August; 43(2): 125-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7260405&dopt=Abstract
•
Generalized islet hypertrophy and beta-cell hyperplasia in a case of long-term juvenile diabetes. Author(s): Evans DJ. Source: Diabetes. 1972 February; 21(2): 114-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4551161&dopt=Abstract
•
Genetics of juvenile diabetes mellitus. A recessive gene closely linked to HLA D and with 50 per cent penetrance. Author(s): Rubinstein P, Suciu-Foca N, Nicholson JF. Source: The New England Journal of Medicine. 1977 November 10; 297(19): 1036-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=909549&dopt=Abstract
•
Genetics of juvenile diabetes. Author(s): Barbosa J, Noreen H, King R, Yunis EJ. Source: The New England Journal of Medicine. 1978 February 23; 298(8): 462-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=622133&dopt=Abstract
•
Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Author(s): Mogensen CE. Source: Scandinavian Journal of Clinical and Laboratory Investigation. 1971 September; 28(1): 91-100. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5093523&dopt=Abstract
•
Glucagon mediation of growth hormone secretion in juvenile diabetes mellitus. Author(s): Avruskin TW, Tang SC, Juan CS. Source: The American Journal of the Medical Sciences. 1974 June; 267(6): 327-36. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4841903&dopt=Abstract
28
Juvenile Diabetes
•
Glucose-stimulated insulin secretion during “remission” of juvenile diabetes. Author(s): Weber B. Source: Diabetologia. 1972 July; 8(3): 189-95. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4625833&dopt=Abstract
•
Glycosylated hemoglobins and their relation to the control of juvenile diabetes mellitus. Author(s): Schroter W, Jentsch E, Stumpf B, Kubel R, Turner-Heckmann E, Gahr M. Source: Helv Paediatr Acta. 1978 December; 33(6): 535-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=738904&dopt=Abstract
•
Growth failure, somatomedin and growth hormone levels in juvenile diabetes mellitus--a pilot study. Author(s): Nash H. Source: Aust N Z J Med. 1979 June; 9(3): 245-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=223535&dopt=Abstract
•
Growth hormone secretion and kidney function during normalization of the metabolic state in newly diagnosed juvenile diabetes. Author(s): Hansen AP, Mogensen CE. Source: Hormone and Metabolic Research. Hormon- Und Stoffwechselforschung. Hormones Et Metabolisme. 1972 January; 4(1): 11-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5011068&dopt=Abstract
•
Growth in juvenile diabetes mellitus. Author(s): Birkbeck JA. Source: Diabetologia. 1972 July; 8(3): 221-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5047264&dopt=Abstract
•
Growth of rabbit aortic smooth muscle cells in serum from patients with juvenile diabetes. Author(s): Ledet T. Source: Acta Pathol Microbiol Scand [a]. 1976 November; 84(6): 508-16. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=998250&dopt=Abstract
•
Growth pattern in juvenile diabetes. Author(s): Sterky G. Source: Acta Paediatr Scand. 1967; : Suppl 177: 80-2. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5586103&dopt=Abstract
Studies
29
•
High urinary insulin-precursor levels in juvenile diabetes. Author(s): Crossley JR, Elliott RB. Source: Lancet. 1973 June 2; 1(7814): 1259-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4122615&dopt=Abstract
•
HLA and insulin-dependent juvenile diabetes mellitus. Author(s): Majsky A, Dvorakova L. Source: Czech Med. 1983; 6(3): 152-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6416792&dopt=Abstract
•
HLA and juvenile diabetes mellitus in the Japanese. Author(s): Wakisaka A, Aizawa M, Matsuura N, Nakagawa S, Nakayama E. Source: Lancet. 1976 October 30; 2(7992): 970. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=62204&dopt=Abstract
•
HLA and the genetic aspects of the predisposition to juvenile diabetes mellitus. A follow-up. Author(s): Rubinstein P, Suciu-Foca N. Source: Advances in Experimental Medicine and Biology. 1979; 119: 33-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=495290&dopt=Abstract
•
HLA antigen in Jewish patients with juvenile diabetes mellitus. Author(s): Gazit E, Sartani A, Mizrachi Y, Ravid M. Source: Diabete Metab. 1977 March; 3(1): 55-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=858444&dopt=Abstract
•
HLA antigens and susceptibility to juvenile diabetes: do additive relative risks imply genetic heterogeneity? Author(s): Curie-Cohen M. Source: Tissue Antigens. 1981 February; 17(2): 136-48. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7233414&dopt=Abstract
•
HLA antigens in patients with juvenile diabetes and their first-degree relatives. Author(s): Krawisz JE, Palumbo PJ, Taswell HF, Elveback LR. Source: Mayo Clinic Proceedings. 1978 December; 53(12): 782-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=732354&dopt=Abstract
•
HLA antigens in patients with juvenile diabetes mellitus, coeliac disease and both of the diseases. Author(s): Koivisto VA, Kuitunen P, Tiilikainen A, Akerblom HK. Source: Diabete Metab. 1977 March; 3(1): 49-53. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=870355&dopt=Abstract
30
Juvenile Diabetes
•
HLA in American blacks with juvenile diabetes. Author(s): Neufeld MR, Maclaren NK, Riley WJ. Source: The New England Journal of Medicine. 1980 July 10; 303(2): 111-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7383065&dopt=Abstract
•
HLA in juvenile diabetes. Author(s): Reitnauer PJ, Roseman JM, Barger BO, Murphy CC, Acton RT. Source: The New England Journal of Medicine. 1980 February 14; 302(7): 406. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7351936&dopt=Abstract
•
HLA in juvenile diabetes. Author(s): MacDonald MJ, Curie-Cohen M. Source: The New England Journal of Medicine. 1980 February 14; 302(7): 405-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7351935&dopt=Abstract
•
HLA, autoimmunity, virus and the pathogenesis of juvenile diabetes mellitus. Author(s): Nerup J, Andersen OO, Christy M, Platz P, Ryder L, Thomsen M, Svejgaard A. Source: Acta Endocrinol Suppl (Copenh). 1976; 205: 167-75. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=793277&dopt=Abstract
•
HLA-antigens and some autoimmune features of juvenile diabetes mellitus. Author(s): Karmazsin L, Ambro I, Stenszky V, Kozma L, Balazs C, Svetlana K. Source: Acta Paediatr Acad Sci Hung. 1979; 20(1): 11-19. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=532626&dopt=Abstract
•
HLA-D--related (DRw) antigens in juvenile diabetes mellitus. Author(s): Farid NR, Sampson L, Noel P, Barnard JM, Davis AJ, Hillman DA. Source: Diabetes. 1979 June; 28(6): 552-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=446915&dopt=Abstract
•
HLA-Dw3 as a marker of resistance against juvenile diabetes mellitus. Author(s): Ilonen J, Herva E, Tiilikainen A, Akerblom HK, Koivukangas T, Kouvalainen K. Source: Tissue Antigens. 1978 February; 11(2): 144-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=77059&dopt=Abstract
•
HLA-types, C-peptide and insulin antibodies in juvenile diabetes. Author(s): Ludvigsson J, Safwenberg J, Heding LG. Source: Diabetologia. 1977 January; 13(1): 13-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=838199&dopt=Abstract
Studies
31
•
Hyperthyroidism in juvenile diabetes mellitus. Author(s): Hung W, August GP, Glasgow AM. Source: Pediatrics. 1978 April; 61(4): 583-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=96415&dopt=Abstract
•
Immunogenetics of insulin-dependent juvenile diabetes. Author(s): Dausset J, Hors J. Source: Diabetes Res. 1984 September; 1(3): 115-23. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6085045&dopt=Abstract
•
Immunopathology of juvenile-onset diabetes mellitus. I. IgA deficiency and juvenile diabetes. Author(s): Smith WI Jr, Rabin BS, Huellmantel A, Van Thiel DH, Drash A. Source: Diabetes. 1978 November; 27(11): 1092-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=720769&dopt=Abstract
•
Impaired leukotactic responsiveness in patients with juvenile diabetes mellitus. Author(s): Hill HR, Sauls HS, Dettloff JL, Quie PG. Source: Clinical Immunology and Immunopathology. 1974 April; 2(3): 395-403. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4826528&dopt=Abstract
•
Impairment of granulocyte function in juvenile diabetes. Author(s): Niethammer D, Heinze E, Teller W, Kleihauer E, Wildfeuer A, Haferkamp O. Source: Klin Wochenschr. 1975 November 15; 53(22): 1057-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=775181&dopt=Abstract
•
Importance of outpatient supervision in the prognosis of juvenile diabetes mellitus: a cost/benefit analysis. Author(s): Deckert T, Poulsen JE, Larsen M. Source: Diabetes Care. 1978 September-October; 1(5): 281-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=102503&dopt=Abstract
•
Incidence and significance of muscle capillary basal lamina thickness in juvenile diabetes. Author(s): Pardo V, Perez-Stable E, Alzamora DB, Cleveland WW. Source: American Journal of Pathology. 1972 July; 68(1): 67-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5080699&dopt=Abstract
32
Juvenile Diabetes
•
Increased integrated concentration of norepinephrine, epinephrine, aldosterone, and growth hormone in patients with uncontrolled juvenile diabetes mellitus. Author(s): Zadik Z, Kayne R, Kappy M, Plotnick LP, Kowarski AA. Source: Diabetes. 1980 August; 29(8): 655-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7439544&dopt=Abstract
•
Increased kidney size and glomerular filtration rate in early juvenile diabetes. Author(s): Mogensen CE, Andersen MJ. Source: Diabetes. 1973 September; 22(9): 706-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4728209&dopt=Abstract
•
Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: normalization by insulin-treatment. Author(s): Mogensen CE, Andersen MJ. Source: Diabetologia. 1975 June; 11(3): 221-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1149954&dopt=Abstract
•
Index-binding index in juvenile diabetes. Author(s): Marks JF, Wolfson JH, Hamlin M, Freeman B. Source: Diabetes. 1966 April; 15(4): 276-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5929543&dopt=Abstract
•
Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes. Author(s): Creutzfeldt W, Talaulicar M, Ebert R, Willms B. Source: Diabetes. 1980 February; 29(2): 140-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6986299&dopt=Abstract
•
Insulin antibodies in juvenile diabetes mellitus. Correlations to diabetic stability, insulin requirement and duration of insulin treatment. Author(s): Keilacker H, Rjasanowski I, Ziegler M, Michaelis D, Woltanski KP, Besch W. Source: Hormone and Metabolic Research. Hormon- Und Stoffwechselforschung. Hormones Et Metabolisme. 1982 May; 14(5): 227-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7047344&dopt=Abstract
•
Insulin resistance in juvenile diabetes mellitus. Immunologic studies. Author(s): Faulk WP, Tomsovic EJ, Fudenberg HH. Source: The American Journal of Medicine. 1970 July; 49(1): 133-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4988190&dopt=Abstract
Studies
33
•
Insulin-like insulinase-resistant material, distinguishable from normal insulin, in juvenile diabetes. Author(s): Crossley JR, Elliott RB. Source: Diabetes. 1975 July; 24(7): 609-17. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1171803&dopt=Abstract
•
Interest of blood glucose values determined at home in juvenile diabetes. Author(s): Ernould C, Graff MP. Source: Acta Paediatr Belg. 1978 January-March; 31(1): 53-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=665235&dopt=Abstract
•
Intra-HLA recombinations in juvenile diabetes mellitus. Author(s): Rubinstein P, Nicholson JF, Suciu-Foca N. Source: Diabete Metab. 1977 September; 3(3): 199-204. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=913752&dopt=Abstract
•
Is juvenile diabetes a viral disease? Author(s): Fohlman J, Friman G. Source: Annals of Medicine. 1993 December; 25(6): 569-74. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8292308&dopt=Abstract
•
Is juvenile diabetes determined by a single gene closely linked to HLA? Author(s): Suarez B, Hodge SE, Reich T. Source: Diabetes. 1979 June; 28(6): 527-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=446910&dopt=Abstract
•
Is mumps virus an etiologic factor in juvenile diabetes mellitus. Author(s): Sultz HA, Hart BA, Zielezny M, Schlesinger ER. Source: The Journal of Pediatrics. 1975 April; 86(4): 654-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1127521&dopt=Abstract
•
Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Author(s): Gepts W, De Mey J. Source: Diabetes. 1978; 27 Suppl 1: 251-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=75815&dopt=Abstract
•
Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Author(s): Lendrum R, Walker G, Gamble DR. Source: Lancet. 1975 April 19; 1(7912): 880-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=47533&dopt=Abstract
34
Juvenile Diabetes
•
Islet-cell-surface antibodies in juvenile diabetes mellitus. Author(s): Lernmark A, Freedman ZR, Hofmann C, Rubenstein AH, Steiner DF, Jackson RL, Winter RJ, Traisman HS. Source: The New England Journal of Medicine. 1978 August 24; 299(8): 375-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=353557&dopt=Abstract
•
Islets of Langerhans in juvenile diabetes mellitus. Author(s): Doniach I, Morgan AG. Source: Clinical Endocrinology. 1973 July; 2(3): 233-48. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4586527&dopt=Abstract
•
Juvenile diabetes and periodontitis. Author(s): Hoge HW, Kirkham DB. Source: Dent Surv. 1978 October; 54(10): 27-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=289602&dopt=Abstract
•
Juvenile diabetes and social class. Author(s): Debono J, Johnson C, Betts P. Source: Lancet. 1983 May 14; 1(8333): 1113-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6133150&dopt=Abstract
•
Juvenile diabetes and the heart. Author(s): Cooper RS. Source: Pediatric Clinics of North America. 1984 June; 31(3): 653-63. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6374592&dopt=Abstract
•
Juvenile Diabetes Foundation Diabetic Nephropathy Workshop, Minneapolis, 1989. Author(s): Bilous RW. Source: Diabetic Medicine : a Journal of the British Diabetic Association. 1990 February; 7(2): 181-2. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2137764&dopt=Abstract
•
Juvenile diabetes manifesting as epilepsia partialis continua. Author(s): Sabharwal RK, Gupta M, Sharma D, Puri V. Source: J Assoc Physicians India. 1989 September; 37(9): 603-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2517290&dopt=Abstract
•
Juvenile diabetes mellitus among Nigerians: problems of long-term management. Author(s): Azubuike JC. Source: East Afr Med J. 1979 July; 56(7): 331-4. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=520245&dopt=Abstract
Studies
35
•
Juvenile diabetes mellitus and optic atrophy. Author(s): Lessell S, Rosman NP. Source: Archives of Neurology. 1977 December; 34(12): 759-65. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=588096&dopt=Abstract
•
Juvenile diabetes mellitus and the HLA system. Author(s): Suciu-Foca N, Rubinstein P, Nicholson J, Susinno E, Weiner J, Godfrey M, Hardy M, Rayfield E, Reemtsma K. Source: Transplantation Proceedings. 1979 June; 11(2): 1309-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=473359&dopt=Abstract
•
Juvenile diabetes mellitus clinical spectrum in Zambian children. Author(s): Sehgal D, Raghu MB, Chintu C. Source: Med J Zambia. 1981 May-July; 15(3): 84-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6812307&dopt=Abstract
•
Juvenile diabetes mellitus in Singapore children. Author(s): Wong HB. Source: J Singapore Paediatr Soc. 1981; 23(1-2): 47-64. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6806537&dopt=Abstract
•
Juvenile diabetes mellitus masquerading as disseminated candidiasis. Author(s): Krishnan J, Gupta P. Source: Indian Pediatrics. 1997 March; 34(3): 257-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9282498&dopt=Abstract
•
Juvenile diabetes mellitus with 50-year survival. Author(s): Kalan JM, Dressler FA, Romain KE, Gallivan MV, Roberts WC. Source: The American Journal of Cardiology. 1988 November 15; 62(16): 1144-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3189183&dopt=Abstract
•
Juvenile diabetes mellitus with hypothyroidism. Author(s): Vaishnava S, Choudhury P. Source: Indian Pediatrics. 1981 March; 18(3): 209-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7263025&dopt=Abstract
•
Juvenile diabetes mellitus with Somogyi phenomenon--concomitant grand mal epilepsy--diagnostic and therapeutic dilemma. Author(s): Albert RJ. Source: J Maine Med Assoc. 1979 November; 70(11 Suppl): 26-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=119022&dopt=Abstract
36
Juvenile Diabetes
•
Juvenile diabetes mellitus. Author(s): Marshall RN Jr. Source: American Family Physician. 1982 January; 25(1): 193-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6798853&dopt=Abstract
•
Juvenile diabetes mellitus. Author(s): Cohen T. Source: Isr J Med Sci. 1979 December; 15(12): 1009-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=528182&dopt=Abstract
•
Juvenile diabetes mellitus: a reassessment of etiology clinical expression and therapy. Author(s): AvRuskin TW. Source: J Nurs Care. 1978 October; 11(10): 10-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=308640&dopt=Abstract
•
Juvenile diabetes mellitus: a reassessment of etiology, clinical expression and therapy. Author(s): AvRuskin TW. Source: Nurs Care. 1978 March; 11(3): 8-11. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=245642&dopt=Abstract
•
Juvenile diabetes mellitus: possibility of prevention. Author(s): Farquhar JW. Source: Archives of Disease in Childhood. 1979 August; 54(8): 569-80. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=389172&dopt=Abstract
•
Juvenile diabetes mellitus--a risk factor for postoperative venous thromboembolism? Author(s): Bergqvist D, Arnadottir M, Bergentz SE, Bornmyr S, Husberg B, Lindholm T, Konrad P. Source: Acta Med Scand. 1985; 217(3): 307-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3887853&dopt=Abstract
•
Juvenile diabetes. Author(s): Rose V. Source: Midwife Health Visit Community Nurse. 1981 September; 17(9): 372-4. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6914449&dopt=Abstract
•
Juvenile diabetes: current trends in psychosocial research. Author(s): Kosub SM, Cerreto MC. Source: Social Work in Health Care. 1981 Summer; 6(4): 91-101. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7323939&dopt=Abstract
Studies
37
•
Juvenile diabetes: impact on the child and family. Author(s): Tarnow JD, Tomlinson N. Source: Psychosomatics. 1978 August; 19(8): 487-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=693781&dopt=Abstract
•
Juvenile diabetes--a team approach. Author(s): Paxinos R, Ferguson R. Source: J Hum Nutr. 1978 August; 32(4): 294-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=712057&dopt=Abstract
•
Kidney function and glomerular permeability to macromolecules in early juvenile diabetes. Author(s): Mogensen CE. Source: Scandinavian Journal of Clinical and Laboratory Investigation. 1971 September; 28(1): 79-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5093522&dopt=Abstract
•
Kidney function and glomerular permeability to macromolecules in juvenile diabetes with special reference to early changes. Author(s): Mogensen CE. Source: Dan Med Bull. 1972 September; 19: Suppl 3: 1-40. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4642311&dopt=Abstract
•
Lanthony 15-Hue Desaturated Test for screening of early color vision defects in uncomplicated juvenile diabetes. Author(s): Giusti C. Source: Japanese Journal of Ophthalmology. 2001 November-December; 45(6): 607-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11754902&dopt=Abstract
•
Letter: Abnormal lung elasticity in juvenile diabetes mellitus. Author(s): Brown R, Wellman JJ. Source: Am Rev Respir Dis. 1976 June; 113(6): 894-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=937825&dopt=Abstract
•
Letter: Aetiology of juvenile diabetes. Author(s): Rolles CJ, Rayner PH, Mackintosh P. Source: Lancet. 1975 August 2; 2(7927): 230. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=51984&dopt=Abstract
38
Juvenile Diabetes
•
Letter: Association between HLA-B8 and autoimmunity in juvenile diabetes mellitus. Author(s): Christy M, Nerup J, Bottazzo GF, Doniach D, Platz P, Svejgaard A, Ryder LP, Thomsen M. Source: Lancet. 1976 July 17; 2(7977): 142-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=59201&dopt=Abstract
•
Letter: Intra-HLA recombination frequency in juvenile diabetes. Author(s): Mayr WR, Schernthaner G, Ludwig H. Source: Lancet. 1976 April 17; 1(7964): 865. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=56689&dopt=Abstract
•
Letter: Intra-HLA recombinations in juvenile diabetes mellitus. Author(s): Suciu-Foca N, Rubinstein P. Source: Lancet. 1976 February 14; 1(7955): 371-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=54787&dopt=Abstract
•
Letter: Is there a sex difference in juvenile diabetes? Author(s): Rosenbloom AL, Giordano B. Source: The Journal of Pediatrics. 1975 July; 87(1): 150-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1151538&dopt=Abstract
•
Letter: Juvenile diabetes and viruses. Author(s): Barbosa J, Noreen H, Goetz F, Simmons R, Najarian J, Yunis EJ. Source: Lancet. 1976 February 14; 1(7955): 371. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=54786&dopt=Abstract
•
Letter: Sex difference in juvenile diabetes mellitus. Author(s): Monteleone JA, Peden VH, Hale RE. Source: The Journal of Pediatrics. 1974 December; 85(6): 874-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4420065&dopt=Abstract
•
Letter: Weight-gain in infancy and development of juvenile diabetes mellitus. Author(s): Karam JH, Grodsky GM, Forsham PH. Source: Lancet. 1976 January 3; 1(7949): 45. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=54553&dopt=Abstract
•
Leukocyte functions in juvenile diabetes mellitus: humoral and cellular aspects. Author(s): Miller ME, Baker L. Source: The Journal of Pediatrics. 1972 November; 81(5): 979-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5086727&dopt=Abstract
Studies
39
•
Levels of the second component of complement and serum insulin in early juvenile diabetes. Author(s): Zorrilla E, Ohrenberg C, Soeldner JS, Sheffer AL. Source: Lahey Clin Found Bull. 1969 April-June; 18(2): 55-63. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5807303&dopt=Abstract
•
Limited joint mobility and retinopathy in juvenile diabetes. Author(s): Gandola CD. Source: Jama : the Journal of the American Medical Association. 1982 October 22; 248(16): 1975. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7120624&dopt=Abstract
•
Living with juvenile diabetes mellitus. Author(s): Ory MG, Kronenfeld JJ. Source: Pediatric Nursing. 1980 September-October; 6(5): 47-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6902829&dopt=Abstract
•
Long-term juvenile diabetes treated with unmeasured diet. Author(s): Knowles HC Jr. Source: Trans Assoc Am Physicians. 1971; 84: 95-101. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5164308&dopt=Abstract
•
Loss of autoregulation of blood flow in subcutaneous tissue in juvenile diabetes. Author(s): Henriksen O, Kastrup J, Parving HH, Lassen NA. Source: Journal of Cardiovascular Pharmacology. 1984; 6 Suppl 4: S666-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6083409&dopt=Abstract
•
Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebocontrolled double blind trial. Author(s): Coutant R, Landais P, Rosilio M, Johnsen C, Lahlou N, Chatelain P, Carel JC, Ludvigsson J, Boitard C, Bougneres PF. Source: Diabetologia. 1998 September; 41(9): 1040-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9754822&dopt=Abstract
•
Management of childhood diseases during the Byzantine period: IV -- juvenile diabetes mellitus. Author(s): Ramoutsaki IA, Dimitriou H, Markaki EA, Kalmanti M. Source: Pediatrics International : Official Journal of the Japan Pediatric Society. 2002 August; 44(4): 463-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12139581&dopt=Abstract
40
Juvenile Diabetes
•
Management of juvenile diabetes mellitus. Author(s): Garfunkel JM. Source: The Journal of Pediatrics. 1981 December; 99(6): 911. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7031211&dopt=Abstract
•
Management of juvenile diabetes mellitus. Author(s): Chaney C, Elders MJ. Source: J Ark Med Soc. 1975 August; 72(3): 111-27. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=125737&dopt=Abstract
•
Management of juvenile diabetes mellitus: usefulness of 24-hour fractional quantitative urine glucose. Author(s): Forman BH, Goldstein PS, Genel M. Source: Pediatrics. 1974 February; 53(2): 257-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4812010&dopt=Abstract
•
Management of juvenile diabetes. Author(s): Moss JM. Source: Gp. 1968 July; 38(1): 78-82. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5666472&dopt=Abstract
•
Matching of host genotype and serotypes of Coxsackie B virus in the development of juvenile diabetes. Author(s): Fohlman J, Bohme J, Rask L, Frisk G, Diderholm H, Friman G, Tuvemo T. Source: Scandinavian Journal of Immunology. 1987 August; 26(2): 105-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2888188&dopt=Abstract
•
Metabolic clearance rate of growth hormone in juvenile diabetes mellitus. Author(s): Lipman RL, Taylor AL, Conly P, Mintz DH. Source: Diabetes. 1972 March; 21(3): 175-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5011982&dopt=Abstract
•
Metabolic considerations in the treatment of juvenile diabetes mellitus. Author(s): Bacon GE, Parkhurst RD. Source: The Medical Clinics of North America. 1969 November; 53(6): 1367-78. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4982939&dopt=Abstract
•
Metabolic homeostasis in juvenile diabetes mellitus. I. Role of growth hormone. Author(s): Baker L, Root AW, Haque N, Kaye R. Source: Metabolism: Clinical and Experimental. 1969 February; 18(2): 110-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5812400&dopt=Abstract
Studies
41
•
Metabolic homeostasis in juvenile diabetes mellitus. II. Increased ketone responsiveness to epinephrine. Author(s): Baker L, Kaye R, Haque N. Source: Diabetes. 1969 June; 18(6): 421-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5795855&dopt=Abstract
•
Microheterogeneity of urinary albumin and tubular proteinuria in juvenile diabetes mellitus. Author(s): Ries M, Scharer K, Wartha R, Schmidt H, Gekle D. Source: Pediatric Nephrology (Berlin, Germany). 1991 September; 5(5): 582-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1911142&dopt=Abstract
•
Mild carbohydrate intolerance developing into classic juvenile diabetes. Author(s): Johansen K. Source: Acta Med Scand. 1971 May; 189(5): 337-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5578484&dopt=Abstract
•
MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Author(s): Thomsen M, Platz P, Andersen OO, Christy M, Lyngsooe, Nerup J, Rasmussen K, Ryder LP, Nielsen LS, Svejgaard A. Source: Transplant Rev. 1975; 22: 125-47. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=46642&dopt=Abstract
•
Mode of presentation of juvenile diabetes. Author(s): Hamilton DV, Mundia SS, Lister J. Source: British Medical Journal. 1976 July 24; 2(6029): 211-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=974495&dopt=Abstract
•
Morphological abnormalities of the terminal neuromuscular apparatus in recent juvenile diabetes. Author(s): Reske-Nielsen E, Gregersen G, Harmsen A, Lundbaek K. Source: Diabetologia. 1970 April; 6(2): 104-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4192894&dopt=Abstract
•
Morphometric studies of the peripheral glomerular basement membrane in early juvenile diabetes. I. Development of initial basement membrane thickening. Author(s): Osterby R. Source: Diabetologia. 1972 April; 8(2): 84-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5031267&dopt=Abstract
42
Juvenile Diabetes
•
Mortality in juvenile diabetes mellitus over 25 years. Author(s): Smith CS, Hudson FP. Source: Archives of Disease in Childhood. 1976 April; 51(4): 297-300. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1275543&dopt=Abstract
•
Mozambin activation of EEG in infantile and juvenile diabetes. Author(s): Lesny I, Rakosnikova M, Dymova N. Source: Electroencephalography and Clinical Neurophysiology. 1971 March; 30(3): 2756. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4103249&dopt=Abstract
•
Muscle capillary basement membrane in juvenile diabetes mellitus. Author(s): Danowski TS, Fisher ER, Khurana RC, Nolan S, Stephan T. Source: Metabolism: Clinical and Experimental. 1972 December; 21(12): 1125-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4641955&dopt=Abstract
•
Myasthenia gravis, primary adrenocortical insufficiency, and juvenile diabetes mellitus in a twelve-year-old boy. Author(s): Andler W. Source: Klinische Padiatrie. 1983 March; 195(2): 133-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6343711&dopt=Abstract
•
Nerve conduction velocity determinations in juvenile diabetes: continuing study of 190 patients. Author(s): Eng GD, Hung W, August GP, Smokvina MD. Source: Archives of Physical Medicine and Rehabilitation. 1976 January; 57(1): 1-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1247369&dopt=Abstract
•
No relation between HL-A and juvenile diabetes. Author(s): Finkelstein S, Zeller E, Walford RL. Source: Tissue Antigens. 1972; 2(1): 74-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5077734&dopt=Abstract
•
Nonenzymatic protein glycosylation. I. Lowered erythrocyte membrane fluidity in juvenile diabetes. Author(s): Watala C, Zawodniak M, Bryszewska M, Nowak S. Source: Ann Clin Res. 1985; 17(6): 327-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4096489&dopt=Abstract
Studies
43
•
Optic atrophy and juvenile diabetes mellitus with familial occurrence. Author(s): Rorsman G, Soderstrom N. Source: Acta Med Scand. 1967 October; 182(4): 419-25. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6054825&dopt=Abstract
•
Osteopenia in juvenile diabetes. Author(s): Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ. Source: Calcified Tissue International. 1981; 33(5): 455-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6797697&dopt=Abstract
•
Overcoming juvenile diabetes with a little planning and high-tech tools. Author(s): McNamara D. Source: Fda Consumer. 2000 July-August; 34(4): 28-32. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11924632&dopt=Abstract
•
Parent and child perceptions of the management of juvenile diabetes. Author(s): Allen DA, Tennen H, McGrade BJ, Affleck G, Ratzan S. Source: Journal of Pediatric Psychology. 1983 June; 8(2): 129-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6875761&dopt=Abstract
•
Peripheral blood flow and metabolic control in juvenile diabetes. Author(s): Gundersen HJ. Source: Diabetologia. 1974 June; 10(3): 225-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4845723&dopt=Abstract
•
Peripheral neuropathy in juvenile diabetes mellitus. Author(s): Ramji S, Khandpur SC. Source: Indian Pediatrics. 1986 April; 23(4): 259-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3744495&dopt=Abstract
•
Phentolamine and juvenile diabetes. Author(s): Cegrell L. Source: Lancet. 1972 December 30; 2(7792): 1421. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4118710&dopt=Abstract
•
Physical exercise and juvenile diabetes--summary and conclusions. Author(s): Larsson Y. Source: Acta Paediatr Scand Suppl. 1980; 283: 120-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7010899&dopt=Abstract
44
Juvenile Diabetes
•
Physical exercise therapy in juvenile diabetes mellitus. Author(s): Jung K. Source: The Journal of Sports Medicine and Physical Fitness. 1982 March; 22(1): 23-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7132312&dopt=Abstract
•
Physical training in juvenile diabetes. Author(s): Koivisto VA, Groop L. Source: Ann Clin Res. 1982; 14 Suppl 34: 74-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6756276&dopt=Abstract
•
Plasma and urinary beta-hexosaminidase in juvenile diabetes mellitus. Author(s): Hanseus K, Hultberg B, Isaksson A, Sjoblad S. Source: Acta Paediatr Scand. 1983 January; 72(1): 77-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6222591&dopt=Abstract
•
Platelet Na(+)-H+ exchange in juvenile diabetes mellitus. Author(s): Salles JP, Ser N, Fauvel J, Couvaras O, Bouissou F, Ghisolfi J, Barthe P, Chap H. Source: Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 1991 December; 9(6): S222-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1667997&dopt=Abstract
•
Possible localization of the gene(s) for juvenile diabetes mellitus (JDM) to the HLA region of chromosome 6. Author(s): Falk CT, Suciu-Foca N, Rubinstein P. Source: Cytogenetics and Cell Genetics. 1978; 22(1-6): 298-300. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=752490&dopt=Abstract
•
Post-mortem histology of the islets of Langerhans in juvenile diabetes mellitus. Author(s): Doniach I. Source: Postgraduate Medical Journal. 1974 August; 50 Suppl 3: 544-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4619441&dopt=Abstract
•
Predictive value of biological markers in etiopathogenesis of juvenile diabetes-reviewing the role of insulin antibodies. Author(s): Vlaski J, Stefan S, Katanic D, Vukadinovic I, Babic L. Source: Med Pregl. 1998 May-June; 51(5-6): 221-7. English, Croatian. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9720347&dopt=Abstract
Studies
45
•
Prevalence of periodontal disease in insulin-dependent diabetes mellitus (juvenile diabetes). Author(s): Cianciola LJ, Park BH, Bruck E, Mosovich L, Genco RJ. Source: The Journal of the American Dental Association. 1982 May; 104(5): 653-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7042797&dopt=Abstract
•
Prevention and cure of juvenile diabetes. In our lifetime? Author(s): Atkison PR. Source: Clinical Biochemistry. 1993 August; 26(4): 316-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8242895&dopt=Abstract
•
Progressive optic atrophy associated with juvenile diabetes mellitus: report of two cases among first cousins. Author(s): Chuah G, Seah S, Chee SP. Source: Singapore Med J. 1993 August; 34(4): 343-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8266210&dopt=Abstract
•
Prolonged exercise in adolescent boys with juvenile diabetes mellitus. Circulatory and metabolic responses in relation to perceived exertion. Author(s): Persson B, Thoren C. Source: Acta Paediatr Scand Suppl. 1980; 283: 62-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7010903&dopt=Abstract
•
Prospective study of incidence of juvenile diabetes mellitus over 10 years in Dar es Salaam, Tanzania. Author(s): Swai AB, Lutale JL, McLarty DG. Source: Bmj (Clinical Research Ed.). 1993 June 12; 306(6892): 1570-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8329915&dopt=Abstract
•
Pseudopapilledema of juvenile diabetes mellitus. Author(s): Lubow M, Makley TA Jr. Source: Archives of Ophthalmology. 1971 April; 85(4): 417-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5554869&dopt=Abstract
•
Psychosocial factors in juvenile diabetes: a review. Author(s): Johnson SB. Source: Journal of Behavioral Medicine. 1980 March; 3(1): 95-116. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6995619&dopt=Abstract
46
Juvenile Diabetes
•
Pulmonary mucormycosis and juvenile diabetes. Author(s): Johnson GM, Baldwin JJ. Source: Am J Dis Child. 1981 June; 135(6): 567-8. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7234794&dopt=Abstract
•
Rapitard insulin in the management of juvenile diabetes. Author(s): Court JM, Amies GC. Source: The Medical Journal of Australia. 1973 July 7; 2(1): 5-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4737647&dopt=Abstract
•
Red blood cell electrolyte changes in patients with juvenile diabetes mellitus. Author(s): Roman F, Toldi Z, Kurti K, Pataki L. Source: Acta Paediatr Hung. 1990; 30(2): 233-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2248802&dopt=Abstract
•
Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. Author(s): Tamborlane WV, Sherwin RS, Genel M, Felig P. Source: The New England Journal of Medicine. 1979 March 15; 300(11): 573-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=763270&dopt=Abstract
•
Relationship between glycosylated hemoglobin and postprandial blood glucose in insulin-dependent juvenile diabetes patients. Author(s): Topper E, Karp M, Doron M, Larson Z. Source: Isr J Med Sci. 1979 March; 15(3): 283-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=457377&dopt=Abstract
•
Remission of juvenile diabetes. Author(s): Illig R, Prader A. Source: Lancet. 1968 November 30; 2(7579): 1190. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4176970&dopt=Abstract
•
Remission phase in newly diagnosed insulin treated juvenile diabetes: behaviour of glucose, FFA, HGH and total-IRI during combined glucose arginine infusion; development of antibodies against exogenous insulin. Author(s): Menzel R, Michaelis D, Neumann I, Schultz B, Wilke W, Wulfert P, Michael R, Bibergeil H. Source: Endokrinologie. 1973 August; 62(1): 100-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4785266&dopt=Abstract
Studies
47
•
Remission phase of juvenile diabetes. Author(s): Jackson RL. Source: Diabetes Care. 1979 January-February; 2(1): 62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=510115&dopt=Abstract
•
Renal allografting in the patient with juvenile diabetes mellitus. Author(s): Habal MB, Birtch AG, Kountz SL, Stephans B, Murray JE. Source: American Journal of Surgery. 1972 November; 124(5): 682-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4562571&dopt=Abstract
•
Renal glomerular and tubular function following acute insulin deprivation in juvenile diabetes mellitus. Author(s): Barash Y, Aladjem M, Sack J, Bistritzer T, Theodor R, Orda S, Boichis H. Source: Nephron. 1982; 31(1): 65-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7050753&dopt=Abstract
•
Renal plasma flow in juvenile diabetes. Author(s): Mogensen CE. Source: Acta Endocrinol Suppl (Copenh). 1981; 242: 33-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6940398&dopt=Abstract
•
Renal transplantation. Complications in patients with juvenile diabetes. Author(s): Bakshandeh K, Picache R, Bastounis E, Haberal MA, Husberg BS. Source: Urology. 1975 January; 5(1): 21-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1090044&dopt=Abstract
•
Renal tubular function and urinary acidification capacity in early juvenile diabetes. Author(s): Garcia Puig J, Mateos Anton F, Grande C, Pallardo LF, Arnalich F, Gaspar G, Gil A, Vazquez JJ, Montero A. Source: Hormone and Metabolic Research. Hormon- Und Stoffwechselforschung. Hormones Et Metabolisme. 1981 November; 13(11): 595-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7308970&dopt=Abstract
•
Response to bicycle exercise testing in long-standing juvenile diabetes. Author(s): Storstein L, Jervell J. Source: Acta Med Scand. 1979; 205(3): 227-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=425849&dopt=Abstract
48
Juvenile Diabetes
•
Retinal function in an unique syndrome of optic atrophy, juvenile diabetes mellitus, diabetes insipidus, neurosensory hearing loss, autonomic dysfunction, and hyperalanineuria. Author(s): Niemeyer G, Marquardt JL. Source: Invest Ophthalmol. 1972 July; 11(7): 617-24. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5046561&dopt=Abstract
•
Retinopathy in juvenile diabetes. Author(s): Barta L, Molnar M. Source: Acta Paediatr Acad Sci Hung. 1971; 12(3): 239-42. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5148786&dopt=Abstract
•
Retinopathy of juvenile diabetes: a comparative clinical study. Author(s): Ferrer O. Source: Southern Medical Journal. 1972 December; 65(12): 1448-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4641083&dopt=Abstract
•
Rhinocerebral mucormycosis and juvenile diabetes mellitus: report of a case with recovery. Author(s): Marr TJ, Traismann HS, Davis AT, Kernahan D. Source: Diabetes Care. 1978 July-August; 1(4): 250-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=554789&dopt=Abstract
•
Role of artificial pancreas in juvenile diabetes. Author(s): Rosenbloom AL. Source: The Journal of Pediatrics. 1978 April; 92(4): 689-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=633046&dopt=Abstract
•
Role of epinephrine in metabolic homeostasis of juvenile diabetes. Author(s): Bostanci N. Source: Isr J Med Sci. 1972 June; 8(6): 850-2. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4626316&dopt=Abstract
•
Self-control with urinalysis in juvenile diabetes. Author(s): Ludvigsson J, Svensson PG. Source: Acta Paediatr Scand. 1979 November; 68(6): 887-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=539411&dopt=Abstract
Studies
49
•
Sensory perception thresholds in patients with juvenile diabetes and their close relatives. Author(s): Chochinov RH, Ullyot GL, Moorhouse JA. Source: The New England Journal of Medicine. 1972 June 8; 286(23): 1233-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4336775&dopt=Abstract
•
Serum and urinary aminoacid pattern in juvenile diabetes. Author(s): Gabr M, Ghaleb HO, Mahfouz M. Source: Gaz Egypt Paediatr Assoc. 1973 October; 21(4): 51-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4804965&dopt=Abstract
•
Serum beta glucuronidase activity in juvenile diabetes mellitus. Author(s): Traisman HS, Greenwood RD, Downey JL. Source: Imj Ill Med J. 1973 March; 143(3): 237-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4405753&dopt=Abstract
•
Serum growth hormone patterns in juvenile diabetes. Author(s): Hansen AP. Source: Dan Med Bull. 1972 April; 19(1): Suppl I: 3-32. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5024691&dopt=Abstract
•
Serum immunoreactive trypsin concentrations in infectious and non-infectious illnesses and in juvenile diabetes. Author(s): Gamble DR, Moffatt A, Marks V. Source: Journal of Clinical Pathology. 1979 September; 32(9): 897-901. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=512051&dopt=Abstract
•
Serum insulin, pancreatic glucagon and growth hormone levels in response to intravenous infusion of L-arginine in patients with recently detected juvenile diabetes. Author(s): Lawecki J, Symonides-Lawecka A, Rogala H. Source: Pol Med Sci Hist Bull. 1976 April-June; 15(2): 177-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=959042&dopt=Abstract
•
Serum-insulin in remission of juvenile diabetes. Author(s): Orskov H, Johansen K. Source: Lancet. 1968 November 16; 2(7577): 1081. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4176888&dopt=Abstract
50
Juvenile Diabetes
•
Sheehan's syndrome of hypothalamic origin in a woman with juvenile diabetes mellitus. Author(s): Herbai G, Werner I. Source: Acta Med Scand. 1976; 199(6): 539-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=937082&dopt=Abstract
•
Socio-psychological factors and metabolic control in juvenile diabetes. Author(s): Ludvigsson J. Source: Acta Paediatr Scand. 1977 July; 66(4): 431-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=899758&dopt=Abstract
•
Spinal somatosensory evoked potentials in juvenile diabetes. Author(s): Cracco J, Castells S, Mark E. Source: Annals of Neurology. 1984 January; 15(1): 55-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6712193&dopt=Abstract
•
Spontaneous food intake in juvenile diabetes mellitus. Author(s): Gillet P, Expaignet H, Francois R. Source: Acta Paediatr Belg. 1978 January-March; 31(1): 59. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=665237&dopt=Abstract
•
Stamping out the rainbow. Towards the rational use of regular insulin in juvenile diabetes mellitus. Author(s): Kohler E. Source: Wis Med J. 1978 April; 77(4): S39-S40. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=645102&dopt=Abstract
•
Studies on the frequency and associations of islet-cell antibodies in juvenile diabetes mellitus. Author(s): Richens ER, Quilley J, Hartog M. Source: Acta Diabetol Lat. 1978 September-December; 15(5-6): 229-35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=373353&dopt=Abstract
•
Study of bladder function in patients with prediabetes, latent diabetes, recent onset diabetes and juvenile diabetes. Author(s): Salama Benarroch I, Scorticatti CH, Rubinstein Salama A, Pagliere H, Cartelli E. Source: Acta Diabetol Lat. 1979 July-September; 16(3): 211-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=525207&dopt=Abstract
Studies
51
•
Study of pituitary secretion in relation to retinopathy in patients with juvenile diabetes mellitus. Author(s): Cerasola GA, Donatelli M, Sinagra D, Russo V, Amico LM, Lodato G. Source: Acta Diabetol Lat. 1981 October-December; 18(4): 319-28. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6277121&dopt=Abstract
•
Subpopulations of peripheral lymphocytes in juvenile diabetes. Author(s): Hann S, Kaye R, Falkner B. Source: Diabetes. 1976 February; 25(2): 101-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=765177&dopt=Abstract
•
Suppressibility of glucagon secretion by glucose in juvenile diabetes. Author(s): Sperling MA, Aleck K, Voina S. Source: The Journal of Pediatrics. 1977 April; 90(4): 543-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=839365&dopt=Abstract
•
Suprarenal cortical reserve capacity in juvenile diabetes. Author(s): Abdel-Salam E, Abdel-Aziz T, Hafiez AA, el-Sharkawy S, Boutros NZ. Source: Gaz Egypt Paediatr Assoc. 1974 January; 22(1): 43-51. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4375644&dopt=Abstract
•
Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas. Author(s): Mirouze J, Selam JL, Pham TC, Mendoza E, Orsetti A. Source: Diabetologia. 1978 April; 14(4): 223-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=640299&dopt=Abstract
•
The association between erythrocyte internal viscosity, protein non-enzymatic glycosylation and erythrocyte membrane dynamic properties in juvenile diabetes mellitus. Author(s): Watala C, Witas H, Olszowska L, Piasecki W. Source: International Journal of Experimental Pathology. 1992 October; 73(5): 655-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1329916&dopt=Abstract
•
The association of HLA with juvenile diabetes mellitus in Newfoundland. Author(s): Farid NR, Barnard JM, Pepper B, Noel EP, Kelly F, Davis AJ, Hobeika C, Marshall WH. Source: Tissue Antigens. 1978 September; 12(3): 215-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=83020&dopt=Abstract
52
Juvenile Diabetes
•
The detection of asymptomatic bacteriuria in juvenile diabetes mellitus. Author(s): Nelson RP, Marr TJ, Traisman HS. Source: Imj Ill Med J. 1978 February; 153(2): 118-20. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=24025&dopt=Abstract
•
The effects of anxiety management training on the control of juvenile diabetes mellitus. Author(s): Rose MI, Firestone P, Heick HM, Faught AK. Source: Journal of Behavioral Medicine. 1983 December; 6(4): 381-95. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6668604&dopt=Abstract
•
The extramural and intramural coronary arteries in juvenile diabetes mellitus: analysis of nine necropsy patients aged 19 to 38 years with onset of diabetes before age 15 years. Author(s): Crall FV Jr, Roberts WC. Source: The American Journal of Medicine. 1978 February; 64(2): 221-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=629271&dopt=Abstract
•
The impact of mothers' sense of empowerment on the metabolic control of their children with juvenile diabetes. Author(s): Florian V, Elad D. Source: Journal of Pediatric Psychology. 1998 August; 23(4): 239-47. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9718897&dopt=Abstract
•
The improved response in endogenous insulin due to continuous subcutaneous infusion of insulin therapy in juvenile diabetes. Author(s): Amemiya S, Kato K, Asayama K. Source: The Tohoku Journal of Experimental Medicine. 1983 December; 141 Suppl: 7137. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6393445&dopt=Abstract
•
The predicaments of “dangerous safety”: living with juvenile diabetes in 20th century America. Author(s): Feudtner C. Source: The Western Journal of Medicine. 2000 July; 173(1): 64-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10903304&dopt=Abstract
•
The prevalence and clinical characteristics of celiac disease in juvenile diabetes in Wisconsin. Author(s): Aktay AN, Lee PC, Kumar V, Parton E, Wyatt DT, Werlin SL. Source: Journal of Pediatric Gastroenterology and Nutrition. 2001 October; 33(4): 462-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11698764&dopt=Abstract
Studies
53
•
The psychophysiologic aspects of stress in juvenile diabetes mellitus. Author(s): Tarnow JD, Silverman SW. Source: International Journal of Psychiatry in Medicine. 1981-82; 11(1): 25-44. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6112208&dopt=Abstract
•
The relationship between periodontitis and tooth decay in juvenile diabetes mellitus cases and in healthy children. Author(s): Akyuz S, Oktay C. Source: J Marmara Univ Dent Fac. 1990 September; 1(1): 58-65. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2129918&dopt=Abstract
•
The remission period in juvenile diabetes mellitus. Author(s): Hensey OJ, Smith CS. Source: Ir J Med Sci. 1983 May; 152(5): 187-90. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6347960&dopt=Abstract
•
The role of trace elements in juvenile diabetes mellitus. Author(s): Tuvemo T, Gebre-Medhin M. Source: Pediatrician. 1983-85; 12(4): 213-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6400452&dopt=Abstract
•
Thyroid function in juvenile diabetes. Author(s): Castells S. Source: Pediatric Clinics of North America. 1984 June; 31(3): 623-34. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6427741&dopt=Abstract
•
Thyroid function in type 1 juvenile diabetes mellitus: tendency to the low T3 syndrome. Author(s): Radetti G, Drei F, Franzellin F, Pasquino B, Mengarda G. Source: Helv Paediatr Acta. 1985; 40(6): 461-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3830971&dopt=Abstract
•
Transdermal scopolamine cycloplegia in juvenile diabetes. Author(s): Lugaresi A, Uncini A, Chiarelli F, Cortelli P. Source: Italian Journal of Neurological Sciences. 1989 April; 10(2): 203-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2737867&dopt=Abstract
54
Juvenile Diabetes
•
Transient hyperopic refractive changes in newly diagnosed juvenile diabetes. Author(s): Giusti C. Source: Swiss Medical Weekly : Official Journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology. 2003 April 5; 133(13-14): 200-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12811676&dopt=Abstract
•
Transient hypogammaglobulinaemia in newly diagnosed juvenile diabetes. Author(s): Kanakoudi-Tsakalidis F, Harsoulis P, Katzos G, Dadaliari M, McNally JN, Bottazzo GF. Source: Acta Endocrinol Suppl (Copenh). 1984; 265: 29-30. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6388210&dopt=Abstract
•
Type I diabetes, also known as insulin dependent diabetes mellitus or juvenile diabetes, is one of the disorders with a complex genetic basis. Author(s): Godambe SV, Sharief N. Source: Early Human Development. 1999 September; 56(1): 83-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10530909&dopt=Abstract
•
Type I diabetes, also known as insulin dependent diabetes mellitus or juvenile diabetes, is one of the disorders with a complex genetic basis. Author(s): Godambe SV, Sharief N. Source: Early Human Development. 1999 April; 54(3): 295-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10321794&dopt=Abstract
•
Ultrastructure of muscle biopsies in recent, short-term and long-term juvenile diabetes. Author(s): Reske-Nielsen E, Harmsen A, Vorre P. Source: Acta Neurologica Scandinavica. 1977 May; 55(5): 345-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=857576&dopt=Abstract
•
Urinary acidic glycohydrolases as an index of kidney damage in juvenile diabetes mellitus. Author(s): Kohler E, Sheth KJ, Good TA. Source: Acta Diabetol Lat. 1979 July-September; 16(3): 247-55. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=118609&dopt=Abstract
•
Urinary albumin excretion during exercise in juvenile diabetes. A provocation test for early abnormalities. Author(s): Mogensen CE, Vittinghus E. Source: Scandinavian Journal of Clinical and Laboratory Investigation. 1975 July; 35(4): 295-300. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1188285&dopt=Abstract
Studies
55
•
Urinary albumin excretion in early and long-term juvenile diabetes. Author(s): Mogensen CE. Source: Scandinavian Journal of Clinical and Laboratory Investigation. 1971 October; 28(2): 183-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5130106&dopt=Abstract
•
Use of an artificial pancreas as a tool to determine subcutaneous insulin doses in juvenile diabetes. Author(s): Lambert AE, Buysschaert M, Lambotte L. Source: Diabetes Care. 1979 May-June; 2(3): 256-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=510117&dopt=Abstract
•
Viral link sought in juvenile diabetes. Author(s): Gunby P. Source: Jama : the Journal of the American Medical Association. 1978 September 15; 240(12): 1219-25. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=355665&dopt=Abstract
•
Vitiligo and juvenile diabetes mellitus. Author(s): Macaron C, Winter RJ, Traisman HS, Kahan BD, Lasser AE, Green OC. Source: Archives of Dermatology. 1977 November; 113(11): 1515-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=931387&dopt=Abstract
57
CHAPTER 2. NUTRITION AND JUVENILE DIABETES Overview In this chapter, we will show you how to find studies dedicated specifically to nutrition and juvenile diabetes.
Finding Nutrition Studies on Juvenile Diabetes The National Institutes of Health’s Office of Dietary Supplements (ODS) offers a searchable bibliographic database called the IBIDS (International Bibliographic Information on Dietary Supplements; National Institutes of Health, Building 31, Room 1B29, 31 Center Drive, MSC 2086, Bethesda, Maryland 20892-2086, Tel: 301-435-2920, Fax: 301-480-1845, E-mail:
[email protected]). The IBIDS contains over 460,000 scientific citations and summaries about dietary supplements and nutrition as well as references to published international, scientific literature on dietary supplements such as vitamins, minerals, and botanicals.7 The IBIDS includes references and citations to both human and animal research studies. As a service of the ODS, access to the IBIDS database is available free of charge at the following Web address: http://ods.od.nih.gov/databases/ibids.html. After entering the search area, you have three choices: (1) IBIDS Consumer Database, (2) Full IBIDS Database, or (3) Peer Reviewed Citations Only. Now that you have selected a database, click on the “Advanced” tab. An advanced search allows you to retrieve up to 100 fully explained references in a comprehensive format. Type “juvenile diabetes” (or synonyms) into the search box, and click “Go.” To narrow the search, you can also select the “Title” field.
7 Adapted from http://ods.od.nih.gov. IBIDS is produced by the Office of Dietary Supplements (ODS) at the National Institutes of Health to assist the public, healthcare providers, educators, and researchers in locating credible, scientific information on dietary supplements. IBIDS was developed and will be maintained through an interagency partnership with the Food and Nutrition Information Center of the National Agricultural Library, U.S. Department of Agriculture.
58
Juvenile Diabetes
The following information is typical of that found when using the “Full IBIDS Database” to search for “juvenile diabetes” (or a synonym): •
Does milk cause juvenile diabetes? Source: Cerrato, P L RN. 1993 January; 56(1): 69-72 0033-7021
•
Early onset juvenile diabetes mellitus controlled with nicotinic acid therapy. Author(s): Department of Pediatrics, Government Medical College, Miraj and Civil Hospital, Sangli. Source: Karmarkar, D P Rajput, C S Wagh, S S Kelkar, P S Indian-J-Pediatr. 1993 NovDecember; 60(6): 825-7 0019-5456
•
Educational video game for juvenile diabetes: results of a controlled trial. Author(s): Raya Systems Inc., Mountain View, CA 94040, USA. Source: Brown, S J Lieberman, D A Germeny, B A Fan, Y C Wilson, D M Pasta, D J MedInform-(Lond). 1997 Jan-March; 22(1): 77-89 0307-7640
•
Low dose linomide in Type I juvenile diabetes of recent onset: a randomised placebocontrolled double blind trial. Author(s): Department of Paediatric Endocrinology, Saint-Vincent-de-Paul Hospital, Paris, France. Source: Coutant, R Landais, P Rosilio, M Johnsen, C Lahlou, N Chatelain, P Carel, J C Ludvigsson, J Boitard, C Bougneres, P F Diabetologia. 1998 September; 41(9): 1040-6 0012-186X
•
Overcoming juvenile diabetes with a little planning and high-tech tools. Source: McNamara, D FDA-Consum. 2000 Jul-August; 34(4): 28-32 0362-1332
Federal Resources on Nutrition In addition to the IBIDS, the United States Department of Health and Human Services (HHS) and the United States Department of Agriculture (USDA) provide many sources of information on general nutrition and health. Recommended resources include: •
healthfinder®, HHS’s gateway to health information, including diet and nutrition: http://www.healthfinder.gov/scripts/SearchContext.asp?topic=238&page=0
•
The United States Department of Agriculture’s Web site dedicated to nutrition information: www.nutrition.gov
•
The Food and Drug Administration’s Web site for federal food safety information: www.foodsafety.gov
•
The National Action Plan on Overweight and Obesity sponsored by the United States Surgeon General: http://www.surgeongeneral.gov/topics/obesity/
•
The Center for Food Safety and Applied Nutrition has an Internet site sponsored by the Food and Drug Administration and the Department of Health and Human Services: http://vm.cfsan.fda.gov/
•
Center for Nutrition Policy and Promotion sponsored by the United States Department of Agriculture: http://www.usda.gov/cnpp/
•
Food and Nutrition Information Center, National Agricultural Library sponsored by the United States Department of Agriculture: http://www.nal.usda.gov/fnic/
Nutrition
•
59
Food and Nutrition Service sponsored by the United States Department of Agriculture: http://www.fns.usda.gov/fns/
Additional Web Resources A number of additional Web sites offer encyclopedic information covering food and nutrition. The following is a representative sample: •
AOL: http://search.aol.com/cat.adp?id=174&layer=&from=subcats
•
Family Village: http://www.familyvillage.wisc.edu/med_nutrition.html
•
Google: http://directory.google.com/Top/Health/Nutrition/
•
Healthnotes: http://www.healthnotes.com/
•
Open Directory Project: http://dmoz.org/Health/Nutrition/
•
Yahoo.com: http://dir.yahoo.com/Health/Nutrition/
•
WebMD®Health: http://my.webmd.com/nutrition
•
WholeHealthMD.com: http://www.wholehealthmd.com/reflib/0,1529,00.html
The following is a specific Web list relating to juvenile diabetes; please note that any particular subject below may indicate either a therapeutic use, or a contraindication (potential danger), and does not reflect an official recommendation: •
Vitamins Niacin Alternative names: Vitamin B3 (Niacin) Source: Integrative Medicine Communications; www.drkoop.com Vitamin B3 (niacin) Alternative names: Niacin Source: Integrative Medicine Communications; www.drkoop.com
•
Minerals Chromium Source: Integrative Medicine Communications; www.drkoop.com
•
Food and Diet Diabetes Source: Healthnotes, Inc.; www.healthnotes.com
61
CHAPTER 3. ALTERNATIVE MEDICINE AND JUVENILE DIABETES Overview In this chapter, we will begin by introducing you to official information sources on complementary and alternative medicine (CAM) relating to juvenile diabetes. At the conclusion of this chapter, we will provide additional sources.
National Center for Complementary and Alternative Medicine The National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (http://nccam.nih.gov/) has created a link to the National Library of Medicine’s databases to facilitate research for articles that specifically relate to juvenile diabetes and complementary medicine. To search the database, go to the following Web site: http://www.nlm.nih.gov/nccam/camonpubmed.html. Select “CAM on PubMed.” Enter “juvenile diabetes” (or synonyms) into the search box. Click “Go.” The following references provide information on particular aspects of complementary and alternative medicine that are related to juvenile diabetes: •
“Governare il diabete” (“to steer diabetes”): a new proposal for diabetic camps. Author(s): Salvatoni A, Pompili V, Biasoli R, Cardani R, Arioli G, Nespoli L. Source: Acta Biomed Ateneo Parmense. 2003; 74 Suppl 1: 29-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12817799&dopt=Abstract
•
Effect of fenugreek seeds on blood glucose and serum lipids in type I diabetes. Author(s): Sharma RD, Raghuram TC, Rao NS. Source: European Journal of Clinical Nutrition. 1990 April; 44(4): 301-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2194788&dopt=Abstract
•
High dose intravenous, but not low dose subcutaneous, insulin-like growth factor-I therapy induces sustained insulin sensitivity in severely resistant type I diabetes
62
Juvenile Diabetes
mellitus. Author(s): Usala AL, Madigan T, Burguera B, Cefalu W, Sinha MK, Powell JG, Usala SJ. Source: The Journal of Clinical Endocrinology and Metabolism. 1994 August; 79(2): 43540. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8045959&dopt=Abstract •
High-carbohydrate, high-fiber diet in children with type I diabetes mellitus. Author(s): Lindsay AN, Hardy S, Jarrett L, Rallison ML. Source: Diabetes Care. 1984 January-February; 7(1): 63-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6323107&dopt=Abstract
•
Microalbuminuria is associated with limited joint mobility in type I diabetes mellitus. Author(s): Montana E, Rozadilla A, Nolla JM, Gomez N, Escofet DR, Soler J. Source: Annals of the Rheumatic Diseases. 1995 July; 54(7): 582-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7668902&dopt=Abstract
•
Social learning intervention to promote metabolic control in type I diabetes mellitus: pilot experiment results. Author(s): Kaplan RM, Chadwick MW, Schimmel LE. Source: Diabetes Care. 1985 March-April; 8(2): 152-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3996172&dopt=Abstract
•
The impact of coping styles on the control of juvenile diabetes. Author(s): Tietz W, Vidmar JT. Source: Psychiatry Med. 1972 January; 3(1): 67-74. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4608347&dopt=Abstract
•
The psychophysiologic aspects of stress in juvenile diabetes mellitus. Author(s): Tarnow JD, Silverman SW. Source: International Journal of Psychiatry in Medicine. 1981-82; 11(1): 25-44. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6112208&dopt=Abstract
Additional Web Resources A number of additional Web sites offer encyclopedic information covering CAM and related topics. The following is a representative sample: •
Alternative Medicine Foundation, Inc.: http://www.herbmed.org/
•
AOL: http://search.aol.com/cat.adp?id=169&layer=&from=subcats
•
Chinese Medicine: http://www.newcenturynutrition.com/
•
drkoop.com®: http://www.drkoop.com/InteractiveMedicine/IndexC.html
Alternative Medicine 63
•
Family Village: http://www.familyvillage.wisc.edu/med_altn.htm
•
Google: http://directory.google.com/Top/Health/Alternative/
•
Healthnotes: http://www.healthnotes.com/
•
MedWebPlus: http://medwebplus.com/subject/Alternative_and_Complementary_Medicine
•
Open Directory Project: http://dmoz.org/Health/Alternative/
•
HealthGate: http://www.tnp.com/
•
WebMD®Health: http://my.webmd.com/drugs_and_herbs
•
WholeHealthMD.com: http://www.wholehealthmd.com/reflib/0,1529,00.html
•
Yahoo.com: http://dir.yahoo.com/Health/Alternative_Medicine/
The following is a specific Web list relating to juvenile diabetes; please note that any particular subject below may indicate either a therapeutic use, or a contraindication (potential danger), and does not reflect an official recommendation: •
General Overview Diabetes Source: Prima Communications, Inc.www.personalhealthzone.com High Cholesterol Source: Healthnotes, Inc.; www.healthnotes.com High Triglycerides Source: Healthnotes, Inc.; www.healthnotes.com
•
Herbs and Supplements Fenugreek Alternative names: Trigonella foenum-graecum Source: Healthnotes, Inc.; www.healthnotes.com Fenugreek Source: Prima Communications, Inc.www.personalhealthzone.com
General References A good place to find general background information on CAM is the National Library of Medicine. It has prepared within the MEDLINEplus system an information topic page dedicated to complementary and alternative medicine. To access this page, go to the MEDLINEplus site at http://www.nlm.nih.gov/medlineplus/alternativemedicine.html. This Web site provides a general overview of various topics and can lead to a number of general sources.
65
CHAPTER 4. DISSERTATIONS ON JUVENILE DIABETES Overview In this chapter, we will give you a bibliography on recent dissertations relating to juvenile diabetes. We will also provide you with information on how to use the Internet to stay current on dissertations. IMPORTANT NOTE: When following the search strategy described below, you may discover non-medical dissertations that use the generic term “juvenile diabetes” (or a synonym) in their titles. To accurately reflect the results that you might find while conducting research on juvenile diabetes, we have not necessarily excluded non-medical dissertations in this bibliography.
Dissertations on Juvenile Diabetes ProQuest Digital Dissertations, the largest archive of academic dissertations available, is located at the following Web address: http://wwwlib.umi.com/dissertations. From this archive, we have compiled the following list covering dissertations devoted to juvenile diabetes. You will see that the information provided includes the dissertation’s title, its author, and the institution with which the author is associated. The following covers recent dissertations found when using this search procedure: •
A Diabetic Camp: Its Implications for Coping with Juvenile Diabetes Mellitus by Sperlich, Sonja B., PhD from The Catholic University of America, 1982, 196 pages http://wwwlib.umi.com/dissertations/fullcit/8221445
•
An Exploratory Study of Father Involvement in the Management of Juvenile Diabetes by Allred, Keith W., PhD from Vanderbilt University, 1988, 182 pages http://wwwlib.umi.com/dissertations/fullcit/8910838
•
Juvenile Diabetes: a Study of Children's Perceptions of Their Illness (diabetes) by Zahorik, Pamela Marie, PhD from Case Western Reserve University, 1991, 185 pages http://wwwlib.umi.com/dissertations/fullcit/9137064
•
Psychosocial and Demographic Predictors of Metabolic Control in Newly Diagnosed Diabetic Children (juvenile Diabetes, Chronic Illness) by Auslander, Wendy F., PhD from Washington University, 1986, 180 pages http://wwwlib.umi.com/dissertations/fullcit/8626363
66
Juvenile Diabetes
•
The Effect of Anxiety Management Training on the Course and Control of Juvenile Diabetes Mellitus by Rose, Malcolm I; PhD from University of Ottawa (Canada), 1981 http://wwwlib.umi.com/dissertations/fullcit/NK53282
•
The Relationship of Cognitive Development on Assuming Self-management in Juvenile Diabetes Mellitus: an Application of Piagetian Theory in Assessing Readiness for Self-care in a Chronic Illness (glycohemoglobin, Locus of Control, Information) by Diamond, Kenneth, PhD from State University of New York at Buffalo, 1984, 104 pages http://wwwlib.umi.com/dissertations/fullcit/8410540
Keeping Current Ask the medical librarian at your library if it has full and unlimited access to the ProQuest Digital Dissertations database. From the library, you should be able to do more complete searches via http://wwwlib.umi.com/dissertations.
67
CHAPTER 5. CLINICAL TRIALS AND JUVENILE DIABETES Overview In this chapter, we will show you how to keep informed of the latest clinical trials concerning juvenile diabetes.
Recent Trials on Juvenile Diabetes The following is a list of recent trials dedicated to juvenile diabetes.8 Further information on a trial is available at the Web site indicated. •
Effect of AC2993 with or without Immunosuppression on Beta Cell Function in Patients with Type I Diabetes Condition(s): Diabetes Mellitus Study Status: This study is currently recruiting patients. Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Purpose - Excerpt: This study will determine 1) the safety of AC2993 in patients with type I diabetes; 2) the ability of AC2993 to improve beta cell function; and 3) the effects of immunosuppression on beta cell function. Type I diabetes is an autoimmune disease, in which the immune system attacks the beta cells of the pancreas. These cells produce insulin, which regulates blood sugar. AC2993 may improve the pancreas's ability to produce insulin and help control blood sugar, but it may also activate the original immune response that caused the diabetes. Thus, this study will examine the effects of AC2993 alone as well as in combination with immunosuppressive drugs. Patients between 18 and 60 years of age who have type I diabetes mellitus may be eligible for this 20-month study. They must have had diabetes for at least 5 years and require insulin treatment. Candidates will be screened with a questionnaire, followed by medical history and physical examination, blood and urine tests, a chest x-ray and skin test for tuberculosis, electrocardiogram (EKG), and arginine stimulated C-peptide test (see description below). Participants will undergo the following tests and procedures: Advanced screening phase: Participants undergo a diabetes education program, including instruction on frequent blood glucose monitoring, dietary education on
8
These are listed at www.ClinicalTrials.gov.
68
Juvenile Diabetes
counting carbohydrates, intensive insulin therapy, review of signs and symptoms of low blood sugar (hypoglycemia), and potential treatment with glucagon shots. Patients must administer insulin via an insulin pump or take at least four injections per day including glargine (Lantus) insulin. 4-month run-in phase - Arginine-stimulated C-peptide test: This test measures the body's insulin production. The patient is injected with a liquid containing arginine, a normal constituent of food that increases insulin release from beta cells into the blood stream. After the injection, seven blood samples are collected over 10 minutes. - Mixed meal stimulated C-peptide test with acetaminophen: This test assesses the response of the beta cells to an ordinary meal and the time it takes for food to pass through the stomach. The patient drinks a food supplement and takes acetaminophen (Tylenol). Blood samples are then drawn through a catheter (plastic tube placed in a vein) every 30 minutes for 4 hours to measure levels of various hormones and the concentration of acetaminophen. - Euglycemic clamp: This test measures the body's sensitivity to insulin. The patient is admitted to the NIH Clinical Center the evening before the study and receives an insulin drip through an intravenous (IV) line overnight to maintain normal blood sugar levels. The next morning, another IV line is placed, glucose and insulin are being infused and frequent blood samples are being collected to measure blood sugar andinsulin levels. Test period A: Patients are randomly assigned to receive 1) AC2993 alone or 2) AC2993 plus immunosuppressive drugs (sirolimus and tacrolimus), along with an antibiotic to reduce the risk of fungal infections, for 6 months. If the patient receives immunosuppressive agents, blood is drawn twice a week to measure drug levels, then once a week for 1 month, and then every 2 weeks for the rest of the study. AC2993 is injected under the skin twice a day at first and then 4 times a day in increasing doses. Test period B: Patients who took immunosuppressive drugs in test period A continue to take them for the 6 months of test period B. Patients who took AC2993 in test period A do not take it in test period B, and those who did not take AC2993 in test period A do take it in test period B. Patients have three argininestimulated C-peptide tests during the last 3 months of test periods A and B and a euglycemic clamp study and mixed meal study at the end of each test period. Drug side effects are monitored throughout the study. Treatment and evaluation may be extended beyond the 20-month study period for patients who benefit from the treatment. Phase(s): Phase I Study Type: Interventional Contact(s): see Web site below Web Site: http://clinicaltrials.gov/ct/show/NCT00064714 •
Islet Cell Transplantation Alone in Patients with Type I Diabetes Mellitus: steroidfree immunosuppression Condition(s): Diabetes Mellitus, Type 1 Study Status: This study is completed. Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Purpose - Excerpt: The goal of islet cell transplantation in patients with Type 1 Diabetes Mellitus is to provide constant normal blood glucose levels. This may eliminate the need for insulin altogether or provide a significant reduction in the amount of insulin necessary to maintain constant normal blood glucose levels. This normalization may prevent or slow progression of diabetic complications. Furthermore, the participant may enjoy a healthier lifestyle and a better quality of life. If you meet the initial inclusion criteria for the trial, you must be able to give informed consent personally. Then you will need to participate in an extensive screening process that involves many standard
Clinical Trials 69
tests and collection of laboratory samples to make sure that the transplant is suitable and safe for you. Phase(s): Phase II Study Type: Interventional Contact(s): see Web site below Web Site: http://clinicaltrials.gov/ct/show/NCT00021788
Keeping Current on Clinical Trials The U.S. National Institutes of Health, through the National Library of Medicine, has developed ClinicalTrials.gov to provide current information about clinical research across the broadest number of diseases and conditions. The site was launched in February 2000 and currently contains approximately 5,700 clinical studies in over 59,000 locations worldwide, with most studies being conducted in the United States. ClinicalTrials.gov receives about 2 million hits per month and hosts approximately 5,400 visitors daily. To access this database, simply go to the Web site at http://www.clinicaltrials.gov/ and search by “juvenile diabetes” (or synonyms). While ClinicalTrials.gov is the most comprehensive listing of NIH-supported clinical trials available, not all trials are in the database. The database is updated regularly, so clinical trials are continually being added. The following is a list of specialty databases affiliated with the National Institutes of Health that offer additional information on trials: •
For clinical studies at the Warren Grant Magnuson Clinical Center located in Bethesda, Maryland, visit their Web site: http://clinicalstudies.info.nih.gov/
•
For clinical studies conducted at the Bayview Campus in Baltimore, Maryland, visit their Web site: http://www.jhbmc.jhu.edu/studies/index.html
•
For cancer trials, visit the National Cancer Institute: http://cancertrials.nci.nih.gov/
•
For eye-related trials, visit and search the Web page of the National Eye Institute: http://www.nei.nih.gov/neitrials/index.htm
•
For heart, lung and blood trials, visit the Web page of the National Heart, Lung and Blood Institute: http://www.nhlbi.nih.gov/studies/index.htm
•
For trials on aging, visit and search the Web site of the National Institute on Aging: http://www.grc.nia.nih.gov/studies/index.htm
•
For rare diseases, visit and search the Web site sponsored by the Office of Rare Diseases: http://ord.aspensys.com/asp/resources/rsch_trials.asp
•
For alcoholism, visit the National Institute on Alcohol Abuse and Alcoholism: http://www.niaaa.nih.gov/intramural/Web_dicbr_hp/particip.htm
•
For trials on infectious, immune, and allergic diseases, visit the site of the National Institute of Allergy and Infectious Diseases: http://www.niaid.nih.gov/clintrials/
•
For trials on arthritis, musculoskeletal and skin diseases, visit newly revised site of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health: http://www.niams.nih.gov/hi/studies/index.htm
70
Juvenile Diabetes
•
For hearing-related trials, visit the National Institute on Deafness and Other Communication Disorders: http://www.nidcd.nih.gov/health/clinical/index.htm
•
For trials on diseases of the digestive system and kidneys, and diabetes, visit the National Institute of Diabetes and Digestive and Kidney Diseases: http://www.niddk.nih.gov/patient/patient.htm
•
For drug abuse trials, visit and search the Web site sponsored by the National Institute on Drug Abuse: http://www.nida.nih.gov/CTN/Index.htm
•
For trials on mental disorders, visit and search the Web site of the National Institute of Mental Health: http://www.nimh.nih.gov/studies/index.cfm
•
For trials on neurological disorders and stroke, visit and search the Web site sponsored by the National Institute of Neurological Disorders and Stroke of the NIH: http://www.ninds.nih.gov/funding/funding_opportunities.htm#Clinical_Trials
71
CHAPTER 6. PATENTS ON JUVENILE DIABETES Overview Patents can be physical innovations (e.g. chemicals, pharmaceuticals, medical equipment) or processes (e.g. treatments or diagnostic procedures). The United States Patent and Trademark Office defines a patent as a grant of a property right to the inventor, issued by the Patent and Trademark Office.9 Patents, therefore, are intellectual property. For the United States, the term of a new patent is 20 years from the date when the patent application was filed. If the inventor wishes to receive economic benefits, it is likely that the invention will become commercially available within 20 years of the initial filing. It is important to understand, therefore, that an inventor’s patent does not indicate that a product or service is or will be commercially available. The patent implies only that the inventor has “the right to exclude others from making, using, offering for sale, or selling” the invention in the United States. While this relates to U.S. patents, similar rules govern foreign patents. In this chapter, we show you how to locate information on patents and their inventors. If you find a patent that is particularly interesting to you, contact the inventor or the assignee for further information. IMPORTANT NOTE: When following the search strategy described below, you may discover non-medical patents that use the generic term “juvenile diabetes” (or a synonym) in their titles. To accurately reflect the results that you might find while conducting research on juvenile diabetes, we have not necessarily excluded nonmedical patents in this bibliography.
Patents on Juvenile Diabetes By performing a patent search focusing on juvenile diabetes, you can obtain information such as the title of the invention, the names of the inventor(s), the assignee(s) or the company that owns or controls the patent, a short abstract that summarizes the patent, and a few excerpts from the description of the patent. The abstract of a patent tends to be more technical in nature, while the description is often written for the public. Full patent descriptions contain much more information than is presented here (e.g. claims, references, figures, diagrams, etc.). We will tell you how to obtain this information later in the chapter. 9Adapted
from the United States Patent and Trademark Office: http://www.uspto.gov/web/offices/pac/doc/general/whatis.htm.
72
Juvenile Diabetes
The following is an example of the type of information that you can expect to obtain from a patent search on juvenile diabetes: •
Bystander suppression of type I diabetes by oral administration of glucagon Inventor(s): Al-Sabbagh; Ahmad (Norwood, MA), Miller; Ariel (Haifa, IL), Weiner; Howard (Brookline, MA), Zhang; Zhengyi (Needham, MA) Assignee(s): AutoImmune Inc. (Lexington, MA) Patent Number: 6,645,504 Date filed: June 6, 1995 Abstract: Described are methods for treating or preventing type I diabetes and insulitis by oral administration of the bystander antigen glucagon. The methods involve oral administration of glucagon in an amounts that are effective to treat or prevent type I diabetes or insulitis. Excerpt(s): This invention pertains to an improvement in the treatment of autoimmune diseases. More specifically, the invention is directed to the use of bystander antigens (i.e. antigens that suppress cells involved in the autoimmune process) for the treatment of autoimmune diseases. The invention also includes pharmaceutical formulations comprising bystander antigens useful in the treatment of autoimmune diseases in mammals. Autoimmune diseases are characterized by an abnormal immune response directed against normal autologous (self) tissues. Based on the type of supranormal immune response involved, autoimmune diseases in mammals can generally be classified in one of two different categories: cell-mediated (i.e., T-cell-mediated) or antibody-mediated disorders. Non-limiting examples of cell-mediated autoimmune diseases include multiple sclerosis (MS), rheumatoid arthritis (RA), autoimmune thyroiditis (AT), diabetes mellitus (juvenile onset or Type 1 diabetes) and autoimmune uveoretinitis (AUR). Antibody-mediated autoimmune diseases include myasthenia gravis (MG) and systemic lupus erythematosus (SLE). Web site: http://www.delphion.com/details?pn=US06645504__
•
Detection methods for type I diabetes Inventor(s): Griffin; Ann C. (Hanover, NH), Hickey; William F. (Lyme, NH) Assignee(s): Trustees of Dartmouth College (Hanover, NH) Patent Number: 6,509,165 Date filed: June 6, 1995 Abstract: Proinsulin peptide compounds that modulate an immunological response by T cells of Type I diabetic subjects are disclosed. The proinsulin peptide compounds of the invention are preferably derived from a region of proinsulin that spans the junction between the B chain and C peptide of proinsulin. Pharmaceutical compositions comprising the proinsulin peptide compounds are also disclosed. An immunological response to a proinsulin peptide compound of the invention can be used as an indicator of Type I diabetes in a subject. Accordingly, the invention provides diagnostic assays for Type I diabetes using the proinsulin peptide compounds. Methods for inhibiting the development or progression of Type I diabetes in a subject by administering a proinsulin peptide compound are also disclosed.
Patents 73
Excerpt(s): Type I, or insulin-dependent, diabetes mellitus (also referred to herein as DM-I) is known to occur spontaneously in humans, rats and mice (Castano, L and Eisenbarth, G. (1990) Ann. Rev. Immunol. 8:647-679). There is a genetic susceptibility to DM-I associated with certain haplotypes of Class II antigens of the major histocompatability complex (MHC), i.e., HLA-DR3, -DR4 and -DQ3.2 in humans (see e.g., Platz. P. et al. (1981) Diabetologia 21:108-115; Todd, J. et al. (1987) Nature 329:599604); RT1.sup.u in Bio-Breeding (BB) rats (see e.g., Colle, E. (1990) Clin. Immunol. & Immunopathol. 57:1-9; Parfrey, N. A. et al. (1989) Crit. Rev. Immunol. 9:45-65) and H2.sup.g7 in non-obese diabetic (NOD) mice (see e.g., Kikutani, H. and Makino, S. in Adv. Immunol. (Dixon, F. J., ed.), pp. 285-323, New York, N.Y.: Academic Press, Inc., 1992). The pathology of DM-I consists of the progressive inflammatory infiltration of pancreatic islets (i.e., insulitis) containing immunocytes targeted specifically to insulinsecreting.beta.-cells (see e.g., Bottazzo, G. F. et al. (1985) N. Eng. J. Med. 313:353-360; Foulis, A. K. et al. (1991) J. Pathol. 165:97-103; Hanenberg, H. et al. (1991) Diabetologia 32:126-134). This pathology develops over an indeterminate period of time (months to years). It has become clear that the development of Type I diabetes occurs as a result of a complex relationship involving genetic predisposition, environmental influences, and additional undefined co-factors. In attempting to understand the pathogenesis of DM-I, the most elusive pieces of information have been the definition of the inciting autoantigen(s), and whether cellular or humoral-mediated autoreactivity is the primary event. Serum autoantibodies directed against islet cell cytoplasm and surface antigens (i.e., ICA, ICSA), insulin (IA'A) and glutamic acid decarboxylase (GAD) can be found in pre-diabetic and newly diagnosed diabetic humans and animals (see e.g., Rowley, M. et al. (1992) Diabetes 41:548-551; Palmer, J. et al. (1983) Science 222:1337-9; MacLaren, N. et al. (1988) Diabetes 38:534-538; Baekkeskov, S. et al. (1990) Nature 347:151-156; Velleso, L. A. et al. (1993) Diabetologia 36:39-46). Unfortunately, correlations between antibody titers against these antigens and the clinical onset of diabetes have not been successfully predictive. In addition, a number of other.beta.-cell antigens become exposed as islets are destroyed such as a 69kd islet cell autoantigen (ICA69) (Pietropaolo, M. et al. (1993) J. Clin. Invest. 92:359-371), 38kd and 62kd insulin secretory granule proteins (Roep, B. O. et al. (1991) Lancet 337:1439-1441; Brudzynski, K. et al. (1992) J. Autoimm. 5:453-463) and proislets (Harrison, L. C. et al. (1992) J. Clin. Invest. 89:1161-65; Harrison, L. et al. in Advances in Endocrinology & Metabolism (Mazzaferri, E. L. et al., ed.), pp. 35-94, St. Louis, Mo.: Mosby-Year Book, 1990). However, it is not clear whether the cellular and/or humoral immune responses to these antigens are the cause or simply a consequence of ongoing islet cell damage. In short, the immunologic nature of the pathogenic mechanism and the exact antigen(s) inducing the diabetogenic attack have yet to be elucidated. Over one half million people in the United States suffer from insulin-dependent diabetes. Prior to 1921, people who developed DM-I were not expected to live much more than a year after diagnosis. Afflicted individuals suffered from clinical signs of chronic hyperglycemia (e.g., excessive thirst and urination, rapid weight loss) as a consequence of abnormal carbohydrate metabolism. Once insulin was purified and administered, the life-expectancy of diabetics increased dramatically. However, DM-I is a chronic disease that requires life-long treatment to prevent acute illness and to reduce the risk of long-term complications. Restrictive diets and daily insulin injections can be burdensome for patients, thus reducing compliance, and even with treatment complications such as cataracts, retinopathy, glaucoma, renal disease and circulatory disease are prevalent. Web site: http://www.delphion.com/details?pn=US06509165__
74
Juvenile Diabetes
•
Method of accessing the risks of developing type I diabetes Inventor(s): Eisenbarth; George S. (Wellesley, MA), Gianani; Roberto (Boston, MA) Assignee(s): Immulogic Pharmaceutical Corporation (Waltham, MA) Patent Number: 5,407,802 Date filed: December 26, 1991 Abstract: Two subsets of Islet Cell Autoantibodies (ICA), termed restricted and nonrestricted, have been identified. The expression of non-restricted ICA correlates with progression to type I diabetes, indicating that these individuals are at much greater risk than are individuals expressing restricted ICA. Differentiation between restricted or non-restricted ICA allows for more accurate prognosis of the development of type I diabetes. Restricted ICA react with beta cells of human and rat islets but not mouse, whereas non-restricted ICA react with humans rat and mouse islets. Restricted ICA can be substantially completely absorbed by incubation with glutamic acid decarboxylase (GAD), whereas non-restricted ICA are partially or not at all absorbed by GAD. Restricted ICA react in a Stiff-Man Syndrome fashion including staining GABAergic neurons in brain sections and western blots of brain extracts, whereas non-restricted ICA does not react with either brain sections nor with GAD antigen in western blots. Restricted ICA contains a higher titer of anti-GAD antibodies than does non-restricted ICA. Excerpt(s): Diabetes is a chronic, complex metabolic disease that results in the inability of the body to properly maintain and use carbohydrates, fats, and proteins. It results from the interaction of various hereditary and environmental factors and is characterized by high blood glucose levels caused by a deficiency in insulin production or an impairment of its utilization. Most cases of diabetes fall into two clinical types: insulin-dependent diabetes mellitus (IDD or type I diabetes) and non-insulin-dependent diabetes mellitus (NIDD). Each type has a different prognosis, treatment and cause. In recent years our understanding of the pathophysiology of type I diabetes has increased such that type I diabetes is now generally considered to be a chronic autoimmune disease with a long prodromal phase (Castano et al. (1990) Ann Rev Immunol 8:647-679; Maclaren et al. (1988) Diabetes 37:591-594; Lernmark et al. (1989) Clin Immunol Immunopath 53:358-399). During this prodromal phase and at the onset of overt diabetes, one or more autoantibodies are usually present. Three abnormalities predictive of type I diabetes are cytoplasmic islet cell autoantibodies (ICA) in excess of 20 JDF units (Bonifacio et al. (1990) Lancet 335:147-149), insulin autoantibodies (IAA) detected with fluid phase radioassays in association with islet cell autoantibodies (Ziegler et al. (1989) Diabetes 38:1320-1325), and first phase insulin release less that than the first percentile during an intravenous glucose tolerance test (Vardi et al. (1991) Diabetologia 34:93-102). Identification of the prediabetic state in diabetes is essential in efforts to prevent the development of the disease. Perhaps the single most important advance of the past two decades in diabetes research has been recognition that autoimmune destruction of beta cells takes months or years to reach completion, whereas currently the clinical diagnosis of diabetes is almost never made until the destructive process is nearly complete and insulin injections are required to prevent death. Intervention before the insulin-producing cells have been irreversibly destroyed can provide a strategy to prevent progression of diabetes and its complications. Web site: http://www.delphion.com/details?pn=US05407802__
Patents 75
•
Method of treating type I diabetes Inventor(s): Lafferty; Kevin (Denver, CO), Panetta; Jill A. (Zionsville, IN) Assignee(s): The University of Colorado Foundation, Inc. (Boulder, CO) Patent Number: 5,158,966 Date filed: February 22, 1991 Abstract: Provided is a method for treating Type I diabetes in mammals utilizing certain aryl-substituted rhodanine derivatives. Excerpt(s): Diabetes mellitus is a systemic disease characterized by disorders in the metabolism of insulin, carbohydrates, fats and proteins, and in the structure and function of blood vessels. The primary symptom of acute diabetes is hyperglycemia, often accompanied by glucosuria, the presence in urine of large amounts of glucose, and polyuria, the excretion of large volumes of urine. Additional symptoms arise in chronic or long standing diabetes. These symptoms include degeneration of the walls of blood vessels. Although many different organs are affected by these vascular changes, the eyes appear to be the most susceptible. As such, longstanding diabetes mellitus, even when treated with insulin, is a leading cause of blindness. There are two recognized types of diabetes. Juvenile onset, or ketosis-prone, diabetes (also known as Type I diabetes) develops early in life, with clinical onset most often occurring before the patient is 18 years of age. Type I diabetes has much more severe symptoms and has a near-certain prospect of later vascular involvement. Control of this type of diabetes is often difficult. The second type of diabetes is adult onset, or ketosis-resistant, diabetes (also known as Type II diabetes). Type II diabetes develops later in life, is milder and has a more gradual onset. One of the most significant advancements in the history of medical science came in 1922 when Banting and Best demonstrated the therapeutic effects of insulin in diabetic humans. However, even today, a clear picture of the basic biochemical defects of the disease is not known, and diabetes is still a serious health problem. It is believed that two percent or more of the population of the United States is afflicted with some form of diabetes, with 0.1-0.5% afflicted with Type I diabetes. Web site: http://www.delphion.com/details?pn=US05158966__
•
Methods for treatment of type I diabetes Inventor(s): Alila; Hector W. (North Wales, PA), Earle; Keith A. (North Wales, PA), Thompson; W. Joseph (Doylestown, PA), Whitehead; Clark M. (Warminster, PA) Assignee(s): Cell Pathways, Inc. (Horsham, PA) Patent Number: 6,479,493 Date filed: August 23, 2001 Abstract: Substituted condensation products of -benzyl-3-indenylacetamides with heterocyclic aldehydes and other such inhibitors are useful for the treatment of type I diabetes. Excerpt(s): This invention relates to the treatment of type I diabetes. Type 1 or Insulin Dependent Diabetes Mellitus (IDDM) is estimated to affect 675,000 people in the United States. This represents 0.3% of the total U.S. population, with an estimated 30,000 new cases diagnosed each year. Complications of diabetes impair the longevity and quality of life, and include atherosclerotic heart disease, gangrene and stroke, as well as diabetic retinopathy, neuropathy and nephropathy. Within 15 years after the onset of diabetes,
76
Juvenile Diabetes
retinopathy may be observed in 97% of Type 1 diabetics. Today diabetic retinopathy remains the leading cause of blindness in the U.S. and patients with diabetes are 25 times more likely to develop blindness than the general population. Symptoms of diabetic neuropathy have been observed in 54% of Type 1 patients studied. Patients present with symptoms ranging from peripheral sensory-deficits (pins and needles/carpal tunnel syndrome) to autonomic neuropathy resulting in bladder and bowel dysfunction. Type 1 diabetes is also responsible for a large proportion of the patients on renal dialysis, the result of diabetes-induced end stage renal disease. More than 40% of Type 1 patients who have had diabetes for more than 20 years have diabetic nephropathy. The prevalence of myocardial infarction, angina and stroke is 2-3 times greater than in non-diabetics, and the Type 1 diabetic's life span is shortened by about 15 years. The estimated total cost of Type 1 diabetes in the United States (medical expenses, lost wages etc.) is greater than $20 billion per year. Web site: http://www.delphion.com/details?pn=US06479493__ •
Therapeutic method and compositions for the treatment of juvenile diabetes mellitus Inventor(s): Cavazza; Claudio (35, Via Marocco, Rome, IT) Assignee(s): none reported Patent Number: 4,362,719 Date filed: May 15, 1981 Abstract: The oral or parenteral administration of L-carnitine or certain acyl L-carnitines, typically propionyl L-carnitine, or the pharmacologically acceptable salts thereof, permits a considerable reduction (from 20 to approximately 50%) of the daily dose of insulin required by patients having juvenile diabetes mellitus to restore normal blood glucose levels.Moreover, L-carnitine and such acyl carnitines actively inhibit ketoacidosis, thus avoiding the risk of ketoacidosic coma in such patients. Excerpt(s): The present invention pertains to a therapeutic method for the treatment of patients having juvenile diabetes mellitus and to a pharmaceutical composition for use in such a method. According to the severity of the insufficiency in insulin secretion, a subject having diabetes mellitus may fall within one of two classes: those prone to ketoacidosis and those who are not. The subject prone to ketoacidosis is a diabetic affected by juvenile diabetes mellitus (generally diabetes with onset before 25 years of age approx.) and to avoid ketoacidosis is insulin-dependent throughout life. This diabetic condition is the most severe, and the patient's life and social and occupational activities are seriously conditioned by the disease. Besides totally depending on daily insulin administration, the patient must constantly be on guard against two events representing the two extremes resulting from insufficient insulin secretion: ketoacidosic coma (requiring immediate insulin administration) and insulin shock (hypoglycaemia) provoked by an overdose of insulin. In addition to the patient himself, persons who are in close contact with him, also must be trained to quickly recognise the premonitory symptoms of the above-described events and to dispense appropriate and immediate treatment, particularly in the case of hypoglycaemia. It is likewise known that the various drugs administerable via the oral route (sulfonylurea compounds, tolbutamide, chlorpropamide, acetohexamide and tolazamide; biguanides; phenformin) developed over the last decade for treating some mild forms of diabetes (since their efficacy is in fact circumscribed to the treatment of a limited number of selected patients) can not be employed as a substitute for insulin in the patient prone to ketoacidosis. Although the mechanisms of action of such drugs have not yet been fully elucidated, it is known that
Patents 77
such drugs are not oral substitutes for insulin. Moreover, the impossibility of accurately measuring the biological half-life following oral administration makes the choice of the dose and administration intervals difficult and to some extent fortuitous. Web site: http://www.delphion.com/details?pn=US04362719__ •
Treatment and/or prevention of type I diabetes mellitus with gamma interferon administration Inventor(s): Sobel; Douglas (Washington, DC) Assignee(s): Georgetown University Medical Center (Washington, DC) Patent Number: 5,624,895 Date filed: February 18, 1994 Abstract: A method for treating and/or preventing Type I diabetes mellitus in mammals and humans by administration of at least one of the following: (i) gamma interferon, (ii) an analog of gamma interferon or (iii) an inducer of gamma interferon thereof is taught. The use of gamma interferon, analogs thereof, or gamma interferon inducers to prevent recurrent Type I diabetes mellitus in transplant subjects is also provided. Excerpt(s): The present invention relates to a method for preventing and/or treating Type I diabetes (insulin dependent diabetes mellitus) by the administration of at least one of the following: (i) gamma interferon, (ii) an analog of gamma interferon, or (iii) an inducer of gamma interferon. The present invention is further directed to a method for preventing and/or treating recurrent Type I diabetes, e.g., in transplant subjects having islet or pancreatic transplants. Type I diabetes mellitus, also referred to as insulindependent diabetes mellitus (IDDM), is a common endocrine disorder in childhood. About 30% to 40% of diabetic children will eventually develop nephropathy requiring dialysis and transplantation. Other significant complications include cardiovascular disease, stroke, blindness and gangrene. Moreover, diabetes mellitus accounts for a significant proportion of morbidity and mortality among dialysis and transplant patients. Web site: http://www.delphion.com/details?pn=US05624895__
•
Treatment for juvenile diabetes Inventor(s): Brand; Stephen J. (Lincoln, MA), Nardi; Ronald V. (Sudbury, MA) Assignee(s): The General Hospital Corporation (Boston, MA), Waratah Pharmaceuticals, Inc. (CA) Patent Number: 6,288,301 Date filed: July 30, 1998 Abstract: A method for treating diabetes mellitus by administering composition providing a gastrin/CCK receptor ligand, e.g. a gastrin, and an EGF receptor ligand, e.g. TGF.alpha., in an amount sufficient to effect differentiation of pancreatic islet precursor cells to mature insulin-secreting cells. The composition can be administered systemically or expressed in situ by cells transgenically supplemented with one or both of a gastrin/CCK receptor ligand gene, e.g. a preprogastrin peptide precursor gene and an EGF receptor ligand gene, e.g. a TGF.alpha. gene.
78
Juvenile Diabetes
Excerpt(s): This invention relates to treatment of diabetes mellitus by effecting the differentiation of pancreatic islet precursor cells into mature insulin-producing cells by the combined synergistic stimulation by a gastrin/cholecystokinin (CCK) receptor ligand, particularly gastrin, and an epidermal growth factor (EGF) receptor ligand, particularly transforming growth factor alpha (TGF.alpha.). The pancreatic islets develop from endodermal stem cells that lie in the fetal ductular pancreatic endothelium, which also contains pluripotent stem cells that develop into the exocrine pancreas. Teitelman, G. and J. K. Lee, Developmental Biology, 121: 454-466 (1987); Pictet, R. and W. J. Rutter, Development of the embryonic endocrine pancreas, in Endocrinology, Handbook of Physiology, ed. R. O.Greep and E. B. Astwood (1972), American Physiological Society: Washington D.C., p. 25-66. Islet development proceeds through discrete developmental states during fetal gestation which are punctuated by dramatic transitions. The initial period is a protodifferentiated state which is characterized by the commitment of these pluripotent stem cells to the islet cell lineage, as manifested by the expression of insulin and glucagon. These protodifferentiated cells comprise a population of committed islet precursor cells which express only low levels of islet specific gene products and lack the cytodifferentiation of mature islet cells. Pictet, R. and W. J. Rutter, supra. Around day 16 in mouse gestation, the protodifferentiated pancreas begins a phase of rapid growth and differentiation characterized by cytodifferentiation of islet cells and a several hundred fold increase in islet specific gene expression. Histologically, islet formation (neogenesis) becomes apparent as proliferating islets bud from the pancreatic ducts (nesidioblastosis). Just before birth the rate of islet growth slows, and islet neogenesis and nesidioblastosis becomes much less apparent. Concomitant with this, the islets attain a fully differentiated state with maximal levels of insulin gene expression. Therefore, similar to many organs, the completion of cellular differentiation is associated with reduced regenerative potential. Since differentiation of protodifferentiated precursors occurs during late fetal development of the pancreas, the factors regulating islet differentiation are likely to be expressed in the pancreas during this period. One of the genes expressed during islet development encodes the gastrointestinal peptide, gastrin. Although gastrin acts in the adult as a gastric hormone regulating acid secretion, the major site of gastrin expression in the fetus is the pancreatic islets. Brand, S. J. and P. J. Fuller, J. Biol Chem., 263:53415347 (1988). Expression of gastrin in the pancreatic islets is transient. It is confined to the period when protodifferentiated islet precursors form differentiated islets. Although the significance of pancreatic gastrin in islet development is unknown, some clinical observations suggest a role for gastrin in this islet development as follows. For example, hypergastrinemia caused by gastrin-expressing islet cell tumors and atrophic gastritis is associated with nesidioblastosis similar to that seen in differentiating fetal islets. Sacchi, T. B., et al., Virchows Archiv B, 48:261-276 (1985); and Heitz, P. U., et al., Diabetes, 26:632-642 (1977). Further, an abnormal persistence of pancreatic gastrin has been documented in a case of infantile nesidioblastosis. Hollande E., et al., Gastroenterology, 71:255-262 (1976). However, in neither observation was a causal relationship established between the nesidioblastosis and gastrin stimulation. Web site: http://www.delphion.com/details?pn=US06288301__
Patents 79
Patent Applications on Juvenile Diabetes As of December 2000, U.S. patent applications are open to public viewing.10 Applications are patent requests which have yet to be granted. (The process to achieve a patent can take several years.) The following patent applications have been filed since December 2000 relating to juvenile diabetes: •
Compositions, kits, and methods for identification and modulation of type I diabetes Inventor(s): Byrne, Michael C.; (Brookline, MA), Hill, Andrew A.; (Cambridge, MA), Wilson, S. Brian; (Lexington, MA) Correspondence: Lahive & Cockfield; 28 State Street; Boston; MA; 02109; US Patent Application Number: 20020039736 Date filed: June 5, 2001 Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating type I diabetes. A variety of markers are provided, wherein changes in the levels of expression of one or more of the markers is correlated with the presence of type I diabetes. Excerpt(s): This application claims priority to U.S. Provisional Application No. 60/209,703 filed on Jun. 5, 2000, incorporated herein in its entirety by this reference. Diabetes mellitus is a syndrome with interrelated metabolic, vascular, and neuropathic components. The metabolic component, generally characterized by hyperglycemia, comprises alterations in carbohydrate, fat and protein metabolism caused by absent or markedly reduced insulin secretion and/or ineffective insulin action. The vascular component includes abnormalities in the blood vessels leading to cardiovascular, retinal and renal complications. Abnormalities in the peripheral and autonomic nervous systems comprise a third component of the diabetic syndrome. There are two types of diabetes mellitus: type I and type II. Type I diabetes is also termed "insulin-dependent" diabetes, due to the fact that subjects afflicted with this disorder cannot synthesize their own insulin, and therefore must periodically inject insulin into their systems. Type II diabetic-afflicted subjects, on the other hand, are able to synthesize insulin, but this insulin is either insufficient for the needs of the subject, or is not effectively used by the subject. Type II diabetes (`non-insulin-dependent` diabetes) is typically controlled by oral medication. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
•
METHOD FOR IN VITRO PROLIFERATION OF DENDRITIC CELL PRECURSORS AND THEIR USE TO PRODUCE IMMUNOGENS Inventor(s): INABA, KAYO; (KYOTO, JP), SCHULER, GEROLD; (INNSBRUCK, AT), STEINMAN, RALPH M.; (WESTPORT, CT) Correspondence: Ann-louise Kerner PhD; Hale And Dorr Llp; 60 State Street; Boston; MA; 02109; US Patent Application Number: 20020085993 Date filed: May 6, 1998
10
This has been a common practice outside the United States prior to December 2000.
80
Juvenile Diabetes
Abstract: A method for producing proliferating cultures of dendritic cell precursors is provided. Also provided is a method for producing mature dendritic cells in culture from the proliferating dendritic cell precursors. The cultures of mature dendritic cells provide an effective means of producing novel T cell dependent antigens comprised of dendritic cell modified antigens or dendritic cells pulsed with antigen, including particulates, which antigen is processed and expressed on the antigen-activated dendritic cell. The novel antigens of the invention may be used as immunogens for vaccines or for the treatment of disease. These antigens may also be used to treat autoimmune diseases such as juvenile diabetes and multiple sclerosis. Excerpt(s): This application is a continuation-in-part of U.S. patent application Ser. No. 07/981,357 filed Nov. 25, 1992 which in turn is a continuation-in-part of U.S. patent application Ser. No. 07/861,612 filed Apr. 1, 1992. This invention relates to a method of culturing cells of the immune system. In particular a method is provided for culturing proliferating dendritic cell precursors and for their maturation in vitro to mature dendritic cells. This invention also relates to dendritic cell modified antigens which are T cell dependent, the method of making them, and their use as immunogens. Vaccines, methods of immunizing animals and humans using the mature dendritic cells of the invention, and the modified antigens are also described. The immune system contains a system of dendritic cells that is specialized to present antigens and initiate several Tdependent immune responses. Dendritic cells are distributed widely throughout the body in various tissues. The distribution of dendritic cells has been reviewed in (1). Dendritic cells are found in nonlymphoid organs either close to body surfaces, as in the skin and airways, or in interstitial regions of organs like heart and liver. Dendritic cells, possibly under the control of the cytokine granulocyte macrophage colony-stimulating factor, (hereinafter GM-CSF), can undergo a maturation process that does not entail cell proliferation (2,3). Initially, the dendritic cells process and present antigens most likely on abundant, newly synthesized MHC class II molecules, and then strong accessory and cell-cell adhesion functions are acquired (4-7). Dendritic cells can migrate via the blood and lymph to lymphoid organs (8-10). There, presumably as the "interdigitating" cells of the T-area (8, 11-13), antigens can be presented to T cells in the recirculating pool (14). However, little is known about the progenitors of dendritic cells in the different compartments outlined above. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html •
Proinsulin peptide compounds for detecting and treating type I diabetes Inventor(s): Griffin, Ann C.; (Hanover, NH), Hickey, William F.; (Lyme, NH) Correspondence: Lahive & Cockfield; 28 State Street; Boston; MA; 02109; US Patent Application Number: 20030220229 Date filed: January 16, 2003 Abstract: Proinsulin peptide compounds that modulate an immunological response by T cells of Type I diabetic subjects are disclosed. The proinsulin peptide compounds of the invention are preferably derived from a region of proinsulin that spans the junction between the B chain and C peptide of proinsulin. Pharmaceutical compositions comprising the proinsulin peptide compounds are also disclosed. An immunological response to a proinsulin peptide compound of the invention can be used as an indicator of Type I diabetes in a subject. Accordingly, the invention provides diagnostic assays for Type I diabetes using the proinsulin peptide compounds. Methods for inhibiting the
Patents 81
development or progression of Type I diabetes in a subject by administering a proinsulin peptide compound are also disclosed. Excerpt(s): This application is a continuation-in-part of U.S. patent application Ser. No. 08/272,220, filed Jul. 8, 1994, pending, the entire contents of which are hereby incorporated by reference. Type I, or insulin-dependent, diabetes mellitus (also referred to herein as DM-I) is known to occur spontaneously in humans, rats and mice (Castafo, L and Eisenbarth, G. (1990) Ann. Rev. Immunol. 8:647-679). There is a genetic susceptibility to DM-I associated with certain haplotypes of Class II antigens of the major histocompatability complex (MHC), i.e., HLA-DR3, -DR4 and -DQ3.2 in humans (see e.g., Platz. P. et al. (1981) Diabetologia 21:108-115; Todd, J. et al. (1987) Nature 322:599-604); RT1.sup.u in Bio-Breeding (BB) rats (see e.g., Colle, E. (1990) Clin. Immunol. & Immunopathol. 51:1-9; Parfrey, N. A. et al. (1989) Crit. Rev. Immunol. 9:4565) and H-2g.sup.7 in non-obese diabetic (NOD) mice (see e.g., Kikutani, H. and Makino, S. in Adv. Immunol. (Dixon, F. J., ed.), pp. 285-323, New York, N.Y.: Academic Press, Inc., 1992). The pathology of DM-I consists of the progressive inflammatory infiltration of pancreatic islets (i.e., insulitis) containing immunocytes targeted specifically to insulin-secreting.beta.-cells (see e.g., Bottazzo, G. F. et al. (1985) N. Eng. J. Med. 313:353-360; Foulis, A. K. et al. (1991) J. Pathol. 16:97-103; Hanenberg, H. et al. (1991) Diabetologia 2: 126-134). This pathology develops over an indeterminate period of time (months to years). It has become clear that the development of Type I diabetes occurs as a result of a complex relationship involving genetic predisposition, environmental influences, and additional undefined co-factors. In attempting to understand the pathogenesis of DM-I, the most elusive pieces of information have been the definition of the inciting autoantigen(s), and whether cellular or humoral-mediated autoreactivity is the primary event. Serum autoantibodies directed against islet cell cytoplasm and surface antigens (i.e., ICA, ICSA), insulin (IAA) and glutamic acid decarboxylase (GAD) can be found in pre-diabetic and newly diagnosed diabetic humans and animals (see e.g., Rowley, M. et al. (1992) Diabetes 41:548-551; Palmer, J. et al. (1983) Science 222:1337-9; MacLaren, N. et al. (1988) Diabetes 38:534-538; Baekkeskov, S. et al. (1990) Nature 347:151-156; Velleso, L. A. et al. (1993) Diabetologia 36:39-46). Unfortunately, correlations between antibody titers against these antigens and the clinical onset of diabetes have not been successfully predictive. In addition, a number of other.beta.-cell antigens become exposed as islets are destroyed such as a 69 kd islet cell autoantigen (ICA69) (Pietropaolo, M. et al. (1993), J. Clin. Invest. 92:359-371), 38 kd and 62 kd insulin secretory granule proteins (Roep, B. O. et al. (1991) Lancet 337:1439-1441; Brudzynski, K. et al. (1992) J. Autoimm. 5:453-463) and proislets (Harrison, L. C. et al. (1992) J. Clin. Invest. 2: 1161-65; Harrison, L. et al. in Advances in Endocrinology & Metabolism (Maztaferri, E. L. et al., ed.), pp. 35-94, St. Louis, Mo.: Mosby-Year Book, 1990). However, it is not clear whether the cellular and/or humoral immune responses to these antigens are the cause or simply a consequence of ongoing islet cell damage. In short, the immunologic nature of the pathogenic mechanism and the exact antigen(s) inducing the diabetogenic attack have yet to be elucidated. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
Keeping Current In order to stay informed about patents and patent applications dealing with juvenile diabetes, you can access the U.S. Patent Office archive via the Internet at the following Web address: http://www.uspto.gov/patft/index.html. You will see two broad options: (1) Issued
82
Juvenile Diabetes
Patent, and (2) Published Applications. To see a list of issued patents, perform the following steps: Under “Issued Patents,” click “Quick Search.” Then, type “juvenile diabetes” (or synonyms) into the “Term 1” box. After clicking on the search button, scroll down to see the various patents which have been granted to date on juvenile diabetes. You can also use this procedure to view pending patent applications concerning juvenile diabetes. Simply go back to http://www.uspto.gov/patft/index.html. Select “Quick Search” under “Published Applications.” Then proceed with the steps listed above.
83
CHAPTER 7. BOOKS ON JUVENILE DIABETES Overview This chapter provides bibliographic book references relating to juvenile diabetes. In addition to online booksellers such as www.amazon.com and www.bn.com, excellent sources for book titles on juvenile diabetes include the Combined Health Information Database and the National Library of Medicine. Your local medical library also may have these titles available for loan.
Book Summaries: Federal Agencies The Combined Health Information Database collects various book abstracts from a variety of healthcare institutions and federal agencies. To access these summaries, go directly to the following hyperlink: http://chid.nih.gov/detail/detail.html. You will need to use the “Detailed Search” option. To find book summaries, use the drop boxes at the bottom of the search page where “You may refine your search by.” Select the dates and language you prefer. For the format option, select “Monograph/Book.” Now type “juvenile diabetes” (or synonyms) into the “For these words:” box. You should check back periodically with this database which is updated every three months. The following is a typical result when searching for books on juvenile diabetes: •
Rufus Comes Home: Rufus, the Bear with Diabetes Source: Valley Park, MO: JayJo Books, LLC. 1998. [31 p.]. Contact: Available from JayJo Books, LLC. P.O. Box 213, Valley Park, MO 63088-0213. (636) 861-1331. Fax (636) 861-2411. E-mail:
[email protected]. Website: www.jayjo.com. PRICE: $11.95. ISBN: 1891383027. Summary: This illustrated book tells the story of Brian, a young boy who is hospitalized and diagnosed with diabetes, to help children who have diabetes better understand their disease. Following Brian's diagnosis, his mother decides to get him a stuffed bear. She sews special patches on the spots where Brian gets his insulin injections and puts hearts on the paws where Brian has do his fingerpricks for glucose testing. She also makes a special medical bracelet for the bear's arm to tell people about the bear's special
84
Juvenile Diabetes
condition and dresses the bear in a T-shirt from the Juvenile Diabetes Foundation. Brian now has his bear to share his feelings and experience living with diabetes. •
Clinical Diabetes Mellitus: A Problem-Oriented Approach. 2nd ed Source: New York, NY: Thieme Medical Publishers, Inc. 1991. 846 p. Contact: Available from Juvenile Diabetes Foundation International. 120 Wall Street, 19th floor, New York, NY 10005. (800) 223-1138 or (212) 785-9500. Fax (212) 785-9595. PRICE: $149. TMP ISBN: 086577370X, GTV ISBN: 3136618025. Summary: This medical textbook integrates research results with clinical practice, presenting current diagnostic and treatment techniques in a problem-oriented format. Fifty-seven chapters are divided into seven sections: the nature of diabetes mellitus, diagnosis and screening, long-term management, complications, concomitant problems, socioeconomic problems, and the development and evaluation of diabetes care problems. Eleven appendices cover the International Diabetes Federation; the American Diabetes Association; camps for children with diabetes; the European Association for the Study of Diabetes; the Juvenile Diabetes Foundation International; recordkeeping forms; and an index to diagnosis, drug-related adverse reactions and procedures, and diabetes surveillance at the Centers for Disease Control. Each chapter, written by experts in the field, includes numerous figures, tables, and references. A subject index concludes the volume.
Book Summaries: Online Booksellers Commercial Internet-based booksellers, such as Amazon.com and Barnes&Noble.com, offer summaries which have been supplied by each title’s publisher. Some summaries also include customer reviews. Your local bookseller may have access to in-house and commercial databases that index all published books (e.g. Books in Print®). IMPORTANT NOTE: Online booksellers typically produce search results for medical and non-medical books. When searching for “juvenile diabetes” at online booksellers’ Web sites, you may discover non-medical books that use the generic term “juvenile diabetes” (or a synonym) in their titles. The following is indicative of the results you might find when searching for “juvenile diabetes” (sorted alphabetically by title; follow the hyperlink to view more details at Amazon.com): •
Borrowing Time: Growing Up With Juvenile Diabetes by Pat Covelli; ISBN: 069001841X; http://www.amazon.com/exec/obidos/ASIN/069001841X/icongroupinterna
•
Childhood and Juvenile Diabetes Mellitus (Current Clinical Practice, No 27) by G. Mimura; ISBN: 4900392723; http://www.amazon.com/exec/obidos/ASIN/4900392723/icongroupinterna
•
Coping With Juvenile Diabetes by Paul I. Ahmed, Nancy Ahmed (Editor); ISBN: 0398050732; http://www.amazon.com/exec/obidos/ASIN/0398050732/icongroupinterna
•
Diabetic Low-Fat and No-Fat Meals in Minutes: More Than 250 Delicious, Easy, and Healthy Recipes & Menus for People With Diabetes, Their Families, and Their Friends (Juvenile Diabetes Foundation Library) by M. J. Smith; ISBN: 1565610849; http://www.amazon.com/exec/obidos/ASIN/1565610849/icongroupinterna
Books
85
•
Future Trends in Juvenile Diabetes: Therapy and Research (Pediatric and Adolescent Endocrinology, Vol 16) by Z. Laron (Editor), M. Karp (Editor) (1986); ISBN: 3805539584; http://www.amazon.com/exec/obidos/ASIN/3805539584/icongroupinterna
•
Juvenile diabetes : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Sixth Congress, first session, special hearing (SuDoc Y 4.AP 6/2:S.HRG.106-370); ISBN: 0160602289; http://www.amazon.com/exec/obidos/ASIN/0160602289/icongroupinterna
•
Kidney function and glomerular permeability to macromolecules in juvenile diabetes; with special references to early changes by Carl Erik Mogensen; ISBN: 8775500086; http://www.amazon.com/exec/obidos/ASIN/8775500086/icongroupinterna
•
Living with Juvenile Diabetes: A Practical Guide for Parents and Caregivers by Victoria Peurrung (2001); ISBN: 1578260574; http://www.amazon.com/exec/obidos/ASIN/1578260574/icongroupinterna
•
Management of Juvenile Diabetes Mellitus by Howard S. Traisman; ISBN: 0801650194; http://www.amazon.com/exec/obidos/ASIN/0801650194/icongroupinterna
•
Serum growth hormone patterns in juvenile diabetes by Aage Prange Hansen; ISBN: 8775500043; http://www.amazon.com/exec/obidos/ASIN/8775500043/icongroupinterna
•
The endocrine pancreas and juvenile diabetes; ISBN: 0306403269; http://www.amazon.com/exec/obidos/ASIN/0306403269/icongroupinterna
The National Library of Medicine Book Index The National Library of Medicine at the National Institutes of Health has a massive database of books published on healthcare and biomedicine. Go to the following Internet site, http://locatorplus.gov/, and then select “Search LOCATORplus.” Once you are in the search area, simply type “juvenile diabetes” (or synonyms) into the search box, and select “books only.” From there, results can be sorted by publication date, author, or relevance. The following was recently catalogued by the National Library of Medicine:11 •
Fourth International Workshop on the Psychological Aspects of Juvenile Diabetes: May 15, 16, 17, 18 1977, Bearskin Meadow Camp, Kings Canyon National Park, California. Author: Diabetic Youth Foundation.; Year: 1977; [s.l.: s.n., 1977?]
•
Juvenile diabetes (a review of 116 cases with particular occurrence of complications). Author: Venegas, Francisco.; Year: 1947; [Minneapolis] 1947
•
Juvenile diabetes mellitus, optic atrophy, hearing loss, diabetes insipidus, atonia of the urinary tract and bladder, and other abnormalities (Wolfram syndrome): a review of 88 cases from the literature with personal observations on 3 newpatients Author:
11
In addition to LOCATORPlus, in collaboration with authors and publishers, the National Center for Biotechnology Information (NCBI) is currently adapting biomedical books for the Web. The books may be accessed in two ways: (1) by searching directly using any search term or phrase (in the same way as the bibliographic database PubMed), or (2) by following the links to PubMed abstracts. Each PubMed abstract has a "Books" button that displays a facsimile of the abstract in which some phrases are hypertext links. These phrases are also found in the books available at NCBI. Click on hyperlinked results in the list of books in which the phrase is found. Currently, the majority of the links are between the books and PubMed. In the future, more links will be created between the books and other types of information, such as gene and protein sequences and macromolecular structures. See http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Books.
86
Juvenile Diabetes
Cremers, C. W. R. J.; Year: 1977; Nijmegen, Netherlands: [s.n.]; Stockholm: distributed by Almqvist; Wiksell, 1977 •
Juvenile diabetes: adjustment and emotional problems; proceedings of a workshop held at Princeton, New Jersey, April 22-23, 1963. Ed. by T. S. Danowski [et al. Author: Danowski, T. S. (Thaddeus Stanley),; Year: 1963; Princeton? 1963]
•
Kidney function and glomerular permeability to macromolecules in juvenile diabetes, with special reference to early changes. Author: Mogensen, Carl Erik.; Year: 1972; Copenhagen, Costers Bogtrykkeri, 1972
•
Management of juvenile diabetes mellitus Author: Traisman, Howard S. (Howard Senn),; Year: 1980; St. Louis: Mosby, 1980; ISBN: 0801650208 http://www.amazon.com/exec/obidos/ASIN/0801650208/icongroupinterna
•
Serum growth hormone patterns in juvenile diabetes. Author: Hansen, Aage Prange.; Year: 1972; Copenhagen, Costers Bogtrykkeri, 1972
•
Symposium on juvenile diabetes Author: Castells, Salvador.; Year: 1984; Philadelphia: Saunders, c1984
•
The Juvenile Diabetes Foundation Workshop on the Spontaneously Diabetic BB Rat-Its Potential for Insight Into Human Juvenile Diabetes: Banff, Alberta, Canada, September 8-10, 1982. Author: Alberta Heritage Foundation for Medical Research.; Year: 1983; New York, N.Y.: Grune; Stratton, c1983
Chapters on Juvenile Diabetes In order to find chapters that specifically relate to juvenile diabetes, an excellent source of abstracts is the Combined Health Information Database. You will need to limit your search to book chapters and juvenile diabetes using the “Detailed Search” option. Go to the following hyperlink: http://chid.nih.gov/detail/detail.html. To find book chapters, use the drop boxes at the bottom of the search page where “You may refine your search by.” Select the dates and language you prefer, and the format option “Book Chapter.” Type “juvenile diabetes” (or synonyms) into the “For these words:” box.
Directories In addition to the references and resources discussed earlier in this chapter, a number of directories relating to juvenile diabetes have been published that consolidate information across various sources. The Combined Health Information Database lists the following, which you may wish to consult in your local medical library:12 •
Directory of Diabetes Organizations Source: Bethesda, MD: National Diabetes Information Clearinghouse (NDIC). 199x. [6 p.].
12 You will need to limit your search to “Directory” and “juvenile diabetes” using the "Detailed Search" option. Go directly to the following hyperlink: http://chid.nih.gov/detail/detail.html. To find directories, use the drop boxes at the bottom of the search page where “You may refine your search by.” For publication date, select “All Years.” Select your preferred language and the format option “Directory.” Type “juvenile diabetes” (or synonyms) into the “For these words:” box. You should check back periodically with this database as it is updated every three months.
Books
87
Contact: Available from National Diabetes Information Clearinghouse (NDIC). 1 Information Way, Bethesda, MD 20892-3560. (800) 860-8747 or (301) 654-3327. Fax (301) 634-0716. E-mail:
[email protected]. Also available at http://www.niddk.nih.gov/. PRICE: Full-text available online at no charge; single copy free; bulk copies available. Order number: DM-128. Summary: This regularly-revised directory lists some major voluntary, governmental, and private organizations involved in diabetes-related activities. Some organizations offer educational or other types of services to people with diabetes and their families and friends; others primarily serve health care professionals. Organizations listed include: the American Association of Diabetes Educators; the American Diabetes Association; the Diabetes Care and Education Practice Group of the American Dietetic Association; the six Diabetes Research and Training Centers; the Division of Diabetes Translation of the Centers for Disease Control and Prevention; the Indian Health Service; the International Diabetes Center; the International Diabetes Federation; the International Diabetic Athletes Association; the Joslin Diabetes Center; the Juvenile Diabetes Foundation; the National Diabetes Information Clearinghouse; the National Eye Institute; the Office of Minority Health Resource Center; and the Pennsylvania Diabetes Academy. Brief descriptions of the organizations and information about their publications are included.
89
CHAPTER 8. MULTIMEDIA ON JUVENILE DIABETES Overview In this chapter, we show you how to keep current on multimedia sources of information on juvenile diabetes. We start with sources that have been summarized by federal agencies, and then show you how to find bibliographic information catalogued by the National Library of Medicine.
Video Recordings An excellent source of multimedia information on juvenile diabetes is the Combined Health Information Database. You will need to limit your search to “Videorecording” and “juvenile diabetes” using the “Detailed Search” option. Go directly to the following hyperlink: http://chid.nih.gov/detail/detail.html. To find video productions, use the drop boxes at the bottom of the search page where “You may refine your search by.” Select the dates and language you prefer, and the format option “Videorecording (videotape, videocassette, etc.).” Type “juvenile diabetes” (or synonyms) into the “For these words:” box. The following is a typical result when searching for video recordings on juvenile diabetes: •
Juvenile Diabetes Source: Sherborn, MA: Aquarius Productions, Inc. 1995. (videocassette). Contact: Available from Aquarius Productions, Inc. 5 Powderhouse Lane, P.O. Box 1159, Sherborn, MA 01770. (508) 651-2963. Fax (508) 650-4216. PRICE: $149.00. Summary: This video explores the lives of children who are managing their diabetes. With an early diagnosis, children become responsible for their health by learning to analyze blood glucose, handle daily injections of insulin, and maintain a balance of food and exercise. The video includes personal stories of families working together to manage the disease and comments from both children and parents. These stories help clarify many misconceptions. The video also reports on a special summer camp for children with diabetes. (AA-M).
•
Doctor is In: Juvenile Diabetes Source: Lebanon, NH: Dartmouth-Hitchcock Medical Center. 199x. (videorecording).
90
Juvenile Diabetes
Contact: Available from Department of Visual Media. Dartmouth-Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03766-9934. (603) 643-7401. Fax (603) 643-7404. PRICE: $29.95. Summary: This videocassette, part of a series which discusses how people cope with various illnesses, provides information on insulin-dependent diabetes mellitus (IDDM, or Type I). The producers note that the children who do best are the ones who handle as many diabetes care responsibilities as possible. The program examines how children learn to analyze their blood sugar levels and manage their care. With the help of their parents, participants aged 9 to 15 demonstrate how they handle daily blood glucose monitoring, insulin injections, food intake, and exercise. A special New Hampshire summer camp for children with diabetes is profiled. (AA-M).
Bibliography: Multimedia on Juvenile Diabetes The National Library of Medicine is a rich source of information on healthcare-related multimedia productions including slides, computer software, and databases. To access the multimedia database, go to the following Web site: http://locatorplus.gov/. Select “Search LOCATORplus.” Once in the search area, simply type in juvenile diabetes (or synonyms). Then, in the option box provided below the search box, select “Audiovisuals and Computer Files.” From there, you can choose to sort results by publication date, author, or relevance. The following multimedia has been indexed on juvenile diabetes: •
Juvenile diabetes [sound recording]: day by day Source: Western New York Diabetes Educators; Year: 1976; Format: Sound recording; Buffalo: Communications in Learning, 1976
•
Juvenile diabetes [videorecording] Source: Marshfield Medical Foundation, in cooperation with Marshfield Clinic & St. Joseph's Hospital; Year: 1983; Format: Videorecording; Marshfield, WI: Marshfield Regional Video Network, 1983
•
Juvenile diabetes [videorecording]: one family's story. Year: 1986; Format: Videorecording; [Springfield, Ill.]: Southern Illinois University, School of Medicine, c1986
•
Juvenile diabetes mellitus [videorecording] Source: [presented by] Queen's University, Dept. of Biochemistry; Queen's Television; Year: 1982; Format: Videorecording; [Kingston, Ont.]: The Department, 1982
91
CHAPTER 9. PERIODICALS AND NEWS ON JUVENILE DIABETES Overview In this chapter, we suggest a number of news sources and present various periodicals that cover juvenile diabetes.
News Services and Press Releases One of the simplest ways of tracking press releases on juvenile diabetes is to search the news wires. In the following sample of sources, we will briefly describe how to access each service. These services only post recent news intended for public viewing. PR Newswire To access the PR Newswire archive, simply go to http://www.prnewswire.com/. Select your country. Type “juvenile diabetes” (or synonyms) into the search box. You will automatically receive information on relevant news releases posted within the last 30 days. The search results are shown by order of relevance. Reuters Health The Reuters’ Medical News and Health eLine databases can be very useful in exploring news archives relating to juvenile diabetes. While some of the listed articles are free to view, others are available for purchase for a nominal fee. To access this archive, go to http://www.reutershealth.com/en/index.html and search by “juvenile diabetes” (or synonyms). The following was recently listed in this archive for juvenile diabetes: •
ViaCell forms endocrine research subsidiary to address type I diabetes Source: Reuters Industry Breifing Date: April 01, 2002
92
Juvenile Diabetes
•
Juvenile diabetes group funds gene therapy research Source: Reuters Medical News Date: May 19, 2000
•
Juvenile Diabetes Foundation funds fast track cure for Type I diabetes at Harvard Source: Reuters Medical News Date: September 11, 1998
•
Pre-eclampsia linked to juvenile diabetes Source: Reuters Health eLine Date: July 27, 1998
•
Use Of Immunosuppressive Rx In Early Juvenile Diabetes Unjustified Source: Reuters Medical News Date: January 18, 1996 The NIH
Within MEDLINEplus, the NIH has made an agreement with the New York Times Syndicate, the AP News Service, and Reuters to deliver news that can be browsed by the public. Search news releases at http://www.nlm.nih.gov/medlineplus/alphanews_a.html. MEDLINEplus allows you to browse across an alphabetical index. Or you can search by date at the following Web page: http://www.nlm.nih.gov/medlineplus/newsbydate.html. Often, news items are indexed by MEDLINEplus within its search engine. Business Wire Business Wire is similar to PR Newswire. To access this archive, simply go to http://www.businesswire.com/. You can scan the news by industry category or company name. Market Wire Market Wire is more focused on technology than the other wires. To browse the latest press releases by topic, such as alternative medicine, biotechnology, fitness, healthcare, legal, nutrition, and pharmaceuticals, access Market Wire’s Medical/Health channel at http://www.marketwire.com/mw/release_index?channel=MedicalHealth. Or simply go to Market Wire’s home page at http://www.marketwire.com/mw/home, type “juvenile diabetes” (or synonyms) into the search box, and click on “Search News.” As this service is technology oriented, you may wish to use it when searching for press releases covering diagnostic procedures or tests. Search Engines Medical news is also available in the news sections of commercial Internet search engines. See the health news page at Yahoo (http://dir.yahoo.com/Health/News_and_Media/), or you can use this Web site’s general news search page at http://news.yahoo.com/. Type in “juvenile diabetes” (or synonyms). If you know the name of a company that is relevant to juvenile diabetes, you can go to any stock trading Web site (such as
Periodicals and News
93
http://www.etrade.com/) and search for the company name there. News items across various news sources are reported on indicated hyperlinks. Google offers a similar service at http://news.google.com/. BBC Covering news from a more European perspective, the British Broadcasting Corporation (BBC) allows the public free access to their news archive located at http://www.bbc.co.uk/. Search by “juvenile diabetes” (or synonyms).
Academic Periodicals covering Juvenile Diabetes Numerous periodicals are currently indexed within the National Library of Medicine’s PubMed database that are known to publish articles relating to juvenile diabetes. In addition to these sources, you can search for articles covering juvenile diabetes that have been published by any of the periodicals listed in previous chapters. To find the latest studies published, go to http://www.ncbi.nlm.nih.gov/pubmed, type the name of the periodical into the search box, and click “Go.” If you want complete details about the historical contents of a journal, you can also visit the following Web site: http://www.ncbi.nlm.nih.gov/entrez/jrbrowser.cgi. Here, type in the name of the journal or its abbreviation, and you will receive an index of published articles. At http://locatorplus.gov/, you can retrieve more indexing information on medical periodicals (e.g. the name of the publisher). Select the button “Search LOCATORplus.” Then type in the name of the journal and select the advanced search option “Journal Title Search.”
95
APPENDICES
97
APPENDIX A. PHYSICIAN RESOURCES Overview In this chapter, we focus on databases and Internet-based guidelines and information resources created or written for a professional audience.
NIH Guidelines Commonly referred to as “clinical” or “professional” guidelines, the National Institutes of Health publish physician guidelines for the most common diseases. Publications are available at the following by relevant Institute13: •
Office of the Director (OD); guidelines consolidated across agencies available at http://www.nih.gov/health/consumer/conkey.htm
•
National Institute of General Medical Sciences (NIGMS); fact sheets available at http://www.nigms.nih.gov/news/facts/
•
National Library of Medicine (NLM); extensive encyclopedia (A.D.A.M., Inc.) with guidelines: http://www.nlm.nih.gov/medlineplus/healthtopics.html
•
National Cancer Institute (NCI); guidelines available at http://www.cancer.gov/cancerinfo/list.aspx?viewid=5f35036e-5497-4d86-8c2c714a9f7c8d25
•
National Eye Institute (NEI); guidelines available at http://www.nei.nih.gov/order/index.htm
•
National Heart, Lung, and Blood Institute (NHLBI); guidelines available at http://www.nhlbi.nih.gov/guidelines/index.htm
•
National Human Genome Research Institute (NHGRI); research available at http://www.genome.gov/page.cfm?pageID=10000375
•
National Institute on Aging (NIA); guidelines available at http://www.nia.nih.gov/health/
13
These publications are typically written by one or more of the various NIH Institutes.
98
Juvenile Diabetes
•
National Institute on Alcohol Abuse and Alcoholism (NIAAA); guidelines available at http://www.niaaa.nih.gov/publications/publications.htm
•
National Institute of Allergy and Infectious Diseases (NIAID); guidelines available at http://www.niaid.nih.gov/publications/
•
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); fact sheets and guidelines available at http://www.niams.nih.gov/hi/index.htm
•
National Institute of Child Health and Human Development (NICHD); guidelines available at http://www.nichd.nih.gov/publications/pubskey.cfm
•
National Institute on Deafness and Other Communication Disorders (NIDCD); fact sheets and guidelines at http://www.nidcd.nih.gov/health/
•
National Institute of Dental and Craniofacial Research (NIDCR); guidelines available at http://www.nidr.nih.gov/health/
•
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); guidelines available at http://www.niddk.nih.gov/health/health.htm
•
National Institute on Drug Abuse (NIDA); guidelines available at http://www.nida.nih.gov/DrugAbuse.html
•
National Institute of Environmental Health Sciences (NIEHS); environmental health information available at http://www.niehs.nih.gov/external/facts.htm
•
National Institute of Mental Health (NIMH); guidelines available at http://www.nimh.nih.gov/practitioners/index.cfm
•
National Institute of Neurological Disorders and Stroke (NINDS); neurological disorder information pages available at http://www.ninds.nih.gov/health_and_medical/disorder_index.htm
•
National Institute of Nursing Research (NINR); publications on selected illnesses at http://www.nih.gov/ninr/news-info/publications.html
•
National Institute of Biomedical Imaging and Bioengineering; general information at http://grants.nih.gov/grants/becon/becon_info.htm
•
Center for Information Technology (CIT); referrals to other agencies based on keyword searches available at http://kb.nih.gov/www_query_main.asp
•
National Center for Complementary and Alternative Medicine (NCCAM); health information available at http://nccam.nih.gov/health/
•
National Center for Research Resources (NCRR); various information directories available at http://www.ncrr.nih.gov/publications.asp
•
Office of Rare Diseases; various fact sheets available at http://rarediseases.info.nih.gov/html/resources/rep_pubs.html
•
Centers for Disease Control and Prevention; various fact sheets on infectious diseases available at http://www.cdc.gov/publications.htm
Physician Resources
99
NIH Databases In addition to the various Institutes of Health that publish professional guidelines, the NIH has designed a number of databases for professionals.14 Physician-oriented resources provide a wide variety of information related to the biomedical and health sciences, both past and present. The format of these resources varies. Searchable databases, bibliographic citations, full-text articles (when available), archival collections, and images are all available. The following are referenced by the National Library of Medicine:15 •
Bioethics: Access to published literature on the ethical, legal, and public policy issues surrounding healthcare and biomedical research. This information is provided in conjunction with the Kennedy Institute of Ethics located at Georgetown University, Washington, D.C.: http://www.nlm.nih.gov/databases/databases_bioethics.html
•
HIV/AIDS Resources: Describes various links and databases dedicated to HIV/AIDS research: http://www.nlm.nih.gov/pubs/factsheets/aidsinfs.html
•
NLM Online Exhibitions: Describes “Exhibitions in the History of Medicine”: http://www.nlm.nih.gov/exhibition/exhibition.html. Additional resources for historical scholarship in medicine: http://www.nlm.nih.gov/hmd/hmd.html
•
Biotechnology Information: Access to public databases. The National Center for Biotechnology Information conducts research in computational biology, develops software tools for analyzing genome data, and disseminates biomedical information for the better understanding of molecular processes affecting human health and disease: http://www.ncbi.nlm.nih.gov/
•
Population Information: The National Library of Medicine provides access to worldwide coverage of population, family planning, and related health issues, including family planning technology and programs, fertility, and population law and policy: http://www.nlm.nih.gov/databases/databases_population.html
•
Cancer Information: Access to cancer-oriented databases: http://www.nlm.nih.gov/databases/databases_cancer.html
•
Profiles in Science: Offering the archival collections of prominent twentieth-century biomedical scientists to the public through modern digital technology: http://www.profiles.nlm.nih.gov/
•
Chemical Information: Provides links to various chemical databases and references: http://sis.nlm.nih.gov/Chem/ChemMain.html
•
Clinical Alerts: Reports the release of findings from the NIH-funded clinical trials where such release could significantly affect morbidity and mortality: http://www.nlm.nih.gov/databases/alerts/clinical_alerts.html
•
Space Life Sciences: Provides links and information to space-based research (including NASA): http://www.nlm.nih.gov/databases/databases_space.html
•
MEDLINE: Bibliographic database covering the fields of medicine, nursing, dentistry, veterinary medicine, the healthcare system, and the pre-clinical sciences: http://www.nlm.nih.gov/databases/databases_medline.html
14
Remember, for the general public, the National Library of Medicine recommends the databases referenced in MEDLINEplus (http://medlineplus.gov/ or http://www.nlm.nih.gov/medlineplus/databases.html). 15 See http://www.nlm.nih.gov/databases/databases.html.
100 Juvenile Diabetes
•
Toxicology and Environmental Health Information (TOXNET): Databases covering toxicology and environmental health: http://sis.nlm.nih.gov/Tox/ToxMain.html
•
Visible Human Interface: Anatomically detailed, three-dimensional representations of normal male and female human bodies: http://www.nlm.nih.gov/research/visible/visible_human.html The Combined Health Information Database
A comprehensive source of information on clinical guidelines written for professionals is the Combined Health Information Database. You will need to limit your search to one of the following: Brochure/Pamphlet, Fact Sheet, or Information Package, and “juvenile diabetes” using the “Detailed Search” option. Go directly to the following hyperlink: http://chid.nih.gov/detail/detail.html. To find associations, use the drop boxes at the bottom of the search page where “You may refine your search by.” For the publication date, select “All Years.” Select your preferred language and the format option “Fact Sheet.” Type “juvenile diabetes” (or synonyms) into the “For these words:” box. The following is a sample result: •
1995 Research Progress Report Source: Countdown. 16(1): 1-100. Winter 1995. Contact: Available from Juvenile Diabetes Foundation (JDF). 120 Wall Street, 19th floor, New York, NY 10005. (800) 223-1138 or (212) 785-9500. Fax (212) 785-9595. Summary: This issue of the Juvenile Diabetes Foundation (JDF) journal presents a special progress report on diabetes research. Articles include an overview of the historical perspective of diabetes research; current research activities that bring a cure for diabetes within reach; international research activities in the areas of nephropathy, tolerance in autoimmunity and transplant immunology, immunopathogenesis of islet transplantation in IDDM, molecular mechanisms of beta cell dysfunction in diabetes, the pathophysiology and immunotherapy of nonobese diabetes mice, and the generation of nonimmunologic functional islet cells; research in the genetic aspects of diabetes; prediction and prevention research and clinical activities; transplantation considerations; research into improved diabetes treatment options; and complications. The article also includes information on research funding through JDF programs and activities.
The NLM Gateway16 The NLM (National Library of Medicine) Gateway is a Web-based system that lets users search simultaneously in multiple retrieval systems at the U.S. National Library of Medicine (NLM). It allows users of NLM services to initiate searches from one Web interface, providing one-stop searching for many of NLM’s information resources or databases.17 To use the NLM Gateway, simply go to the search site at http://gateway.nlm.nih.gov/gw/Cmd. Type “juvenile diabetes” (or synonyms) into the search box and click “Search.” The results
16 17
Adapted from NLM: http://gateway.nlm.nih.gov/gw/Cmd?Overview.x.
The NLM Gateway is currently being developed by the Lister Hill National Center for Biomedical Communications (LHNCBC) at the National Library of Medicine (NLM) of the National Institutes of Health (NIH).
Physician Resources
101
will be presented in a tabular form, indicating the number of references in each database category. Results Summary Category Journal Articles Books / Periodicals / Audio Visual Consumer Health Meeting Abstracts Other Collections Total
Items Found 24770 167 925 14 3 25879
HSTAT18 HSTAT is a free, Web-based resource that provides access to full-text documents used in healthcare decision-making.19 These documents include clinical practice guidelines, quickreference guides for clinicians, consumer health brochures, evidence reports and technology assessments from the Agency for Healthcare Research and Quality (AHRQ), as well as AHRQ’s Put Prevention Into Practice.20 Simply search by “juvenile diabetes” (or synonyms) at the following Web site: http://text.nlm.nih.gov.
Coffee Break: Tutorials for Biologists21 Coffee Break is a general healthcare site that takes a scientific view of the news and covers recent breakthroughs in biology that may one day assist physicians in developing treatments. Here you will find a collection of short reports on recent biological discoveries. Each report incorporates interactive tutorials that demonstrate how bioinformatics tools are used as a part of the research process. Currently, all Coffee Breaks are written by NCBI staff.22 Each report is about 400 words and is usually based on a discovery reported in one or more articles from recently published, peer-reviewed literature.23 This site has new articles every few weeks, so it can be considered an online magazine of sorts. It is intended for general background information. You can access the Coffee Break Web site at the following hyperlink: http://www.ncbi.nlm.nih.gov/Coffeebreak/. 18
Adapted from HSTAT: http://www.nlm.nih.gov/pubs/factsheets/hstat.html.
19
The HSTAT URL is http://hstat.nlm.nih.gov/.
20
Other important documents in HSTAT include: the National Institutes of Health (NIH) Consensus Conference Reports and Technology Assessment Reports; the HIV/AIDS Treatment Information Service (ATIS) resource documents; the Substance Abuse and Mental Health Services Administration's Center for Substance Abuse Treatment (SAMHSA/CSAT) Treatment Improvement Protocols (TIP) and Center for Substance Abuse Prevention (SAMHSA/CSAP) Prevention Enhancement Protocols System (PEPS); the Public Health Service (PHS) Preventive Services Task Force's Guide to Clinical Preventive Services; the independent, nonfederal Task Force on Community Services’ Guide to Community Preventive Services; and the Health Technology Advisory Committee (HTAC) of the Minnesota Health Care Commission (MHCC) health technology evaluations. 21 Adapted from http://www.ncbi.nlm.nih.gov/Coffeebreak/Archive/FAQ.html. 22 The figure that accompanies each article is frequently supplied by an expert external to NCBI, in which case the source of the figure is cited. The result is an interactive tutorial that tells a biological story. 23 After a brief introduction that sets the work described into a broader context, the report focuses on how a molecular understanding can provide explanations of observed biology and lead to therapies for diseases. Each vignette is accompanied by a figure and hypertext links that lead to a series of pages that interactively show how NCBI tools and resources are used in the research process.
102 Juvenile Diabetes
Other Commercial Databases In addition to resources maintained by official agencies, other databases exist that are commercial ventures addressing medical professionals. Here are some examples that may interest you: •
CliniWeb International: Index and table of contents to selected clinical information on the Internet; see http://www.ohsu.edu/cliniweb/.
•
Medical World Search: Searches full text from thousands of selected medical sites on the Internet; see http://www.mwsearch.com/.
103
APPENDIX B. PATIENT RESOURCES Overview Official agencies, as well as federally funded institutions supported by national grants, frequently publish a variety of guidelines written with the patient in mind. These are typically called “Fact Sheets” or “Guidelines.” They can take the form of a brochure, information kit, pamphlet, or flyer. Often they are only a few pages in length. Since new guidelines on juvenile diabetes can appear at any moment and be published by a number of sources, the best approach to finding guidelines is to systematically scan the Internet-based services that post them.
Patient Guideline Sources The remainder of this chapter directs you to sources which either publish or can help you find additional guidelines on topics related to juvenile diabetes. Due to space limitations, these sources are listed in a concise manner. Do not hesitate to consult the following sources by either using the Internet hyperlink provided, or, in cases where the contact information is provided, contacting the publisher or author directly. The National Institutes of Health The NIH gateway to patients is located at http://health.nih.gov/. From this site, you can search across various sources and institutes, a number of which are summarized below. Topic Pages: MEDLINEplus The National Library of Medicine has created a vast and patient-oriented healthcare information portal called MEDLINEplus. Within this Internet-based system are “health topic pages” which list links to available materials relevant to juvenile diabetes. To access this system, log on to http://www.nlm.nih.gov/medlineplus/healthtopics.html. From there you can either search using the alphabetical index or browse by broad topic areas. Recently, MEDLINEplus listed the following when searched for “juvenile diabetes”:
104 Juvenile Diabetes
•
Guides on juvenile diabetes Diabetes http://www.nlm.nih.gov/medlineplus/diabetes.html Juvenile Diabetes http://www.nlm.nih.gov/medlineplus/juvenilediabetes.html
•
Other guides Diabetic Diet http://www.nlm.nih.gov/medlineplus/diabeticdiet.html Diabetic Eye Problems http://www.nlm.nih.gov/medlineplus/diabeticeyeproblems.html Islet Cell Transplantation http://www.nlm.nih.gov/medlineplus/isletcelltransplantation.html
Within the health topic page dedicated to juvenile diabetes, the following was listed: •
General/Overviews Diabetes http://www.fda.gov/opacom/lowlit/diabetes.html Insulin-Dependent Diabetes Source: Nemours Foundation http://kidshealth.org/parent/medical/endocrine/diabetes.html JAMA Patient Page:Type 1 Diabetes Source: American Medical Association http://www.medem.com/medlb/article_detaillb.cfm?article_ID=ZZZ65Y0D2MD& sub_cat=101 Type 1 Diabetes Facts Source: Juvenile Diabetes Research Foundation International http://www.jdrf.org/index.cfm?fuseaction=home.viewPage&page_id=14AF69BCBE51-42DA-B1B41955029FBC7F
•
Diagnosis/Symptoms A1C Test Source: American Association for Clinical Chemistry http://www.labtestsonline.org/understanding/analytes/a1c/test.html Diagnosis of Diabetes Source: National Diabetes Information Clearinghouse http://diabetes.niddk.nih.gov/dm/pubs/diagnosis/index.htm Glucose Tests Source: American Association for Clinical Chemistry http://www.labtestsonline.org/understanding/analytes/glucose/test.html
Patient Resources
•
105
Alternative Therapy Alternative Therapies for Diabetes Source: National Diabetes Information Clearinghouse http://diabetes.niddk.nih.gov/dm/pubs/alternativetherapies/index.htm
•
Coping Coping with Bad Feelings Source: American Diabetes Association http://www.diabetes.org/type1/living/coping/default.jsp Diabetes: Helping a Family Member Who Has Diabetes Source: American Academy of Family Physicians http://familydoctor.org/handouts/353.html
•
Specific Conditions/Aspects Alcohol Source: American Diabetes Association http://www.diabetes.org/health/nutrition/alcohol/alcohol.jsp Complications of Diabetes Source: Food and Drug Administration http://www.fda.gov/diabetes/related.html Diabetes and Dental Care Source: Juvenile Diabetes Research Foundation International http://www.jdrf.org/index.cfm?fuseaction=home.viewPage&page_id=2A9C1063CDBF-47DA-BEF2F5141A9FC7F6 Diabetic Arthritis Source: Mayo Foundation for Medical Education and Research http://www.mayoclinic.com/invoke.cfm?id=AN00526 Financial Help for Diabetes Care Source: National Diabetes Information Clearinghouse http://diabetes.niddk.nih.gov/dm/pubs/financialhelp/index.htm Hyperglycemia (High Blood Sugar) Source: American Diabetes Association http://www.diabetes.org/type2/medical/hyperglycemia/default.jsp Hyperosmolar Hyperglycemic Nonketotic Syndrome (HHNS) Source: American Diabetes Association http://www.diabetes.org/type2/medical/HHNS.jsp JAMA Patient Page: Safe Driving for People with Diabetes Source: American Medical Association http://www.medem.com/MedLB/article_detaillb.cfm?article_ID=ZZZRHSKYMA C&sub_cat=268 Ketoacidosis Source: American Diabetes Association http://www.diabetes.org/main/type1/medical/ketoacidosis/ketoacidosis.jsp
106 Juvenile Diabetes
Lancing Devices & Sharps Disposal Source: Food and Drug Administration http://www.fda.gov/diabetes/lancing.html Low/High Blood Sugar Emergencies Source: Juvenile Diabetes Research Foundation International http://www.jdrf.org/index.cfm?fuseaction=home.viewPage&page_id=B8B391DAD9C4-4C36-9D6BC63A1F69DAAA Stress Source: American Diabetes Association http://www.diabetes.org/health/stress/stress.jsp Traveling with Diabetes Supplies Source: American Diabetes Association http://www.diabetes.org/main/community/advocacy/travel.jsp When You're Sick Source: American Diabetes Association http://www.diabetes.org/type2/living/sick/default.jsp •
Children All about the Insulin Pump Source: Juvenile Diabetes Research Foundation International http://216.167.3.245/kids/cfk/1999/09/pump.html Child with Diabetes Is in Your Care Source: Juvenile Diabetes Research Foundation International http://www.jdrf.org/index.cfm?fuseaction=home.viewPage&page_id=A71E26151C66-4017-BE0AC0D93D093374 Diabetes in Children and Adolescents Source: National Diabetes Education Program http://ndep.nih.gov/diabetes/youth/youth_FS.htm Do You Know about Diabetes? Source: Nemours Foundation http://kidshealth.org/kid/health_problems/gland/diabetes.html Helping Your Child Live with Diabetes Source: Juvenile Diabetes Research Foundation International http://www.jdrf.org/index.cfm?fuseaction=home.viewPage&page_id=B894522F7185-48E9-A7123C0E9EEC8252 JDRF Kids Online Source: Juvenile Diabetes Research Foundation International http://216.167.3.245/kids/index.html Wizdom Youth Zone Source: American Diabetes Association http://www.diabetes.org/wizdom/
Patient Resources
•
107
From the National Institutes of Health Diabetes Overview Source: National Diabetes Information Clearinghouse http://diabetes.niddk.nih.gov/dm/pubs/overview/index.htm Your Guide to Diabetes: Type 1 and Type 2 Source: National Diabetes Information Clearinghouse http://diabetes.niddk.nih.gov/dm/pubs/type1and2/index.htm
•
Journals/Newsletter Countdown for Kids Magazine Source: Juvenile Diabetes Research Foundation International http://www.jdrf.org/kids/cfk/index.html
•
Latest News ADA Recommends Flu Shots Source: 10/07/2003, American Diabetes Association http://ada.yellowbrix.com/pages/ada/Story.nsp?story_id=42401232&ID=ada Diabetic Tastes Freedom After Cell Transplant Source: 11/12/2003, New York Times Syndicate http://www.nlm.nih.gov//www.nlm.nih.gov/medlineplus/news/fullstory_14626 .html Donor Spleen Cells Save Diabetic Mice Source: 11/13/2003, Reuters Health http://www.nlm.nih.gov//www.nlm.nih.gov/medlineplus/news/fullstory_14664 .html
•
Law and Policy Fighting Discrimination Based on Diabetes Source: American Diabetes Association http://www.diabetes.org/main/community/advocacy/discrimination.jsp Your School and Your Rights Source: American Diabetes Association http://www.diabetes.org/main/type1/parents_kids/away/scrights.jsp
•
Men Diabetes Can Affect Men's Sexual Health http://www.diabetes.org/main/uedocuments/Channel16-Men.pdf
•
Organizations American Diabetes Association http://www.diabetes.org/ CDC's Diabetes Public Health Resource Source: National Center for Chronic Disease Prevention and Health Promotion http://www.cdc.gov/diabetes/
108 Juvenile Diabetes
Juvenile Diabetes Research Foundation International http://www.jdrf.org/ National Diabetes Information Clearinghouse Source: National Institute of Diabetes and Digestive and Kidney Diseases http://diabetes.niddk.nih.gov/ National Institute of Diabetes and Digestive and Kidney Diseases http://www.niddk.nih.gov/ •
Prevention/Screening Diabetes: Preventing Diabetic Complications Source: American Academy of Family Physicians http://familydoctor.org/handouts/356.html GAD (Glutamic Acid Decarboxylase) Test: An Early Screening Test for Type 1 Diabetes? Source: Mayo Foundation for Medical Education and Research http://www.mayoclinic.com/invoke.cfm?id=AN00663
•
Research Diabetes Control and Complications Trial (DCCT) Source: National Diabetes Information Clearinghouse http://diabetes.niddk.nih.gov/dm/pubs/control/index.htm New Resources to Treat Type I Diabetes Source: National Center for Research Resources http://www.nih.gov/news/pr/oct2001/ncrr-10.htm Oral Insulin Does Not Prevent Type 1 Diabetes Source: National Institute of Diabetes and Digestive and Kidney Diseases http://www.nih.gov/news/pr/jun2003/niddk-15.htm Pancreatic Islet Transplantation to Treat Type I Diabetes Source: Food and Drug Administration http://www.fda.gov/cber/genetherapy/pancislet.htm Tight Glucose Control in Diabetes Lowers Risk of Atherosclerosis Source: National Institute of Diabetes and Digestive and Kidney Diseases http://www.nih.gov/news/pr/jun2003/niddk-04.htm Young Adults with Insulin-Treated Diabetes Have Elevated Stroke Risk Source: American Heart Association http://www.americanheart.org/presenter.jhtml?identifier=3007660
•
Statistics National Diabetes Statistics Source: National Diabetes Information Clearinghouse http://diabetes.niddk.nih.gov/dm/pubs/statistics/index.htm
Patient Resources
•
109
Teenagers Dealing with Diabetes Source: Nemours Foundation http://kidshealth.org/teen/diseases_conditions/growth/diabetes.html Diabetes in Children and Adolescents Source: National Diabetes Education Program http://ndep.nih.gov/diabetes/youth/youth_FS.htm Just for Teens Source: American Diabetes Association http://www.diabetes.org/type1/parents_kids/teens/default.jsp
•
Women Diabetes Can Affect Women's Sexual Health http://www.diabetes.org/main/uedocuments/Channel15-Women.pdf
You may also choose to use the search utility provided by MEDLINEplus at the following Web address: http://www.nlm.nih.gov/medlineplus/. Simply type a keyword into the search box and click “Search.” This utility is similar to the NIH search utility, with the exception that it only includes materials that are linked within the MEDLINEplus system (mostly patient-oriented information). It also has the disadvantage of generating unstructured results. We recommend, therefore, that you use this method only if you have a very targeted search. The Combined Health Information Database (CHID) CHID Online is a reference tool that maintains a database directory of thousands of journal articles and patient education guidelines on juvenile diabetes. CHID offers summaries that describe the guidelines available, including contact information and pricing. CHID’s general Web site is http://chid.nih.gov/. To search this database, go to http://chid.nih.gov/detail/detail.html. In particular, you can use the advanced search options to look up pamphlets, reports, brochures, and information kits. The following was recently posted in this archive: •
Major Currents in Juvenile Diabetes Foundation Funded Research Source: New York, NY: Juvenile Diabetes Foundation International. 1997. 2 p. Contact: Available from Juvenile Diabetes Foundation International. 120 Wall Street, 19th Floor, New York, NY 10005-4001. (212) 785-9500. Fax (212) 785-9595. PRICE: Single copy free. Summary: This fact sheet focuses on the work of the Diabetes Interdisciplinary Research Programs (DIRPs) of the Juvenile Diabetes Foundation International (JDFI). These programs, which are currently operating at 26 academic health centers throughout the world, fund a wide range of research activities including the immune causes of diabetes, the alteration of the immune response, genetics, islet cell transplantation, insulin action, and the prevention and reversal of diabetic complications. The fact sheet presents some of the accomplishments and goals of the fourteen programs in seven categories: immunological tolerance, autoimmune pathways, genetic engineering, transplantation, insulin action, complications, and immunological versus genetic causes. (AA-M).
110 Juvenile Diabetes
The National Guideline Clearinghouse™ The National Guideline Clearinghouse™ offers hundreds of evidence-based clinical practice guidelines published in the United States and other countries. You can search this site located at http://www.guideline.gov/ by using the keyword “juvenile diabetes” (or synonyms). The following was recently posted: •
Type I diabetes practice guidelines Source: International Diabetes Center - Private Nonprofit Organization; 2000; 39 pages http://www.guideline.gov/summary/summary.aspx?doc_id=2561&nbr=1787&a mp;string=juvenile+AND+diabetes Healthfinder™
Healthfinder™ is sponsored by the U.S. Department of Health and Human Services and offers links to hundreds of other sites that contain healthcare information. This Web site is located at http://www.healthfinder.gov. Again, keyword searches can be used to find guidelines. The following was recently found in this database: •
Type 1 Diabetes Summary: A general overview of this diabetes type, commonly called juvenile diabetes, even though adults get it too. Diagnosis, management and disorders related to diabetes are discussed. Source: American Diabetes Association http://www.healthfinder.gov/scripts/recordpass.asp?RecordType=0&RecordID=6262 The NIH Search Utility
The NIH search utility allows you to search for documents on over 100 selected Web sites that comprise the NIH-WEB-SPACE. Each of these servers is “crawled” and indexed on an ongoing basis. Your search will produce a list of various documents, all of which will relate in some way to juvenile diabetes. The drawbacks of this approach are that the information is not organized by theme and that the references are often a mix of information for professionals and patients. Nevertheless, a large number of the listed Web sites provide useful background information. We can only recommend this route, therefore, for relatively rare or specific disorders, or when using highly targeted searches. To use the NIH search utility, visit the following Web page: http://search.nih.gov/index.html. Additional Web Sources A number of Web sites are available to the public that often link to government sites. These can also point you in the direction of essential information. The following is a representative sample: •
AOL: http://search.aol.com/cat.adp?id=168&layer=&from=subcats
•
Family Village: http://www.familyvillage.wisc.edu/specific.htm
•
Google: http://directory.google.com/Top/Health/Conditions_and_Diseases/
Patient Resources
•
Med Help International: http://www.medhelp.org/HealthTopics/A.html
•
Open Directory Project: http://dmoz.org/Health/Conditions_and_Diseases/
•
Yahoo.com: http://dir.yahoo.com/Health/Diseases_and_Conditions/
•
WebMD®Health: http://my.webmd.com/health_topics
111
Associations and Juvenile Diabetes The following is a list of associations that provide information on and resources relating to juvenile diabetes: •
Juvenile Diabetes Foundation Australia Telephone: 61 2 9966 0400 Fax: 61 2 9966 0172 Email:
[email protected] Web Site: http://www.jdfa.org.au Background: The Juvenile Diabetes Research Foundation Australia is a not-for-profit organization affiliated with the Juvenile Diabetes Research Foundation International in the United States. Established in 1982, the Foundation is dedicated to funding basic and applied medical research to help discover a cure for diabetes and prevent its complications. Juvenile diabetes, also known as insulin-dependent diabetes or type I diabetes mellitus, is characterized by impaired carbohydrate, fat, and protein metabolism due to deficient production of insulin. This form of diabetes is an autoimmune disease in which insulin-secreting cells of the pancreas are destroyed due to an abnormal immune response. Associated symptoms have an abrupt onset and typically include excessive thirst and urination, weight loss and blurred vision. The Juvenile Diabetes Research Foundation Australia is committed to promoting and supporting scientific research; providing educational resources that are specific to the needs of children, young adults, and family members affected by juvenile diabetes; engaging in advocacy and lobbying efforts; and providing networking opportunities that enable those affected by juvenile diabetes to exchange information, resources, and mutual support.
•
Juvenile Diabetes Research Foundation International Telephone: (212) 785-9500 Toll-free: (800) 533-2873 Fax: (212) 785-2873 Email: info@jdrf@org Web Site: www.jdrf.org Background: The Juvenile Diabetes Research Foundation International (JDRF) is the leading charitable funder and advocate of juvenile (type 1) diabetes research worldwide. The mission of JDRF is to find a cure for diabetes and its complications through the support of research.
112 Juvenile Diabetes
Finding Associations There are several Internet directories that provide lists of medical associations with information on or resources relating to juvenile diabetes. By consulting all of associations listed in this chapter, you will have nearly exhausted all sources for patient associations concerned with juvenile diabetes. The National Health Information Center (NHIC) The National Health Information Center (NHIC) offers a free referral service to help people find organizations that provide information about juvenile diabetes. For more information, see the NHIC’s Web site at http://www.health.gov/NHIC/ or contact an information specialist by calling 1-800-336-4797. Directory of Health Organizations The Directory of Health Organizations, provided by the National Library of Medicine Specialized Information Services, is a comprehensive source of information on associations. The Directory of Health Organizations database can be accessed via the Internet at http://www.sis.nlm.nih.gov/Dir/DirMain.html. It is composed of two parts: DIRLINE and Health Hotlines. The DIRLINE database comprises some 10,000 records of organizations, research centers, and government institutes and associations that primarily focus on health and biomedicine. To access DIRLINE directly, go to the following Web site: http://dirline.nlm.nih.gov/. Simply type in “juvenile diabetes” (or a synonym), and you will receive information on all relevant organizations listed in the database. Health Hotlines directs you to toll-free numbers to over 300 organizations. You can access this database directly at http://www.sis.nlm.nih.gov/hotlines/. On this page, you are given the option to search by keyword or by browsing the subject list. When you have received your search results, click on the name of the organization for its description and contact information. The Combined Health Information Database Another comprehensive source of information on healthcare associations is the Combined Health Information Database. Using the “Detailed Search” option, you will need to limit your search to “Organizations” and “juvenile diabetes”. Type the following hyperlink into your Web browser: http://chid.nih.gov/detail/detail.html. To find associations, use the drop boxes at the bottom of the search page where “You may refine your search by.” For publication date, select “All Years.” Then, select your preferred language and the format option “Organization Resource Sheet.” Type “juvenile diabetes” (or synonyms) into the “For these words:” box. You should check back periodically with this database since it is updated every three months.
Patient Resources
113
The National Organization for Rare Disorders, Inc. The National Organization for Rare Disorders, Inc. has prepared a Web site that provides, at no charge, lists of associations organized by health topic. You can access this database at the following Web site: http://www.rarediseases.org/search/orgsearch.html. Type “juvenile diabetes” (or a synonym) into the search box, and click “Submit Query.”
115
APPENDIX C. FINDING MEDICAL LIBRARIES Overview In this Appendix, we show you how to quickly find a medical library in your area.
Preparation Your local public library and medical libraries have interlibrary loan programs with the National Library of Medicine (NLM), one of the largest medical collections in the world. According to the NLM, most of the literature in the general and historical collections of the National Library of Medicine is available on interlibrary loan to any library. If you would like to access NLM medical literature, then visit a library in your area that can request the publications for you.24
Finding a Local Medical Library The quickest method to locate medical libraries is to use the Internet-based directory published by the National Network of Libraries of Medicine (NN/LM). This network includes 4626 members and affiliates that provide many services to librarians, health professionals, and the public. To find a library in your area, simply visit http://nnlm.gov/members/adv.html or call 1-800-338-7657.
Medical Libraries in the U.S. and Canada In addition to the NN/LM, the National Library of Medicine (NLM) lists a number of libraries with reference facilities that are open to the public. The following is the NLM’s list and includes hyperlinks to each library’s Web site. These Web pages can provide information on hours of operation and other restrictions. The list below is a small sample of
24
Adapted from the NLM: http://www.nlm.nih.gov/psd/cas/interlibrary.html.
116 Juvenile Diabetes
libraries recommended by the National Library of Medicine (sorted alphabetically by name of the U.S. state or Canadian province where the library is located)25: •
Alabama: Health InfoNet of Jefferson County (Jefferson County Library Cooperative, Lister Hill Library of the Health Sciences), http://www.uab.edu/infonet/
•
Alabama: Richard M. Scrushy Library (American Sports Medicine Institute)
•
Arizona: Samaritan Regional Medical Center: The Learning Center (Samaritan Health System, Phoenix, Arizona), http://www.samaritan.edu/library/bannerlibs.htm
•
California: Kris Kelly Health Information Center (St. Joseph Health System, Humboldt), http://www.humboldt1.com/~kkhic/index.html
•
California: Community Health Library of Los Gatos, http://www.healthlib.org/orgresources.html
•
California: Consumer Health Program and Services (CHIPS) (County of Los Angeles Public Library, Los Angeles County Harbor-UCLA Medical Center Library) - Carson, CA, http://www.colapublib.org/services/chips.html
•
California: Gateway Health Library (Sutter Gould Medical Foundation)
•
California: Health Library (Stanford University Medical Center), http://wwwmed.stanford.edu/healthlibrary/
•
California: Patient Education Resource Center - Health Information and Resources (University of California, San Francisco), http://sfghdean.ucsf.edu/barnett/PERC/default.asp
•
California: Redwood Health Library (Petaluma Health Care District), http://www.phcd.org/rdwdlib.html
•
California: Los Gatos PlaneTree Health Library, http://planetreesanjose.org/
•
California: Sutter Resource Library (Sutter Hospitals Foundation, Sacramento), http://suttermedicalcenter.org/library/
•
California: Health Sciences Libraries (University of California, Davis), http://www.lib.ucdavis.edu/healthsci/
•
California: ValleyCare Health Library & Ryan Comer Cancer Resource Center (ValleyCare Health System, Pleasanton), http://gaelnet.stmarysca.edu/other.libs/gbal/east/vchl.html
•
California: Washington Community Health Resource Library (Fremont), http://www.healthlibrary.org/
•
Colorado: William V. Gervasini Memorial Library (Exempla Healthcare), http://www.saintjosephdenver.org/yourhealth/libraries/
•
Connecticut: Hartford Hospital Health Science Libraries (Hartford Hospital), http://www.harthosp.org/library/
•
Connecticut: Healthnet: Connecticut Consumer Health Information Center (University of Connecticut Health Center, Lyman Maynard Stowe Library), http://library.uchc.edu/departm/hnet/
25
Abstracted from http://www.nlm.nih.gov/medlineplus/libraries.html.
Finding Medical Libraries
117
•
Connecticut: Waterbury Hospital Health Center Library (Waterbury Hospital, Waterbury), http://www.waterburyhospital.com/library/consumer.shtml
•
Delaware: Consumer Health Library (Christiana Care Health System, Eugene du Pont Preventive Medicine & Rehabilitation Institute, Wilmington), http://www.christianacare.org/health_guide/health_guide_pmri_health_info.cfm
•
Delaware: Lewis B. Flinn Library (Delaware Academy of Medicine, Wilmington), http://www.delamed.org/chls.html
•
Georgia: Family Resource Library (Medical College of Georgia, Augusta), http://cmc.mcg.edu/kids_families/fam_resources/fam_res_lib/frl.htm
•
Georgia: Health Resource Center (Medical Center of Central Georgia, Macon), http://www.mccg.org/hrc/hrchome.asp
•
Hawaii: Hawaii Medical Library: Consumer Health Information Service (Hawaii Medical Library, Honolulu), http://hml.org/CHIS/
•
Idaho: DeArmond Consumer Health Library (Kootenai Medical Center, Coeur d’Alene), http://www.nicon.org/DeArmond/index.htm
•
Illinois: Health Learning Center of Northwestern Memorial Hospital (Chicago), http://www.nmh.org/health_info/hlc.html
•
Illinois: Medical Library (OSF Saint Francis Medical Center, Peoria), http://www.osfsaintfrancis.org/general/library/
•
Kentucky: Medical Library - Services for Patients, Families, Students & the Public (Central Baptist Hospital, Lexington), http://www.centralbap.com/education/community/library.cfm
•
Kentucky: University of Kentucky - Health Information Library (Chandler Medical Center, Lexington), http://www.mc.uky.edu/PatientEd/
•
Louisiana: Alton Ochsner Medical Foundation Library (Alton Ochsner Medical Foundation, New Orleans), http://www.ochsner.org/library/
•
Louisiana: Louisiana State University Health Sciences Center Medical LibraryShreveport, http://lib-sh.lsuhsc.edu/
•
Maine: Franklin Memorial Hospital Medical Library (Franklin Memorial Hospital, Farmington), http://www.fchn.org/fmh/lib.htm
•
Maine: Gerrish-True Health Sciences Library (Central Maine Medical Center, Lewiston), http://www.cmmc.org/library/library.html
•
Maine: Hadley Parrot Health Science Library (Eastern Maine Healthcare, Bangor), http://www.emh.org/hll/hpl/guide.htm
•
Maine: Maine Medical Center Library (Maine Medical Center, Portland), http://www.mmc.org/library/
•
Maine: Parkview Hospital (Brunswick), http://www.parkviewhospital.org/
•
Maine: Southern Maine Medical Center Health Sciences Library (Southern Maine Medical Center, Biddeford), http://www.smmc.org/services/service.php3?choice=10
•
Maine: Stephens Memorial Hospital’s Health Information Library (Western Maine Health, Norway), http://www.wmhcc.org/Library/
118 Juvenile Diabetes
•
Manitoba, Canada: Consumer & Patient Health Information Service (University of Manitoba Libraries), http://www.umanitoba.ca/libraries/units/health/reference/chis.html
•
Manitoba, Canada: J.W. Crane Memorial Library (Deer Lodge Centre, Winnipeg), http://www.deerlodge.mb.ca/crane_library/about.asp
•
Maryland: Health Information Center at the Wheaton Regional Library (Montgomery County, Dept. of Public Libraries, Wheaton Regional Library), http://www.mont.lib.md.us/healthinfo/hic.asp
•
Massachusetts: Baystate Medical Center Library (Baystate Health System), http://www.baystatehealth.com/1024/
•
Massachusetts: Boston University Medical Center Alumni Medical Library (Boston University Medical Center), http://med-libwww.bu.edu/library/lib.html
•
Massachusetts: Lowell General Hospital Health Sciences Library (Lowell General Hospital, Lowell), http://www.lowellgeneral.org/library/HomePageLinks/WWW.htm
•
Massachusetts: Paul E. Woodard Health Sciences Library (New England Baptist Hospital, Boston), http://www.nebh.org/health_lib.asp
•
Massachusetts: St. Luke’s Hospital Health Sciences Library (St. Luke’s Hospital, Southcoast Health System, New Bedford), http://www.southcoast.org/library/
•
Massachusetts: Treadwell Library Consumer Health Reference Center (Massachusetts General Hospital), http://www.mgh.harvard.edu/library/chrcindex.html
•
Massachusetts: UMass HealthNet (University of Massachusetts Medical School, Worchester), http://healthnet.umassmed.edu/
•
Michigan: Botsford General Hospital Library - Consumer Health (Botsford General Hospital, Library & Internet Services), http://www.botsfordlibrary.org/consumer.htm
•
Michigan: Helen DeRoy Medical Library (Providence Hospital and Medical Centers), http://www.providence-hospital.org/library/
•
Michigan: Marquette General Hospital - Consumer Health Library (Marquette General Hospital, Health Information Center), http://www.mgh.org/center.html
•
Michigan: Patient Education Resouce Center - University of Michigan Cancer Center (University of Michigan Comprehensive Cancer Center, Ann Arbor), http://www.cancer.med.umich.edu/learn/leares.htm
•
Michigan: Sladen Library & Center for Health Information Resources - Consumer Health Information (Detroit), http://www.henryford.com/body.cfm?id=39330
•
Montana: Center for Health Information (St. Patrick Hospital and Health Sciences Center, Missoula)
•
National: Consumer Health Library Directory (Medical Library Association, Consumer and Patient Health Information Section), http://caphis.mlanet.org/directory/index.html
•
National: National Network of Libraries of Medicine (National Library of Medicine) provides library services for health professionals in the United States who do not have access to a medical library, http://nnlm.gov/
•
National: NN/LM List of Libraries Serving the Public (National Network of Libraries of Medicine), http://nnlm.gov/members/
Finding Medical Libraries
119
•
Nevada: Health Science Library, West Charleston Library (Las Vegas-Clark County Library District, Las Vegas), http://www.lvccld.org/special_collections/medical/index.htm
•
New Hampshire: Dartmouth Biomedical Libraries (Dartmouth College Library, Hanover), http://www.dartmouth.edu/~biomed/resources.htmld/conshealth.htmld/
•
New Jersey: Consumer Health Library (Rahway Hospital, Rahway), http://www.rahwayhospital.com/library.htm
•
New Jersey: Dr. Walter Phillips Health Sciences Library (Englewood Hospital and Medical Center, Englewood), http://www.englewoodhospital.com/links/index.htm
•
New Jersey: Meland Foundation (Englewood Hospital and Medical Center, Englewood), http://www.geocities.com/ResearchTriangle/9360/
•
New York: Choices in Health Information (New York Public Library) - NLM Consumer Pilot Project participant, http://www.nypl.org/branch/health/links.html
•
New York: Health Information Center (Upstate Medical University, State University of New York, Syracuse), http://www.upstate.edu/library/hic/
•
New York: Health Sciences Library (Long Island Jewish Medical Center, New Hyde Park), http://www.lij.edu/library/library.html
•
New York: ViaHealth Medical Library (Rochester General Hospital), http://www.nyam.org/library/
•
Ohio: Consumer Health Library (Akron General Medical Center, Medical & Consumer Health Library), http://www.akrongeneral.org/hwlibrary.htm
•
Oklahoma: The Health Information Center at Saint Francis Hospital (Saint Francis Health System, Tulsa), http://www.sfh-tulsa.com/services/healthinfo.asp
•
Oregon: Planetree Health Resource Center (Mid-Columbia Medical Center, The Dalles), http://www.mcmc.net/phrc/
•
Pennsylvania: Community Health Information Library (Milton S. Hershey Medical Center, Hershey), http://www.hmc.psu.edu/commhealth/
•
Pennsylvania: Community Health Resource Library (Geisinger Medical Center, Danville), http://www.geisinger.edu/education/commlib.shtml
•
Pennsylvania: HealthInfo Library (Moses Taylor Hospital, Scranton), http://www.mth.org/healthwellness.html
•
Pennsylvania: Hopwood Library (University of Pittsburgh, Health Sciences Library System, Pittsburgh), http://www.hsls.pitt.edu/guides/chi/hopwood/index_html
•
Pennsylvania: Koop Community Health Information Center (College of Physicians of Philadelphia), http://www.collphyphil.org/kooppg1.shtml
•
Pennsylvania: Learning Resources Center - Medical Library (Susquehanna Health System, Williamsport), http://www.shscares.org/services/lrc/index.asp
•
Pennsylvania: Medical Library (UPMC Health System, Pittsburgh), http://www.upmc.edu/passavant/library.htm
•
Quebec, Canada: Medical Library (Montreal General Hospital), http://www.mghlib.mcgill.ca/
120 Juvenile Diabetes
•
South Dakota: Rapid City Regional Hospital Medical Library (Rapid City Regional Hospital), http://www.rcrh.org/Services/Library/Default.asp
•
Texas: Houston HealthWays (Houston Academy of Medicine-Texas Medical Center Library), http://hhw.library.tmc.edu/
•
Washington: Community Health Library (Kittitas Valley Community Hospital), http://www.kvch.com/
•
Washington: Southwest Washington Medical Center Library (Southwest Washington Medical Center, Vancouver), http://www.swmedicalcenter.com/body.cfm?id=72
121
ONLINE GLOSSARIES The Internet provides access to a number of free-to-use medical dictionaries. The National Library of Medicine has compiled the following list of online dictionaries: •
ADAM Medical Encyclopedia (A.D.A.M., Inc.), comprehensive medical reference: http://www.nlm.nih.gov/medlineplus/encyclopedia.html
•
MedicineNet.com Medical Dictionary (MedicineNet, Inc.): http://www.medterms.com/Script/Main/hp.asp
•
Merriam-Webster Medical Dictionary (Inteli-Health, Inc.): http://www.intelihealth.com/IH/
•
Multilingual Glossary of Technical and Popular Medical Terms in Eight European Languages (European Commission) - Danish, Dutch, English, French, German, Italian, Portuguese, and Spanish: http://allserv.rug.ac.be/~rvdstich/eugloss/welcome.html
•
On-line Medical Dictionary (CancerWEB): http://cancerweb.ncl.ac.uk/omd/
•
Rare Diseases Terms (Office of Rare Diseases): http://ord.aspensys.com/asp/diseases/diseases.asp
•
Technology Glossary (National Library of Medicine) - Health Care Technology: http://www.nlm.nih.gov/nichsr/ta101/ta10108.htm
Beyond these, MEDLINEplus contains a very patient-friendly encyclopedia covering every aspect of medicine (licensed from A.D.A.M., Inc.). The ADAM Medical Encyclopedia can be accessed at http://www.nlm.nih.gov/medlineplus/encyclopedia.html. ADAM is also available on commercial Web sites such as drkoop.com (http://www.drkoop.com/) and Web MD (http://my.webmd.com/adam/asset/adam_disease_articles/a_to_z/a). The NIH suggests the following Web sites in the ADAM Medical Encyclopedia when searching for information on juvenile diabetes: •
Basic Guidelines for Juvenile Diabetes Type I diabetes Web site: http://www.nlm.nih.gov/medlineplus/ency/article/000305.htm
•
Signs & Symptoms for Juvenile Diabetes Abdominal pain Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003120.htm Blindness Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003040.htm Confusion Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003205.htm Convulsions Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003200.htm
122 Juvenile Diabetes
Dizziness Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003093.htm Double vision Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003029.htm Drowsiness Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003208.htm Excessive thirst Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003085.htm Fatigue Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003088.htm Headache Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003024.htm Hunger Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003134.htm Increased appetite Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003134.htm Increased thirst Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003085.htm Increased urination Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003146.htm Lack of coordination Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003198.htm Loss of consciousness Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003202.htm Loss of hair Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003246.htm Menstruation, absent Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003149.htm Nausea Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003117.htm Rapid breathing Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003071.htm Stress Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003211.htm
Online Glossaries 123
Trembling Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003192.htm Vomiting Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003117.htm Weakness Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003174.htm Weight loss Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003107.htm •
Diagnostics and Tests for Juvenile Diabetes Blood glucose Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003482.htm Blood glucose levels Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003482.htm Blood glucose monitoring Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003438.htm Blood-sugar levels Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003482.htm Fasting blood glucose Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003482.htm GLUCAGON Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003716.htm Glucose monitoring Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003438.htm Glycohemoglobin Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003640.htm Glycosylated hemoglobin Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003640.htm Hemoglobin Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003645.htm Hyperglycemia Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003482.htm Insulin test Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003700.htm Random glucose Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003438.htm
124 Juvenile Diabetes
Triglyceride level Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003493.htm Urinalysis Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003579.htm Urine ketones Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003585.htm •
Nutrition for Juvenile Diabetes Carbohydrates Web site: http://www.nlm.nih.gov/medlineplus/ency/article/002469.htm Cholesterol Web site: http://www.nlm.nih.gov/medlineplus/ency/article/002472.htm Fats Web site: http://www.nlm.nih.gov/medlineplus/ency/article/002468.htm Proteins Web site: http://www.nlm.nih.gov/medlineplus/ency/article/002467.htm
•
Background Topics for Juvenile Diabetes Bleeding Web site: http://www.nlm.nih.gov/medlineplus/ency/article/000045.htm Chronic Web site: http://www.nlm.nih.gov/medlineplus/ency/article/002312.htm Diabetes - support group Web site: http://www.nlm.nih.gov/medlineplus/ency/article/002179.htm Diabetic education Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003996.htm Diabetic foot care Web site: http://www.nlm.nih.gov/medlineplus/ency/article/003937.htm Exercise Web site: http://www.nlm.nih.gov/medlineplus/ency/article/001941.htm Iris Web site: http://www.nlm.nih.gov/medlineplus/ency/article/002386.htm Kidney disease Web site: http://www.nlm.nih.gov/medlineplus/ency/article/000457.htm Metabolism Web site: http://www.nlm.nih.gov/medlineplus/ency/article/002257.htm
Online Glossaries 125
Necrosis Web site: http://www.nlm.nih.gov/medlineplus/ency/article/002266.htm PHYSICAL ACTIVITY Web site: http://www.nlm.nih.gov/medlineplus/ency/article/001941.htm Relieved by Web site: http://www.nlm.nih.gov/medlineplus/ency/article/002288.htm Retina Web site: http://www.nlm.nih.gov/medlineplus/ency/article/002291.htm Support group Web site: http://www.nlm.nih.gov/medlineplus/ency/article/002150.htm Unconsciousness Web site: http://www.nlm.nih.gov/medlineplus/ency/article/000022.htm Weight control Web site: http://www.nlm.nih.gov/medlineplus/ency/article/001943.htm
Online Dictionary Directories The following are additional online directories compiled by the National Library of Medicine, including a number of specialized medical dictionaries: •
Medical Dictionaries: Medical & Biological (World Health Organization): http://www.who.int/hlt/virtuallibrary/English/diction.htm#Medical
•
MEL-Michigan Electronic Library List of Online Health and Medical Dictionaries (Michigan Electronic Library): http://mel.lib.mi.us/health/health-dictionaries.html
•
Patient Education: Glossaries (DMOZ Open Directory Project): http://dmoz.org/Health/Education/Patient_Education/Glossaries/
•
Web of Online Dictionaries (Bucknell University): http://www.yourdictionary.com/diction5.html#medicine
127
JUVENILE DIABETES DICTIONARY The definitions below are derived from official public sources, including the National Institutes of Health [NIH] and the European Union [EU]. Abdominal: Having to do with the abdomen, which is the part of the body between the chest and the hips that contains the pancreas, stomach, intestines, liver, gallbladder, and other organs. [NIH] Abdominal Pain: Sensation of discomfort, distress, or agony in the abdominal region. [NIH] Accommodation: Adjustment, especially that of the eye for various distances. [EU] Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak antiinflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage. [NIH] Acetohexamide: A sulfonylurea hypoglycemic agent that is metabolized in the liver to 1hydrohexamide. [NIH] Acyl: Chemical signal used by bacteria to communicate. [NIH] Adaptability: Ability to develop some form of tolerance to conditions extremely different from those under which a living organism evolved. [NIH] Adaptation: 1. The adjustment of an organism to its environment, or the process by which it enhances such fitness. 2. The normal ability of the eye to adjust itself to variations in the intensity of light; the adjustment to such variations. 3. The decline in the frequency of firing of a neuron, particularly of a receptor, under conditions of constant stimulation. 4. In dentistry, (a) the proper fitting of a denture, (b) the degree of proximity and interlocking of restorative material to a tooth preparation, (c) the exact adjustment of bands to teeth. 5. In microbiology, the adjustment of bacterial physiology to a new environment. [EU] Adipose Tissue: Connective tissue composed of fat cells lodged in the meshes of areolar tissue. [NIH] Adjustment: The dynamic process wherein the thoughts, feelings, behavior, and biophysiological mechanisms of the individual continually change to adjust to the environment. [NIH] Adoptive Transfer: Form of passive immunization where previously sensitized immunologic agents (cells or serum) are transferred to non-immune recipients. When transfer of cells is used as a therapy for the treatment of neoplasms, it is called adoptive immunotherapy (immunotherapy, adoptive). [NIH] Adrenal Cortex: The outer layer of the adrenal gland. It secretes mineralocorticoids, androgens, and glucocorticoids. [NIH] Adrenal Medulla: The inner part of the adrenal gland; it synthesizes, stores and releases catecholamines. [NIH] Adrenergic: Activated by, characteristic of, or secreting epinephrine or substances with similar activity; the term is applied to those nerve fibres that liberate norepinephrine at a synapse when a nerve impulse passes, i.e., the sympathetic fibres. [EU] Adverse Effect: An unwanted side effect of treatment. [NIH] Aerobic: In biochemistry, reactions that need oxygen to happen or happen when oxygen is present. [NIH]
128 Juvenile Diabetes
Affinity: 1. Inherent likeness or relationship. 2. A special attraction for a specific element, organ, or structure. 3. Chemical affinity; the force that binds atoms in molecules; the tendency of substances to combine by chemical reaction. 4. The strength of noncovalent chemical binding between two substances as measured by the dissociation constant of the complex. 5. In immunology, a thermodynamic expression of the strength of interaction between a single antigen-binding site and a single antigenic determinant (and thus of the stereochemical compatibility between them), most accurately applied to interactions among simple, uniform antigenic determinants such as haptens. Expressed as the association constant (K litres mole -1), which, owing to the heterogeneity of affinities in a population of antibody molecules of a given specificity, actually represents an average value (mean intrinsic association constant). 6. The reciprocal of the dissociation constant. [EU] Airways: Tubes that carry air into and out of the lungs. [NIH] Albumin: 1. Any protein that is soluble in water and moderately concentrated salt solutions and is coagulable by heat. 2. Serum albumin; the major plasma protein (approximately 60 per cent of the total), which is responsible for much of the plasma colloidal osmotic pressure and serves as a transport protein carrying large organic anions, such as fatty acids, bilirubin, and many drugs, and also carrying certain hormones, such as cortisol and thyroxine, when their specific binding globulins are saturated. Albumin is synthesized in the liver. Low serum levels occur in protein malnutrition, active inflammation and serious hepatic and renal disease. [EU] Albuminuria: More than normal amounts of a protein called albumin in the urine. Albuminuria may be a sign of kidney disease. [NIH] Aldehydes: Organic compounds containing a carbonyl group in the form -CHO. [NIH] Aldosterone: (11 beta)-11,21-Dihydroxy-3,20-dioxopregn-4-en-18-al. A hormone secreted by the adrenal cortex that functions in the regulation of electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. [NIH] Algorithms: A procedure consisting of a sequence of algebraic formulas and/or logical steps to calculate or determine a given task. [NIH] Alimentary: Pertaining to food or nutritive material, or to the organs of digestion. [EU] Alkaline: Having the reactions of an alkali. [EU] Alkaloid: A member of a large group of chemicals that are made by plants and have nitrogen in them. Some alkaloids have been shown to work against cancer. [NIH] Alleles: Mutually exclusive forms of the same gene, occupying the same locus on homologous chromosomes, and governing the same biochemical and developmental process. [NIH] Alpha Particles: Positively charged particles composed of two protons and two neutrons, i.e., helium nuclei, emitted during disintegration of very heavy isotopes; a beam of alpha particles or an alpha ray has very strong ionizing power, but weak penetrability. [NIH] Alternative medicine: Practices not generally recognized by the medical community as standard or conventional medical approaches and used instead of standard treatments. Alternative medicine includes the taking of dietary supplements, megadose vitamins, and herbal preparations; the drinking of special teas; and practices such as massage therapy, magnet therapy, spiritual healing, and meditation. [NIH] Amino Acid Sequence: The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining protein conformation. [NIH] Amino Acids: Organic compounds that generally contain an amino (-NH2) and a carboxyl (-
Dictionary 129
COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. [NIH] Amino Acids: Organic compounds that generally contain an amino (-NH2) and a carboxyl (COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. [NIH] Analgesic: An agent that alleviates pain without causing loss of consciousness. [EU] Analog: In chemistry, a substance that is similar, but not identical, to another. [NIH] Analytes: A component of a test sample the presence of which has to be demonstrated. The term "analyte" includes where appropriate formed from the analyte during the analyses. [NIH]
Anaphylatoxins: The family of peptides C3a, C4a, C5a, and C5a des-arginine produced in the serum during complement activation. They produce smooth muscle contraction, mast cell histamine release, affect platelet aggregation, and act as mediators of the local inflammatory process. The order of anaphylatoxin activity from strongest to weakest is C5a, C3a, C4a, and C5a des-arginine. The latter is the so-called "classical" anaphylatoxin but shows no spasmogenic activity though it contains some chemotactic ability. [NIH] Anatomical: Pertaining to anatomy, or to the structure of the organism. [EU] Anergy: Absence of immune response to particular substances. [NIH] Anesthetics: Agents that are capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general anesthesia, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. [NIH] Angina: Chest pain that originates in the heart. [NIH] Angiography: Radiography of blood vessels after injection of a contrast medium. [NIH] Animal model: An animal with a disease either the same as or like a disease in humans. Animal models are used to study the development and progression of diseases and to test new treatments before they are given to humans. Animals with transplanted human cancers or other tissues are called xenograft models. [NIH] Anions: Negatively charged atoms, radicals or groups of atoms which travel to the anode or positive pole during electrolysis. [NIH] Anomalies: Birth defects; abnormalities. [NIH] Antibacterial: A substance that destroys bacteria or suppresses their growth or reproduction. [EU] Antibiotic: A drug used to treat infections caused by bacteria and other microorganisms. [NIH]
Antibodies: Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the antigen that induced their synthesis in cells of the lymphoid series (especially plasma cells), or with an antigen closely related to it. [NIH] Antibody: A type of protein made by certain white blood cells in response to a foreign substance (antigen). Each antibody can bind to only a specific antigen. The purpose of this binding is to help destroy the antigen. Antibodies can work in several ways, depending on the nature of the antigen. Some antibodies destroy antigens directly. Others make it easier for white blood cells to destroy the antigen. [NIH] Antigen: Any substance which is capable, under appropriate conditions, of inducing a specific immune response and of reacting with the products of that response, that is, with specific antibody or specifically sensitized T-lymphocytes, or both. Antigens may be soluble
130 Juvenile Diabetes
substances, such as toxins and foreign proteins, or particulate, such as bacteria and tissue cells; however, only the portion of the protein or polysaccharide molecule known as the antigenic determinant (q.v.) combines with antibody or a specific receptor on a lymphocyte. Abbreviated Ag. [EU] Antigen-Antibody Complex: The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes immune complex diseases. [NIH] Antigen-presenting cell: APC. A cell that shows antigen on its surface to other cells of the immune system. This is an important part of an immune response. [NIH] Anti-inflammatory: Having to do with reducing inflammation. [NIH] Antipyretic: An agent that relieves or reduces fever. Called also antifebrile, antithermic and febrifuge. [EU] Antispasmodic: An agent that relieves spasm. [EU] Antiviral: Destroying viruses or suppressing their replication. [EU] Anxiety: Persistent feeling of dread, apprehension, and impending disaster. [NIH] Apolipoproteins: The protein components of lipoproteins which remain after the lipids to which the proteins are bound have been removed. They play an important role in lipid transport and metabolism. [NIH] Aqueous: Having to do with water. [NIH] Arginine: An essential amino acid that is physiologically active in the L-form. [NIH] Arterial: Pertaining to an artery or to the arteries. [EU] Arteries: The vessels carrying blood away from the heart. [NIH] Arterioles: The smallest divisions of the arteries located between the muscular arteries and the capillaries. [NIH] Artificial Pancreas: A large machine used in hospitals that constantly measures glucose (sugar) in the blood and, in response, releases the right amount of insulin. Scientists are also working to develop a small unit that could be implanted in the body, functioning like a real pancreas. [NIH] Ascorbic Acid: A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant. [NIH] Aspartic: The naturally occurring substance is L-aspartic acid. One of the acidic-amino-acids is obtained by the hydrolysis of proteins. [NIH] Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter. [NIH] Asymptomatic: Having no signs or symptoms of disease. [NIH] Atrophic Gastritis: Chronic irritation of the stomach lining. Causes the stomach lining and glands to wither away. [NIH] Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. [NIH] Atropine: A toxic alkaloid, originally from Atropa belladonna, but found in other plants,
Dictionary 131
mainly Solanaceae. [NIH] Attenuated: Strain with weakened or reduced virulence. [NIH] Auditory: Pertaining to the sense of hearing. [EU] Autoantibodies: Antibodies that react with self-antigens (autoantigens) of the organism that produced them. [NIH] Autoantigens: Endogenous tissue constituents that have the ability to interact with autoantibodies and cause an immune response. [NIH] Autoimmune disease: A condition in which the body recognizes its own tissues as foreign and directs an immune response against them. [NIH] Autoimmunity: Process whereby the immune system reacts against the body's own tissues. Autoimmunity may produce or be caused by autoimmune diseases. [NIH] Autologous: Taken from an individual's own tissues, cells, or DNA. [NIH] Autonomic: Self-controlling; functionally independent. [EU] Autonomic Nervous System: The enteric, parasympathetic, and sympathetic nervous systems taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the central nervous system, especially the hypothalamus and the solitary nucleus, which receive information relayed from visceral afferents; these and related central and sensory structures are sometimes (but not here) considered to be part of the autonomic nervous system itself. [NIH] Autonomic Neuropathy: A disease of the nerves affecting mostly the internal organs such as the bladder muscles, the cardiovascular system, the digestive tract, and the genital organs. These nerves are not under a person's conscious control and function automatically. Also called visceral neuropathy. [NIH] Autopsy: Postmortem examination of the body. [NIH] Axons: Nerve fibers that are capable of rapidly conducting impulses away from the neuron cell body. [NIH] Backcross: A cross between a hybrid and either one of its parents. [NIH] Bacteria: Unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. [NIH] Bacterial Physiology: Physiological processes and activities of bacteria. [NIH] Bacteriuria: The presence of bacteria in the urine with or without consequent urinary tract infection. Since bacteriuria is a clinical entity, the term does not preclude the use of urine/microbiology for technical discussions on the isolation and segregation of bacteria in the urine. [NIH] Base: In chemistry, the nonacid part of a salt; a substance that combines with acids to form salts; a substance that dissociates to give hydroxide ions in aqueous solutions; a substance whose molecule or ion can combine with a proton (hydrogen ion); a substance capable of donating a pair of electrons (to an acid) for the formation of a coordinate covalent bond. [EU] Basement Membrane: Ubiquitous supportive tissue adjacent to epithelium and around smooth and striated muscle cells. This tissue contains intrinsic macromolecular components such as collagen, laminin, and sulfated proteoglycans. As seen by light microscopy one of its subdivisions is the basal (basement) lamina. [NIH] Benign: Not cancerous; does not invade nearby tissue or spread to other parts of the body. [NIH]
132 Juvenile Diabetes
Bile: An emulsifying agent produced in the liver and secreted into the duodenum. Its composition includes bile acids and salts, cholesterol, and electrolytes. It aids digestion of fats in the duodenum. [NIH] Bilirubin: A bile pigment that is a degradation product of heme. [NIH] Biochemical: Relating to biochemistry; characterized by, produced by, or involving chemical reactions in living organisms. [EU] Biological Markers: Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc. [NIH] Biological response modifier: BRM. A substance that stimulates the body's response to infection and disease. [NIH] Biological Transport: The movement of materials (including biochemical substances and drugs) across cell membranes and epithelial layers, usually by passive diffusion. [NIH] Biopsy: Removal and pathologic examination of specimens in the form of small pieces of tissue from the living body. [NIH] Biotechnology: Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., genetic engineering) is a central focus; laboratory methods used include transfection and cloning technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction. [NIH] Bladder: The organ that stores urine. [NIH] Bleeding Time: Duration of blood flow after skin puncture. This test is used as a measure of capillary and platelet function. [NIH] Blood Coagulation: The process of the interaction of blood coagulation factors that results in an insoluble fibrin clot. [NIH] Blood Glucose: Glucose in blood. [NIH] Blood pressure: The pressure of blood against the walls of a blood vessel or heart chamber. Unless there is reference to another location, such as the pulmonary artery or one of the heart chambers, it